| 1st level
|
2nd level
|
3rd level
|
4th level
|
5th level
|
Contents
|
| A
|
|
|
|
|
Alimentary tract and metabolism
|
|
|
A01
|
|
|
|
Stomatological preparations
|
|
|
|
A01A
|
|
|
Stomatological preparations
|
|
|
|
|
A01AA
|
|
Caries prophylactic agents
|
|
|
|
|
|
A01AA01
|
Sodium fluoride
|
|
|
|
|
|
A01AA02
|
Sodium monofluorophosphate
|
|
|
|
|
|
A01AA03
|
Olaflur
|
|
|
|
|
|
A01AA04
|
Stannous fluoride
|
|
|
|
|
|
A01AA30
|
Combinations
|
|
|
|
|
|
A01AA51
|
Sodium fluoride, combinations
|
|
|
|
|
A01AB
|
|
Anti-infectives and antiseptics for local oral treatment
|
|
|
|
|
|
A01AB02
|
Hydrogen peroxide
|
|
|
|
|
|
A01AB03
|
Chlorhexidine
|
|
|
|
|
|
A01AB04
|
Amphotericin B
|
|
|
|
|
|
A01AB05
|
Polynoxylin
|
|
|
|
|
|
A01AB06
|
Domiphen
|
|
|
|
|
|
A01AB07
|
Oxyquinoline
|
|
|
|
|
|
A01AB08
|
Neomycin
|
|
|
|
|
|
A01AB09
|
Miconazole
|
|
|
|
|
|
A01AB10
|
Natamycin
|
|
|
|
|
|
A01AB11
|
Various
|
|
|
|
|
|
A01AB12
|
Hexetidine
|
|
|
|
|
|
A01AB13
|
Tetracycline
|
|
|
|
|
|
A01AB14
|
Benzoxonium chloride
|
|
|
|
|
|
A01AB15
|
Tibezonium iodide
|
|
|
|
|
|
A01AB16
|
Mepartricin
|
|
|
|
|
|
A01AB17
|
Metronidazole
|
|
|
|
|
|
A01AB18
|
Clotrimazole
|
|
|
|
|
|
A01AB19
|
Sodium perborate
|
|
|
|
|
|
A01AB21
|
Chlortetracycline
|
|
|
|
|
|
A01AB22
|
Doxycycline
|
|
|
|
|
|
A01AB23
|
Minocycline
|
|
|
|
|
A01AC
|
|
Corticosteroids for local oral treatment
|
|
|
|
|
|
A01AC01
|
Triamcinolone
|
|
|
|
|
|
A01AC02
|
Dexamethasone
|
|
|
|
|
|
A01AC03
|
Hydrocortisone
|
|
|
|
|
|
A01AC54
|
Prednisolone, combinations
|
|
|
|
|
A01AD
|
|
Other agents for local oral treatment
|
|
|
|
|
|
A01AD01
|
Epinephrine
|
|
|
|
|
|
A01AD02
|
Benzydamine
|
|
|
|
|
|
A01AD05
|
Acetylsalicylic acid
|
|
|
|
|
|
A01AD06
|
Adrenalone
|
|
|
|
|
|
A01AD07
|
Amlexanox
|
|
|
|
|
|
A01AD08
|
Becaplermin
|
|
|
|
|
|
A01AD11
|
Various
|
|
|
A02
|
|
|
|
Drugs for acid related disorders
|
|
|
|
A02A
|
|
|
Antacids
|
|
|
|
|
A02AA
|
|
Magnesium compounds
|
|
|
|
|
|
A02AA01
|
Magnesium carbonate
|
|
|
|
|
|
A02AA02
|
Magnesium oxide
|
|
|
|
|
|
A02AA03
|
Magnesium peroxide
|
|
|
|
|
|
A02AA04
|
Magnesium hydroxide
|
|
|
|
|
|
A02AA05
|
Magnesium silicate
|
|
|
|
|
|
A02AA10
|
Combinations
|
|
|
|
|
A02AB
|
|
Aluminium compounds
|
|
|
|
|
|
A02AB01
|
Aluminium hydroxide
|
|
|
|
|
|
A02AB02
|
Algeldrate
|
|
|
|
|
|
A02AB03
|
Aluminium phosphate
|
|
|
|
|
|
A02AB04
|
Dihydroxialumini sodium carbonate
|
|
|
|
|
|
A02AB05
|
Aluminium acetoacetate
|
|
|
|
|
|
A02AB06
|
Aloglutamol
|
|
|
|
|
|
A02AB07
|
Aluminium glycinate
|
|
|
|
|
|
A02AB10
|
Combinations
|
|
|
|
|
A02AC
|
|
Calcium compounds
|
|
|
|
|
|
A02AC01
|
Calcium carbonate
|
|
|
|
|
|
A02AC02
|
Calcium silicate
|
|
|
|
|
|
A02AC10
|
Combinations
|
|
|
|
|
A02AD
|
|
Combinations and complexes of aluminium, calcium and magnesium compounds
|
|
|
|
|
|
A02AD01
|
Ordinary salt combinations
|
|
|
|
|
|
A02AD02
|
Magaldrate
|
|
|
|
|
|
A02AD03
|
Almagate
|
|
|
|
|
|
A02AD04
|
Hydrotalcite
|
|
|
|
|
|
A02AD05
|
Almasilate
|
|
|
|
|
A02AF
|
|
Antacids with antiflatulents
|
|
|
|
|
|
A02AF01
|
Magaldrate and antiflatulents
|
|
|
|
|
|
A02AF02
|
Ordinary salt combinations and antiflatulents
|
|
|
|
|
A02AG
|
|
Antacids with antispasmodics
|
|
|
|
|
|
|
Empty
|
|
|
|
|
A02AH
|
|
Antacids with sodium bicarbonate
|
|
|
|
|
|
|
Empty
|
|
|
|
|
A02AX
|
|
Antacids, other combinations
|
|
|
|
|
|
|
Empty
|
|
|
|
A02B
|
|
|
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
A02BA
|
|
H2-receptor antagonists
|
|
|
|
|
|
A02BA01
|
Cimetidine
|
|
|
|
|
|
A02BA02
|
Ranitidine
|
|
|
|
|
|
A02BA03
|
Famotidine
|
|
|
|
|
|
A02BA04
|
Nizatidine
|
|
|
|
|
|
A02BA05
|
Niperotidine
|
|
|
|
|
|
A02BA06
|
Roxatidine
|
|
|
|
|
|
A02BA07
|
Ranitidine bismuth citrate
|
|
|
|
|
|
A02BA08
|
Lafutidine
|
|
|
|
|
|
A02BA51
|
Cimetidine, combinations
|
|
|
|
|
|
A02BA53
|
Famotidine, combinations
|
|
|
|
|
A02BB
|
|
Prostaglandins
|
|
|
|
|
|
A02BB01
|
Misoprostol
|
|
|
|
|
|
A02BB02
|
Enprostil
|
|
|
|
|
A02BC
|
|
Proton pump inhibitors
|
|
|
|
|
|
A02BC01
|
Omeprazole
|
|
|
|
|
|
A02BC02
|
Pantoprazole
|
|
|
|
|
|
A02BC03
|
Lansoprazole
|
|
|
|
|
|
A02BC04
|
Rabeprazole
|
|
|
|
|
|
A02BC05
|
Esomeprazole
|
|
|
|
|
|
A02BC06
|
Dexlansoprazole
|
|
|
|
|
A02BD
|
|
Combinations for eradication of Helicobacter pylori
|
|
|
|
|
|
A02BD01
|
Omeprazole, amoxicillin and metronidazole
|
|
|
|
|
|
A02BD02
|
Lansoprazole, tetracycline and metronidazole
|
|
|
|
|
|
A02BD03
|
Lansoprazole, amoxicillin and metronidazole
|
|
|
|
|
|
A02BD04
|
Pantoprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD05
|
Omeprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD06
|
Esomeprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD07
|
Lansoprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD08
|
Bismuth subcitrate, tetracycline and metronidazole
|
|
|
|
|
A02BX
|
|
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
|
A02BX01
|
Carbenoxolone
|
|
|
|
|
|
A02BX02
|
Sucralfate
|
|
|
|
|
|
A02BX03
|
Pirenzepine
|
|
|
|
|
|
A02BX04
|
Methiosulfonium chloride
|
|
|
|
|
|
A02BX05
|
Bismuth subcitrate
|
|
|
|
|
|
A02BX06
|
Proglumide
|
|
|
|
|
|
A02BX07
|
Gefarnate
|
|
|
|
|
|
A02BX08
|
Sulglicotide
|
|
|
|
|
|
A02BX09
|
Acetoxolone
|
|
|
|
|
|
A02BX10
|
Zolimidine
|
|
|
|
|
|
A02BX11
|
Troxipide
|
|
|
|
|
|
A02BX12
|
Bismuth subnitrate
|
|
|
|
|
|
A02BX13
|
Alginic acid
|
|
|
|
|
|
A02BX51
|
Carbenoxolone, combinations excluding psycholeptics
|
|
|
|
|
|
A02BX71
|
Carbenoxolone, combinations with psycholeptics
|
|
|
|
|
|
A02BX77
|
Gefarnate, combinations with psycholeptics
|
|
|
|
A02X
|
|
|
Other drugs for acid related disorders
|
|
|
|
|
|
|
Empty
|
|
|
A03
|
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
A03A
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
|
A03AA
|
|
Synthetic anticholinergics, esters with tertiary amino group
|
|
|
|
|
|
A03AA01
|
Oxyphencyclimine
|
|
|
|
|
|
A03AA03
|
Camylofin
|
|
|
|
|
|
A03AA04
|
Mebeverine
|
|
|
|
|
|
A03AA05
|
Trimebutine
|
|
|
|
|
|
A03AA06
|
Rociverine
|
|
|
|
|
|
A03AA07
|
Dicycloverine
|
|
|
|
|
|
A03AA08
|
Dihexyverine
|
|
|
|
|
|
A03AA09
|
Difemerine
|
|
|
|
|
|
A03AA30
|
Piperidolate
|
|
|
|
|
A03AB
|
|
Synthetic anticholinergics, quaternary ammonium compounds
|
|
|
|
|
|
A03AB01
|
Benzilone
|
|
|
|
|
|
A03AB02
|
Glycopyrronium
|
|
|
|
|
|
A03AB03
|
Oxyphenonium
|
|
|
|
|
|
A03AB04
|
Penthienate
|
|
|
|
|
|
A03AB05
|
Propantheline
|
|
|
|
|
|
A03AB06
|
Otilonium bromide
|
|
|
|
|
|
A03AB07
|
Methantheline
|
|
|
|
|
|
A03AB08
|
Tridihexethyl
|
|
|
|
|
|
A03AB09
|
Isopropamide
|
|
|
|
|
|
A03AB10
|
Hexocyclium
|
|
|
|
|
|
A03AB11
|
Poldine
|
|
|
|
|
|
A03AB12
|
Mepenzolate
|
|
|
|
|
|
A03AB13
|
Bevonium
|
|
|
|
|
|
A03AB14
|
Pipenzolate
|
|
|
|
|
|
A03AB15
|
Diphemanil
|
|
|
|
|
|
A03AB16
|
(2-benzhydryloxyethyl)diethyl-methylammonium iodide
|
|
|
|
|
|
A03AB17
|
Tiemonium iodide
|
|
|
|
|
|
A03AB18
|
Prifinium bromide
|
|
|
|
|
|
A03AB19
|
Timepidium bromide
|
|
|
|
|
|
A03AB21
|
Fenpiverinium
|
|
|
|
|
|
A03AB53
|
Oxyphenonium, combinations
|
|
|
|
|
A03AC
|
|
Synthetic antispasmodics, amides with tertiary amines
|
|
|
|
|
|
A03AC02
|
Dimethylaminopropionylphenothiazine
|
|
|
|
|
|
A03AC04
|
Nicofetamide
|
|
|
|
|
|
A03AC05
|
Tiropramide
|
|
|
|
|
A03AD
|
|
Papaverine and derivatives
|
|
|
|
|
|
A03AD01
|
Papaverine
|
|
|
|
|
|
A03AD02
|
Drotaverine
|
|
|
|
|
|
A03AD30
|
Moxaverine
|
|
|
|
|
A03AE
|
|
Serotonin receptor antagonists
|
|
|
|
|
|
A03AE01
|
Alosetron
|
|
|
|
|
|
A03AE03
|
Cilansetron
|
|
|
|
|
A03AX
|
|
Other drugs for functional gastrointestinal disorders
|
|
|
|
|
|
A03AX01
|
Fenpiprane
|
|
|
|
|
|
A03AX02
|
Diisopromine
|
|
|
|
|
|
A03AX03
|
Chlorbenzoxamine
|
|
|
|
|
|
A03AX04
|
Pinaverium
|
|
|
|
|
|
A03AX05
|
Fenoverine
|
|
|
|
|
|
A03AX06
|
Idanpramine
|
|
|
|
|
|
A03AX07
|
Proxazole
|
|
|
|
|
|
A03AX08
|
Alverine
|
|
|
|
|
|
A03AX09
|
Trepibutone
|
|
|
|
|
|
A03AX10
|
Isometheptene
|
|
|
|
|
|
A03AX11
|
Caroverine
|
|
|
|
|
|
A03AX12
|
Phloroglucinol
|
|
|
|
|
|
A03AX13
|
Silicones
|
|
|
|
|
|
A03AX30
|
Trimethyldiphenylpropylamine
|
|
|
|
|
|
A03AX58
|
Alverine, combinations
|
|
|
|
A03B
|
|
|
Belladonna and derivatives, plain
|
|
|
|
|
A03BA
|
|
Belladonna alkaloids, tertiary amines
|
|
|
|
|
|
A03BA01
|
Atropine
|
|
|
|
|
|
A03BA03
|
Hyoscyamine
|
|
|
|
|
|
A03BA04
|
Belladonna total alkaloids
|
|
|
|
|
A03BB
|
|
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
|
|
|
|
|
|
A03BB01
|
Butylscopolamine
|
|
|
|
|
|
A03BB02
|
Methylatropine
|
|
|
|
|
|
A03BB03
|
Methylscopolamine
|
|
|
|
|
|
A03BB04
|
Fentonium
|
|
|
|
|
|
A03BB05
|
Cimetropium bromide
|
|
|
|
A03C
|
|
|
Antispasmodics in combination with psycholeptics
|
|
|
|
|
A03CA
|
|
Synthetic anticholinergic agents in combination with psycholeptics
|
|
|
|
|
|
A03CA01
|
Isopropamide and psycholeptics
|
|
|
|
|
|
A03CA02
|
Clidinium and psycholeptics
|
|
|
|
|
|
A03CA03
|
Oxyphencyclimine and psycholeptics
|
|
|
|
|
|
A03CA04
|
Otilonium bromide and psycholeptics
|
|
|
|
|
|
A03CA05
|
Glycopyrronium and psycholeptics
|
|
|
|
|
|
A03CA06
|
Bevonium and psycholeptics
|
|
|
|
|
|
A03CA07
|
Ambutonium and psycholeptics
|
|
|
|
|
|
A03CA08
|
Diphemanil and psycholeptics
|
|
|
|
|
|
A03CA30
|
Emepronium and psycholeptics
|
|
|
|
|
|
A03CA34
|
Propantheline and psycholeptics
|
|
|
|
|
A03CB
|
|
Belladonna and derivatives in combination with psycholeptics
|
|
|
|
|
|
A03CB01
|
Methylscopolamine and psycholeptics
|
|
|
|
|
|
A03CB02
|
Belladonna total alkaloids and psycholeptics
|
|
|
|
|
|
A03CB03
|
Atropine and psycholeptics
|
|
|
|
|
|
A03CB04
|
Methylhomatropine and psycholeptics
|
|
|
|
|
|
A03CB31
|
Hyoscyamine and psycholeptics
|
|
|
|
|
A03CC
|
|
Other antispasmodics in combination with psycholeptics
|
|
|
|
|
|
|
empty
|
|
|
|
A03D
|
|
|
Antispasmodics in combination with analgesics
|
|
|
|
|
A03DA
|
|
Synthetic anticholinergic agents in combination with analgesics
|
|
|
|
|
|
A03DA01
|
Tropenzilone and analgesics
|
|
|
|
|
|
A03DA02
|
Pitofenone and analgesics
|
|
|
|
|
|
A03DA03
|
Bevonium and analgesics
|
|
|
|
|
|
A03DA04
|
Ciclonium and analgesics
|
|
|
|
|
|
A03DA05
|
Camylofin and analgesics
|
|
|
|
|
|
A03DA06
|
Trospium and analgesics
|
|
|
|
|
|
A03DA07
|
Tiemonium iodide and analgesics
|
|
|
|
|
A03DB
|
|
Belladonna and derivatives in combination with analgesics
|
|
|
|
|
|
A03DB04
|
Butylscopolamine and analgesics
|
|
|
|
|
A03DC
|
|
Other antispasmodics in combination with analgesics
|
|
|
|
|
|
|
empty
|
|
|
|
A03E
|
|
|
Antispasmodics and anticholinergics in combination with other drugs
|
|
|
|
|
A03EA
|
|
Antispasmodics, psycholeptics and analgesics in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
A03ED
|
|
Antispasmodics in combination with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
A03F
|
|
|
Propulsives
|
|
|
|
|
A03FA
|
|
Propulsives
|
|
|
|
|
|
A03FA01
|
Metoclopramide
|
|
|
|
|
|
A03FA02
|
Cisapride
|
|
|
|
|
|
A03FA03
|
Domperidone
|
|
|
|
|
|
A03FA04
|
Bromopride
|
|
|
|
|
|
A03FA05
|
Alizapride
|
|
|
|
|
|
A03FA06
|
Clebopride
|
|
|
A04
|
|
|
|
Antiemetics and antinauseants
|
|
|
|
A04A
|
|
|
Antiemetics and antinauseants
|
|
|
|
|
A04AA
|
|
Serotonin (5-HT3) antagonists
|
|
|
|
|
|
A04AA01
|
Ondansetron
|
|
|
|
|
|
A04AA02
|
Granisetron
|
|
|
|
|
|
A04AA03
|
Tropisetron
|
|
|
|
|
|
A04AA04
|
Dolasetron
|
|
|
|
|
|
A04AA05
|
Palonosetron
|
|
|
|
|
A04AD
|
|
Other antiemetics
|
|
|
|
|
|
A04AD01
|
Scopolamine
|
|
|
|
|
|
A04AD02
|
Cerium oxalate
|
|
|
|
|
|
A04AD04
|
Chlorobutanol
|
|
|
|
|
|
A04AD05
|
Metopimazine
|
|
|
|
|
|
A04AD10
|
Dronabinol
|
|
|
|
|
|
A04AD11
|
Nabilone
|
|
|
|
|
|
A04AD12
|
Aprepitant
|
|
|
|
|
|
A04AD13
|
Casopitant
|
|
|
|
|
|
A04AD51
|
Scopolamine, combinations
|
|
|
|
|
|
A04AD54
|
Chlorobutanol, combinations
|
|
|
A05
|
|
|
|
Bile and liver therapy
|
|
|
|
A05A
|
|
|
Bile therapy
|
|
|
|
|
A05AA
|
|
Bile acid preparations
|
|
|
|
|
|
A05AA01
|
Chenodeoxycholic acid
|
|
|
|
|
|
A05AA02
|
Ursodeoxycholic acid
|
|
|
|
|
|
A05AA03
|
Cholic acid
|
|
|
|
|
A05AB
|
|
Preparations for biliary tract therapy
|
|
|
|
|
|
A05AB01
|
Nicotinyl methylamide
|
|
|
|
|
A05AX
|
|
Other drugs for bile therapy
|
|
|
|
|
|
A05AX01
|
Piprozolin
|
|
|
|
|
|
A05AX02
|
Hymecromone
|
|
|
|
|
|
A05AX03
|
Cyclobutyrol
|
|
|
|
A05B
|
|
|
Liver therapy, lipotropics
|
|
|
|
|
A05BA
|
|
Liver therapy
|
|
|
|
|
|
A05BA01
|
Arginine glutamate
|
|
|
|
|
|
A05BA03
|
Silymarin
|
|
|
|
|
|
A05BA04
|
Citiolone
|
|
|
|
|
|
A05BA05
|
Epomediol
|
|
|
|
|
|
A05BA06
|
Ornithine oxoglutarate
|
|
|
|
|
|
A05BA07
|
Tidiacic arginine
|
|
|
|
|
|
A05BA08
|
Glycyrrhizic acid (glycyrrhizin)
|
|
|
|
A05C
|
|
|
Drugs for bile therapy and lipotropics in combination
|
|
|
|
|
|
|
Empty
|
|
|
A06
|
|
|
|
Drugs for constipation
|
|
|
|
A06A
|
|
|
Drugs for constipation
|
|
|
|
|
A06AA
|
|
Softeners, emollients
|
|
|
|
|
|
A06AA01
|
Liquid paraffin
|
|
|
|
|
|
A06AA02
|
Docusate sodium
|
|
|
|
|
|
A06AA51
|
Liquid paraffin, combinations
|
|
|
|
|
A06AB
|
|
Contact laxatives
|
|
|
|
|
|
A06AB01
|
Oxyphenisatine
|
|
|
|
|
|
A06AB02
|
Bisacodyl
|
|
|
|
|
|
A06AB03
|
Dantron
|
|
|
|
|
|
A06AB04
|
Phenolphthalein
|
|
|
|
|
|
A06AB05
|
Castor oil
|
|
|
|
|
|
A06AB06
|
Senna glycosides
|
|
|
|
|
|
A06AB07
|
Cascara
|
|
|
|
|
|
A06AB08
|
Sodium picosulfate
|
|
|
|
|
|
A06AB09
|
Bisoxatin
|
|
|
|
|
|
A06AB20
|
Contact laxatives in combination
|
|
|
|
|
|
A06AB30
|
Contact laxatives in combination with belladonna alkaloids
|
|
|
|
|
|
A06AB52
|
Bisacodyl, combinations
|
|
|
|
|
|
A06AB53
|
Dantron, combinations
|
|
|
|
|
|
A06AB56
|
Senna glycosides, combinations
|
|
|
|
|
|
A06AB57
|
Cascara, combinations
|
|
|
|
|
|
A06AB58
|
Sodium picosulfate, combinations
|
|
|
|
|
A06AC
|
|
Bulk-forming laxatives
|
|
|
|
|
|
A06AC01
|
Ispaghula (psylla seeds)
|
|
|
|
|
|
A06AC02
|
Ethulose
|
|
|
|
|
|
A06AC03
|
Sterculia
|
|
|
|
|
|
A06AC05
|
Linseed
|
|
|
|
|
|
A06AC06
|
Methylcellulose
|
|
|
|
|
|
A06AC07
|
Triticum (wheat fibre)
|
|
|
|
|
|
A06AC08
|
Polycarbophil calcium
|
|
|
|
|
|
A06AC51
|
Ispaghula, combinations
|
|
|
|
|
|
A06AC53
|
Sterculia, combinations
|
|
|
|
|
|
A06AC55
|
Linseed, combinations
|
|
|
|
|
A06AD
|
|
Osmotically acting laxatives
|
|
|
|
|
|
A06AD01
|
Magnesium carbonate
|
|
|
|
|
|
A06AD02
|
Magnesium oxide
|
|
|
|
|
|
A06AD03
|
Magnesium peroxide
|
|
|
|
|
|
A06AD04
|
Magnesium sulfate
|
|
|
|
|
|
A06AD10
|
Mineral salts in combination
|
|
|
|
|
|
A06AD11
|
Lactulose
|
|
|
|
|
|
A06AD12
|
Lactitol
|
|
|
|
|
|
A06AD13
|
Sodium sulfate
|
|
|
|
|
|
A06AD14
|
Pentaerithrityl
|
|
|
|
|
|
A06AD15
|
Macrogol
|
|
|
|
|
|
A06AD16
|
Mannitol
|
|
|
|
|
|
A06AD17
|
Sodium phosphate
|
|
|
|
|
|
A06AD18
|
Sorbitol
|
|
|
|
|
|
A06AD19
|
Magnesium citrate
|
|
|
|
|
|
A06AD21
|
Sodium tartrate
|
|
|
|
|
|
A06AD61
|
Lactulose, combinations
|
|
|
|
|
|
A06AD65
|
Macrogol, combinations
|
|
|
|
|
A06AG
|
|
Enemas
|
|
|
|
|
|
A06AG01
|
Sodium phosphate
|
|
|
|
|
|
A06AG02
|
Bisacodyl
|
|
|
|
|
|
A06AG03
|
Dantron, including combinations
|
|
|
|
|
|
A06AG04
|
Glycerol
|
|
|
|
|
|
A06AG06
|
Oil
|
|
|
|
|
|
A06AG07
|
Sorbitol
|
|
|
|
|
|
A06AG10
|
Docusate sodium, including combinations
|
|
|
|
|
|
A06AG11
|
Laurilsulfate, including combinations
|
|
|
|
|
|
A06AG20
|
Combinations
|
|
|
|
|
A06AH
|
|
Peripheral opioid receptor antagonists
|
|
|
|
|
|
A06AH01
|
Methylnaltrexone bromide
|
|
|
|
|
|
A06AH02
|
Alvimopan
|
|
|
|
|
A06AX
|
|
Other drugs for constipation
|
|
|
|
|
|
A06AX01
|
Glycerol
|
|
|
|
|
|
A06AX02
|
Carbon dioxide producing drugs
|
|
|
|
|
|
A06AX03
|
Lubiprostone
|
|
|
|
|
|
A06AX04
|
Linaclotide
|
|
|
|
|
|
A06AX05
|
Prucalopride
|
|
|
|
|
|
A06AX06
|
Tegaserod
|
|
|
A07
|
|
|
|
Antidiarrheals, intestinal anti-inflammatory/anti-infective agents
|
|
|
|
A07A
|
|
|
Intestinal anti-infectives
|
|
|
|
|
A07AA
|
|
Antibiotics
|
|
|
|
|
|
A07AA01
|
Neomycin
|
|
|
|
|
|
A07AA02
|
Nystatin
|
|
|
|
|
|
A07AA03
|
Natamycin
|
|
|
|
|
|
A07AA04
|
Streptomycin
|
|
|
|
|
|
A07AA05
|
Polymyxin B
|
|
|
|
|
|
A07AA06
|
Paromomycin
|
|
|
|
|
|
A07AA07
|
Amphotericin B
|
|
|
|
|
|
A07AA08
|
Kanamycin
|
|
|
|
|
|
A07AA09
|
Vancomycin
|
|
|
|
|
|
A07AA10
|
Colistin
|
|
|
|
|
|
A07AA11
|
Rifaximin
|
|
|
|
|
|
A07AA12
|
Fidaxomicin
|
|
|
|
|
|
A07AA51
|
Neomycin, combinations
|
|
|
|
|
|
A07AA54
|
Streptomycin, combinations
|
|
|
|
|
A07AB
|
|
Sulfonamides
|
|
|
|
|
|
A07AB02
|
Phthalylsulfathiazole
|
|
|
|
|
|
A07AB03
|
Sulfaguanidine
|
|
|
|
|
|
A07AB04
|
Succinylsulfathiazole
|
|
|
|
|
A07AC
|
|
Imidazole derivatives
|
|
|
|
|
|
A07AC01
|
Miconazole
|
|
|
|
|
A07AX
|
|
Other intestinal anti-infectives
|
|
|
|
|
|
A07AX01
|
Broxyquinoline
|
|
|
|
|
|
A07AX02
|
Acetarsol
|
|
|
|
|
|
A07AX03
|
Nifuroxazide
|
|
|
|
|
|
A07AX04
|
Nifurzide
|
|
|
|
A07B
|
|
|
Intestinal adsorbents
|
|
|
|
|
A07BA
|
|
Charcoal preparations
|
|
|
|
|
|
A07BA01
|
Medicinal charcoal
|
|
|
|
|
|
A07BA51
|
Medicinal charcoal, combinations
|
|
|
|
|
A07BB
|
|
Bismuth preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
A07BC
|
|
Other intestinal adsorbents
|
|
|
|
|
|
A07BC01
|
Pectin
|
|
|
|
|
|
A07BC02
|
Kaolin
|
|
|
|
|
|
A07BC03
|
Crospovidone
|
|
|
|
|
|
A07BC04
|
Attapulgite
|
|
|
|
|
|
A07BC05
|
Diosmectite
|
|
|
|
|
|
A07BC30
|
Combinations
|
|
|
|
|
|
A07BC54
|
Attapulgite, combinations
|
|
|
|
A07C
|
|
|
Electrolytes with carbohydrates
|
|
|
|
|
A07CA
|
|
Oral rehydration salt formulations
|
|
|
|
|
|
|
human ATC classification.
|
|
|
|
A07D
|
|
|
Antipropulsives
|
|
|
|
|
A07DA
|
|
Antipropulsives
|
|
|
|
|
|
A07DA01
|
Diphenoxylate
|
|
|
|
|
|
A07DA02
|
Opium
|
|
|
|
|
|
A07DA03
|
Loperamide
|
|
|
|
|
|
A07DA04
|
Difenoxin
|
|
|
|
|
|
A07DA05
|
Loperamide oxide
|
|
|
|
|
|
A07DA52
|
Morphine, combinations
|
|
|
|
|
|
A07DA53
|
Loperamide, combinations
|
|
|
|
A07E
|
|
|
Intestinal anti-inflammatory agents
|
|
|
|
|
A07EA
|
|
Corticosteroids acting locally
|
|
|
|
|
|
A07EA01
|
Prednisolone
|
|
|
|
|
|
A07EA02
|
Hydrocortisone
|
|
|
|
|
|
A07EA03
|
Prednisone
|
|
|
|
|
|
A07EA04
|
Betamethasone
|
|
|
|
|
|
A07EA05
|
Tixocortol
|
|
|
|
|
|
A07EA06
|
Budesonide
|
|
|
|
|
|
A07EA07
|
Beclometasone
|
|
|
|
|
A07EB
|
|
Antiallergic agents, excluding corticosteroids
|
|
|
|
|
|
A07EB01
|
Cromoglicic acid
|
|
|
|
|
A07EC
|
|
Aminosalicylic acid and similar agents
|
|
|
|
|
|
A07EC01
|
Sulfasalazine
|
|
|
|
|
|
A07EC02
|
Mesalazine
|
|
|
|
|
|
A07EC03
|
Olsalazine
|
|
|
|
|
|
A07EC04
|
Balsalazide
|
|
|
|
A07F
|
|
|
Antidiarrheal micro-organisms
|
|
|
|
|
A07FA
|
|
Antidiarrheal micro-organisms
|
|
|
|
|
|
A07FA01
|
Lactic acid producing organisms
|
|
|
|
|
|
A07FA02
|
Saccharomyces boulardii
|
|
|
|
|
|
A07FA51
|
Lactic acid producing organisms, combinations
|
|
|
|
A07X
|
|
|
Other antidiarrheals
|
|
|
|
|
A07XA
|
|
Other antidiarrheals
|
|
|
|
|
|
A07XA01
|
Albumin tannate
|
|
|
|
|
|
A07XA02
|
Ceratonia
|
|
|
|
|
|
A07XA03
|
Calcium compounds
|
|
|
|
|
|
A07XA04
|
Racecadotril
|
|
|
|
|
|
A07XA51
|
Albumin tannate, combinations
|
|
|
A08
|
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
A08A
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
|
A08AA
|
|
Centrally acting antiobesity products
|
|
|
|
|
|
A08AA01
|
Phentermine
|
|
|
|
|
|
A08AA02
|
Fenfluramine
|
|
|
|
|
|
A08AA03
|
Amfepramone
|
|
|
|
|
|
A08AA04
|
Dexfenfluramine
|
|
|
|
|
|
A08AA05
|
Mazindol
|
|
|
|
|
|
A08AA06
|
Etilamfetamine
|
|
|
|
|
|
A08AA07
|
Cathine
|
|
|
|
|
|
A08AA08
|
Clobenzorex
|
|
|
|
|
|
A08AA09
|
Mefenorex
|
|
|
|
|
|
A08AA10
|
Sibutramine
|
|
|
|
|
|
A08AA56
|
Ephedrine, combinations
|
|
|
|
|
A08AB
|
|
Peripherally acting antiobesity products
|
|
|
|
|
|
A08AB01
|
Orlistat
|
|
|
|
|
A08AX
|
|
Other antiobesity drugs
|
|
|
|
|
|
A08AX01
|
Rimonabant
|
|
|
A09
|
|
|
|
Digestives,including enzymes
|
|
|
|
A09A
|
|
|
Digestives, including enzymes
|
|
|
|
|
A09AA
|
|
Enzyme preparations
|
|
|
|
|
|
A09AA01
|
Diastase
|
|
|
|
|
|
A09AA02
|
Multienzymes (lipase, protease, etc.)
|
|
|
|
|
|
A09AA03
|
Pepsin
|
|
|
|
|
|
A09AA04
|
Tilactase
|
|
|
|
|
A09AB
|
|
Acid preparations
|
|
|
|
|
|
A09AB01
|
Glutamic acid hydrochloride
|
|
|
|
|
|
A09AB02
|
Betaine hydrochloride
|
|
|
|
|
|
A09AB03
|
Hydrochloric acid
|
|
|
|
|
|
A09AB04
|
Citric acid
|
|
|
|
|
A09AC
|
|
Enzyme and acid preparations, combinations
|
|
|
|
|
|
A09AC01
|
Pepsin and acid preparations
|
|
|
|
|
|
A09AC02
|
Multienzymes and acid preparations
|
|
|
A10
|
|
|
|
Drugs used in diabetes
|
|
|
|
A10A
|
|
|
Insulins and analogues
|
|
|
|
|
A10AB
|
|
Insulins and analogues for injection, fast-acting
|
|
|
|
|
|
A10AB01
|
Insulin (human)
|
|
|
|
|
|
A10AB02
|
Insulin (beef)
|
|
|
|
|
|
A10AB03
|
Insulin (pork)
|
|
|
|
|
|
A10AB04
|
Insulin lispro
|
|
|
|
|
|
A10AB05
|
Insulin aspart
|
|
|
|
|
|
A10AB06
|
Insulin glulisine
|
|
|
|
|
|
A10AB30
|
Combinations
|
|
|
|
|
A10AC
|
|
Insulins and analogues for injection, intermediate-acting
|
|
|
|
|
|
A10AC01
|
Insulin (human)
|
|
|
|
|
|
A10AC02
|
Insulin (beef)
|
|
|
|
|
|
A10AC03
|
Insulin (pork)
|
|
|
|
|
|
A10AC04
|
Insulin lispro
|
|
|
|
|
|
A10AC30
|
Combinations
|
|
|
|
|
A10AD
|
|
Insulins and analogues for injection, intermediate-acting combined with fast-acting
|
|
|
|
|
|
A10AD01
|
Insulin (human)
|
|
|
|
|
|
A10AD02
|
Insulin (beef)
|
|
|
|
|
|
A10AD03
|
Insulin (pork)
|
|
|
|
|
|
A10AD04
|
Insulin lispro
|
|
|
|
|
|
A10AD05
|
Insulin aspart
|
|
|
|
|
|
A10AD30
|
Combinations
|
|
|
|
|
A10AE
|
|
Insulins and analogues for injection, long-acting
|
|
|
|
|
|
A10AE01
|
Insulin (human)
|
|
|
|
|
|
A10AE02
|
Insulin (beef)
|
|
|
|
|
|
A10AE03
|
Insulin (pork)
|
|
|
|
|
|
A10AE04
|
Insulin glargine
|
|
|
|
|
|
A10AE05
|
Insulin detemir
|
|
|
|
|
|
A10AE30
|
Combinations
|
|
|
|
|
A10AF
|
|
Insulins and analogues for inhalation
|
|
|
|
|
|
A10AF01
|
Insulin (human)
|
|
|
|
A10B
|
|
|
Blood glucose lowering drugs, excluding insulins
|
|
|
|
|
A10BA
|
|
Biguanides
|
|
|
|
|
|
A10BA01
|
Phenformin
|
|
|
|
|
|
A10BA02
|
Metformin
|
|
|
|
|
|
A10BA03
|
Buformin
|
|
|
|
|
A10BB
|
|
Sulfonamides, urea derivatives
|
|
|
|
|
|
A10BB01
|
Glibenclamide
|
|
|
|
|
|
A10BB02
|
Chlorpropamide
|
|
|
|
|
|
A10BB03
|
Tolbutamide
|
|
|
|
|
|
A10BB04
|
Glibornuride
|
|
|
|
|
|
A10BB05
|
Tolazamide
|
|
|
|
|
|
A10BB06
|
Carbutamide
|
|
|
|
|
|
A10BB07
|
Glipizide
|
|
|
|
|
|
A10BB08
|
Gliquidone
|
|
|
|
|
|
A10BB09
|
Gliclazide
|
|
|
|
|
|
A10BB10
|
Metahexamide
|
|
|
|
|
|
A10BB11
|
Glisoxepide
|
|
|
|
|
|
A10BB12
|
Glimepiride
|
|
|
|
|
|
A10BB31
|
Acetohexamide
|
|
|
|
|
A10BC
|
|
Sulfonamides (heterocyclic)
|
|
|
|
|
|
A10BC01
|
Glymidine
|
|
|
|
|
A10BD
|
|
Combinations of oral blood glucose lowering drugs
|
|
|
|
|
|
A10BD01
|
Phenformin and sulfonamides
|
|
|
|
|
|
A10BD02
|
Metformin and sulfonamides
|
|
|
|
|
|
A10BD03
|
Metformin and rosiglitazone
|
|
|
|
|
|
A10BD04
|
Glimepiride and rosiglitazone
|
|
|
|
|
|
A10BD05
|
Metformin and pioglitazone
|
|
|
|
|
|
A10BD06
|
Glimepiride and pioglitazone
|
|
|
|
|
|
A10BD07
|
Metformin and sitagliptin
|
|
|
|
|
|
A10BD08
|
Metformin and vildagliptin
|
|
|
|
|
|
A10BD09
|
Pioglitazone and alogliptin
|
|
|
|
|
|
A10BD10
|
Metformin and saxagliptin
|
|
|
|
|
|
A10BD11
|
Metformin and linagliptin
|
|
|
|
|
|
A10BD12
|
Pioglitazone and sitagliptin
|
|
|
|
|
|
A10BD13
|
Metformin and alogliptin
|
|
|
|
|
A10BF
|
|
Alpha glucosidase inhibitors
|
|
|
|
|
|
A10BF01
|
Acarbose
|
|
|
|
|
|
A10BF02
|
Miglitol
|
|
|
|
|
|
A10BF03
|
Voglibose
|
|
|
|
|
A10BG
|
|
Thiazolidinediones
|
|
|
|
|
|
A10BG01
|
Troglitazone
|
|
|
|
|
|
A10BG02
|
Rosiglitazone
|
|
|
|
|
|
A10BG03
|
Pioglitazone
|
|
|
|
|
A10BH
|
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
|
|
|
|
|
A10BH01
|
Sitagliptin
|
|
|
|
|
|
A10BH02
|
Vildagliptin
|
|
|
|
|
|
A10BH03
|
Saxagliptin
|
|
|
|
|
|
A10BH04
|
Alogliptin
|
|
|
|
|
|
A10BH05
|
Linagliptin
|
|
|
|
|
|
A10BH51
|
Sitagliptin and simvastatin
|
|
|
|
|
A10BX
|
|
Other blood glucose lowering drugs, excluding insulins
|
|
|
|
|
|
A10BX01
|
Guar gum
|
|
|
|
|
|
A10BX02
|
Repaglinide
|
|
|
|
|
|
A10BX03
|
Nateglinide
|
|
|
|
|
|
A10BX04
|
Exenatide
|
|
|
|
|
|
A10BX05
|
Pramlintide
|
|
|
|
|
|
A10BX06
|
Benfluorex
|
|
|
|
|
|
A10BX07
|
Liraglutide
|
|
|
|
|
|
A10BX08
|
Mitiglinide
|
|
|
|
|
|
A10BX09
|
Dapagliflozin
|
|
|
|
A10X
|
|
|
Other drugs used in diabetes
|
|
|
|
|
A10XA
|
|
Aldose reductase inhibitors
|
|
|
|
|
|
A10XA01
|
Tolrestat
|
|
|
A11
|
|
|
|
Vitamins
|
|
|
|
A11A
|
|
|
Multivitamins, combinations
|
|
|
|
|
A11AA
|
|
Multivitamins with minerals
|
|
|
|
|
|
A11AA01
|
Multivitamins and iron
|
|
|
|
|
|
A11AA02
|
Multivitamins and calcium
|
|
|
|
|
|
A11AA03
|
Multivitamins and other minerals, including combinations
|
|
|
|
|
|
A11AA04
|
Multivitamins and trace elements
|
|
|
|
|
A11AB
|
|
Multivitamins, other combinations
|
|
|
|
|
|
|
empty
|
|
|
|
A11B
|
|
|
Multivitamins, plain
|
|
|
|
|
A11BA
|
|
Multivitamins, plain
|
|
|
|
|
|
|
empty
|
|
|
|
A11C
|
|
|
Vitamin A and D, including combinations of the two
|
|
|
|
|
A11CA
|
|
Vitamin A, plain
|
|
|
|
|
|
A11CA01
|
Retinol (vitamin A)
|
|
|
|
|
|
A11CA02
|
Betacarotene
|
|
|
|
|
A11CB
|
|
Vitamin A and D in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11CC
|
|
Vitamin D and analogues
|
|
|
|
|
|
A11CC01
|
Ergocalciferol
|
|
|
|
|
|
A11CC02
|
Dihydrotachysterol
|
|
|
|
|
|
A11CC03
|
Alfacalcidol
|
|
|
|
|
|
A11CC04
|
Calcitriol
|
|
|
|
|
|
A11CC05
|
Colecalciferol
|
|
|
|
|
|
A11CC06
|
Calcifediol
|
|
|
|
|
|
A11CC20
|
Combinations
|
|
|
|
A11D
|
|
|
Vitamin B1, plain and in combination with vitamin B6 and B12
|
|
|
|
|
A11DA
|
|
Vitamin B1, plain
|
|
|
|
|
|
A11DA01
|
Thiamine (vitamin B1)
|
|
|
|
|
|
A11DA02
|
Sulbutiamine
|
|
|
|
|
|
A11DA03
|
Benfotiamine
|
|
|
|
|
A11DB
|
|
Vitamin B1 in combination with vitamin B6 and/or vitamin B12
|
|
|
|
|
|
|
empty
|
|
|
|
A11E
|
|
|
Vitamin B-complex, including combinations
|
|
|
|
|
A11EA
|
|
Vitamin B-complex, plain
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EB
|
|
Vitamin B-complex with vitamin C
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EC
|
|
Vitamin B-complex with minerals
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11ED
|
|
Vitamin B-complex with anabolic steroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EX
|
|
Vitamin B-complex, other combinations
|
|
|
|
|
|
|
empty
|
|
|
|
A11G
|
|
|
Ascorbic acid (vitamin C), including combinations
|
|
|
|
|
A11GA
|
|
Ascorbic acid (vitamin C), plain
|
|
|
|
|
|
A11GA01
|
Ascorbic acid (vitamin C)
|
|
|
|
|
A11GB
|
|
Ascorbic acid (vitamin C), combinations
|
|
|
|
|
|
A11GB01
|
Ascorbic acid (vitamin C) and calcium
|
|
|
|
A11H
|
|
|
Other plain vitamin preparations
|
|
|
|
|
A11HA
|
|
Other plain vitamin preparations A11HA01 Nicotinamide
|
|
|
|
|
|
A11HA02
|
Pyridoxine (vitamin B6)
|
|
|
|
|
|
A11HA03
|
Tocopherol (vitamin E)
|
|
|
|
|
|
A11HA04
|
Riboflavin (vitamin B2)
|
|
|
|
|
|
A11HA05
|
Biotin
|
|
|
|
|
|
A11HA06
|
Pyridoxal phosphate
|
|
|
|
|
|
A11HA07
|
Inositol
|
|
|
|
|
|
A11HA08
|
Tocofersolan
|
|
|
|
|
|
A11HA30
|
Dexpanthenol
|
|
|
|
|
|
A11HA31
|
Calcium pantothenate
|
|
|
|
|
|
A11HA32
|
Pantethine
|
|
|
|
A11J
|
|
|
Other vitamin products, combinations
|
|
|
|
|
A11JA
|
|
Combinations of vitamins
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11JB
|
|
Vitamins with minerals
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11JC
|
|
Vitamins, other combinations
|
|
|
|
|
|
|
empty
|
|
|
A12
|
|
|
|
Mineral supplements
|
|
|
|
A12A
|
|
|
Calcium
|
|
|
|
|
A12AA
|
|
Calcium
|
|
|
|
|
|
A12AA01
|
Calcium phosphate
|
|
|
|
|
|
A12AA02
|
Calcium glubionate
|
|
|
|
|
|
A12AA03
|
Calcium gluconate
|
|
|
|
|
|
A12AA04
|
Calcium carbonate
|
|
|
|
|
|
A12AA05
|
Calcium lactate
|
|
|
|
|
|
A12AA06
|
Calcium lactate gluconate
|
|
|
|
|
|
A12AA07
|
Calcium chloride
|
|
|
|
|
|
A12AA08
|
Calcium glycerylphosphate
|
|
|
|
|
|
A12AA09
|
Calcium citrate lysine complex
|
|
|
|
|
|
A12AA10
|
Calcium glucoheptonate
|
|
|
|
|
|
A12AA11
|
Calcium pangamate
|
|
|
|
|
|
A12AA12
|
Calcium acetate anhydrous
|
|
|
|
|
|
A12AA20
|
Calcium (different salts in combination)
|
|
|
|
|
|
A12AA30
|
Calcium laevulate
|
|
|
|
|
A12AX
|
|
Calcium, combinations with vitamin D and/or other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
A12B
|
|
|
Potassium
|
|
|
|
|
A12BA
|
|
Potassium
|
|
|
|
|
|
A12BA01
|
Potassium chloride
|
|
|
|
|
|
A12BA02
|
Potassium citrate
|
|
|
|
|
|
A12BA03
|
Potassium hydrogentartrate
|
|
|
|
|
|
A12BA04
|
Potassium hydrogencarbonate
|
|
|
|
|
|
A12BA05
|
Potassium gluconate
|
|
|
|
|
|
A12BA30
|
Combinations
|
|
|
|
|
|
A12BA51
|
Potassium chloride, combinations
|
|
|
|
A12C
|
|
|
Other mineral supplements
|
|
|
|
|
A12CA
|
|
Sodium
|
|
|
|
|
|
A12CA01
|
Sodium chloride
|
|
|
|
|
|
A12CA02
|
Sodium sulfate
|
|
|
|
|
A12CB
|
|
Zinc
|
|
|
|
|
|
A12CB01
|
Zinc sulfate
|
|
|
|
|
|
A12CB02
|
Zinc gluconate
|
|
|
|
|
|
A12CB03
|
Zinc protein complex
|
|
|
|
|
A12CC
|
|
Magnesium
|
|
|
|
|
|
A12CC01
|
Magnesium chloride
|
|
|
|
|
|
A12CC02
|
Magnesium sulfate
|
|
|
|
|
|
A12CC03
|
Magnesium gluconate
|
|
|
|
|
|
A12CC04
|
Magnesium citrate
|
|
|
|
|
|
A12CC05
|
Magnesium aspartate
|
|
|
|
|
|
A12CC06
|
Magnesium lactate
|
|
|
|
|
|
A12CC07
|
Magnesium levulinate
|
|
|
|
|
|
A12CC08
|
Magnesium pidolate
|
|
|
|
|
|
A12CC09
|
Magnesium orotate
|
|
|
|
|
|
A12CC10
|
Magnesium oxide
|
|
|
|
|
|
A12CC30
|
Magnesium (different salts in combination)
|
|
|
|
|
A12CD
|
|
Fluoride
|
|
|
|
|
|
A12CD01
|
Sodium fluoride
|
|
|
|
|
|
A12CD02
|
Sodium monofluorophosphate
|
|
|
|
|
|
A12CD51
|
Fluoride, combinations
|
|
|
|
|
A12CE
|
|
Selenium
|
|
|
|
|
|
A12CE01
|
Sodium selenate
|
|
|
|
|
|
A12CE02
|
Sodium selenite
|
|
|
|
|
A12CX
|
|
Other mineral products
|
|
|
|
|
|
|
empty
|
|
|
A13
|
|
|
|
Tonics
|
|
|
|
A13A
|
|
|
Tonics
|
|
|
|
|
|
|
empty
|
|
|
A14
|
|
|
|
Anabolic agents for systemic use
|
|
|
|
A14A
|
|
|
Anabolic steroids
|
|
|
|
|
A14AA
|
|
Androstan derivatives
|
|
|
|
|
|
A14AA01
|
Androstanolone
|
|
|
|
|
|
A14AA02
|
Stanozolol
|
|
|
|
|
|
A14AA03
|
Metandienone
|
|
|
|
|
|
A14AA04
|
Metenolone
|
|
|
|
|
|
A14AA05
|
Oxymetholone
|
|
|
|
|
|
A14AA06
|
Quinbolone
|
|
|
|
|
|
A14AA07
|
Prasterone
|
|
|
|
|
|
A14AA08
|
Oxandrolone
|
|
|
|
|
|
A14AA09
|
Norethandrolone
|
|
|
|
|
A14AB
|
|
Estren derivatives
|
|
|
|
|
|
A14AB01
|
Nandrolone
|
|
|
|
|
|
A14AB02
|
Ethylestrenol
|
|
|
|
|
|
A14AB03
|
Oxabolone cipionate
|
|
|
|
A14B
|
|
|
Other anabolic agents
|
|
|
|
|
|
|
empty
|
|
|
A15
|
|
|
|
Appetite stimulants
|
|
|
|
|
|
|
empty
|
|
|
A16
|
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
A16A
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
|
A16AA
|
|
Amino acids and derivatives
|
|
|
|
|
|
A16AA01
|
Levocarnitine
|
|
|
|
|
|
A16AA02
|
Ademetionine
|
|
|
|
|
|
A16AA03
|
Levoglutamide
|
|
|
|
|
|
A16AA04
|
Mercaptamine
|
|
|
|
|
|
A16AA05
|
Carglumic acid
|
|
|
|
|
|
A16AA06
|
Betaine
|
|
|
|
|
A16AB
|
|
Enzymes
|
|
|
|
|
|
A16AB01
|
Alglucerase
|
|
|
|
|
|
A16AB02
|
Imiglucerase
|
|
|
|
|
|
A16AB03
|
Agalsidase alfa
|
|
|
|
|
|
A16AB04
|
Agalsidase beta
|
|
|
|
|
|
A16AB05
|
Laronidase
|
|
|
|
|
|
A16AB06
|
Sacrosidase
|
|
|
|
|
|
A16AB07
|
Alglucosidase alfa
|
|
|
|
|
|
A16AB08
|
Galsulfase
|
|
|
|
|
|
A16AB09
|
Idursulfase
|
|
|
|
|
|
A16AB10
|
Velaglucerase alfa
|
|
|
|
|
|
A16AB11
|
Taliglucerase alfa
|
|
|
|
|
A16AX
|
|
Various alimentary tract and metabolism products
|
|
|
|
|
|
A16AX01
|
Thioctic acid
|
|
|
|
|
|
A16AX02
|
Anethole trithione
|
|
|
|
|
|
A16AX03
|
Sodium phenylbutyrate
|
|
|
|
|
|
A16AX04
|
Nitisinone
|
|
|
|
|
|
A16AX05
|
Zinc acetate
|
|
|
|
|
|
A16AX06
|
Miglustat
|
|
|
|
|
|
A16AX07
|
Sapropterin
|
|
|
|
|
|
A16AX08
|
Teduglutide
|
|
|
|
|
|
A16AX09
|
Glycerol phenylbutyrate
|
| B
|
|
|
|
|
Blood and blood forming organs
|
|
|
B01
|
|
|
|
Antithrombotic agents
|
|
|
|
B01A
|
|
|
Antithrombotic agents
|
|
|
|
|
B01AA
|
|
Vitamin K antagonists
|
|
|
|
|
|
B01AA01
|
Dicoumarol
|
|
|
|
|
|
B01AA02
|
Phenindione
|
|
|
|
|
|
B01AA03
|
Warfarin
|
|
|
|
|
|
B01AA04
|
Phenprocoumon
|
|
|
|
|
|
B01AA07
|
Acenocoumarol
|
|
|
|
|
|
B01AA08
|
Ethyl biscoumacetate
|
|
|
|
|
|
B01AA09
|
Clorindione
|
|
|
|
|
|
B01AA10
|
Diphenadione
|
|
|
|
|
|
B01AA11
|
Tioclomarol
|
|
|
|
|
|
B01AA12
|
Fluindione
|
|
|
|
|
B01AB
|
|
Heparin group
|
|
|
|
|
|
B01AB01
|
Heparin
|
|
|
|
|
|
B01AB02
|
Antithrombin III
|
|
|
|
|
|
B01AB04
|
Dalteparin
|
|
|
|
|
|
B01AB05
|
Enoxaparin
|
|
|
|
|
|
B01AB06
|
Nadroparin
|
|
|
|
|
|
B01AB07
|
Parnaparin
|
|
|
|
|
|
B01AB08
|
Reviparin
|
|
|
|
|
|
B01AB09
|
Danaparoid
|
|
|
|
|
|
B01AB10
|
Tinzaparin
|
|
|
|
|
|
B01AB11
|
Sulodexide
|
|
|
|
|
|
B01AB12
|
Bemiparin
|
|
|
|
|
|
B01AB51
|
Heparin, combinations
|
|
|
|
|
B01AC
|
|
Platelet aggregation inhibitors excluding heparin
|
|
|
|
|
|
B01AC01
|
Ditazole
|
|
|
|
|
|
B01AC02
|
Cloricromen
|
|
|
|
|
|
B01AC03
|
Picotamide
|
|
|
|
|
|
B01AC04
|
Clopidogrel
|
|
|
|
|
|
B01AC05
|
Ticlopidine
|
|
|
|
|
|
B01AC06
|
Acetylsalicylic acid
|
|
|
|
|
|
B01AC07
|
Dipyridamole
|
|
|
|
|
|
B01AC08
|
Carbasalate calcium
|
|
|
|
|
|
B01AC09
|
Epoprostenol
|
|
|
|
|
|
B01AC10
|
Indobufen
|
|
|
|
|
|
B01AC11
|
Iloprost
|
|
|
|
|
|
B01AC13
|
Abciximab
|
|
|
|
|
|
B01AC15
|
Aloxiprin
|
|
|
|
|
|
B01AC16
|
Eptifibatide
|
|
|
|
|
|
B01AC17
|
Tirofiban
|
|
|
|
|
|
B01AC18
|
Triflusal
|
|
|
|
|
|
B01AC19
|
Beraprost
|
|
|
|
|
|
B01AC21
|
Treprostinil
|
|
|
|
|
|
B01AC22
|
Prasugrel
|
|
|
|
|
|
B01AC23
|
Cilostazol
|
|
|
|
|
|
B01AC24
|
Ticagrelor
|
|
|
|
|
|
B01AC30
|
Combinations
|
|
|
|
|
|
B01AC56
|
Acetylsalicylic acid and esomeprazole
|
|
|
|
|
B01AD
|
|
Enzymes
|
|
|
|
|
|
B01AD01
|
Streptokinase
|
|
|
|
|
|
B01AD02
|
Alteplase
|
|
|
|
|
|
B01AD03
|
Anistreplase
|
|
|
|
|
|
B01AD04
|
Urokinase
|
|
|
|
|
|
B01AD05
|
Fibrinolysin
|
|
|
|
|
|
B01AD06
|
Brinase
|
|
|
|
|
|
B01AD07
|
Reteplase
|
|
|
|
|
|
B01AD08
|
Saruplase
|
|
|
|
|
|
B01AD09
|
Ancrod
|
|
|
|
|
|
B01AD10
|
Drotrecogin alfa (activated)
|
|
|
|
|
|
B01AD11
|
Tenecteplase
|
|
|
|
|
|
B01AD12
|
Protein C
|
|
|
|
|
B01AE
|
|
Direct thrombin inhibitors
|
|
|
|
|
|
B01AE01
|
Desirudin
|
|
|
|
|
|
B01AE02
|
Lepirudin
|
|
|
|
|
|
B01AE03
|
Argatroban
|
|
|
|
|
|
B01AE04
|
Melagatran
|
|
|
|
|
|
B01AE05
|
Ximelagatran
|
|
|
|
|
|
B01AE06
|
Bivalirudin
|
|
|
|
|
|
B01AE07
|
Dabigatran etexilate
|
|
|
|
|
B01AF
|
|
Direct factor Xa inhibitors
|
|
|
|
|
|
B01AF01
|
Rivaroxaban
|
|
|
|
|
|
B01AF02
|
Apixaban
|
|
|
|
|
B01AX
|
|
Other antithrombotic agents
|
|
|
|
|
|
B01AX01
|
Defibrotide
|
|
|
|
|
|
B01AX04
|
Dermatan sulfate
|
|
|
|
|
|
B01AX05
|
Fondaparinux
|
|
|
B02
|
|
|
|
Antihemorrhagics
|
|
|
|
B02A
|
|
|
Antifibrinolytics
|
|
|
|
|
B02AA
|
|
Amino acids
|
|
|
|
|
|
B02AA01
|
Aminocaproic acid
|
|
|
|
|
|
B02AA02
|
Tranexamic acid
|
|
|
|
|
|
B02AA03
|
Aminomethylbenzoic acid
|
|
|
|
|
B02AB
|
|
Proteinase inhibitors
|
|
|
|
|
|
B02AB01
|
Aprotinin
|
|
|
|
|
|
B02AB02
|
Alfa1 antitrypsin
|
|
|
|
|
|
B02AB04
|
Camostat
|
|
|
|
B02B
|
|
|
Vitamin K and other hemostatics
|
|
|
|
|
B02BA
|
|
Vitamin K
|
|
|
|
|
|
B02BA01
|
Phytomenadione
|
|
|
|
|
|
B02BA02
|
Menadione
|
|
|
|
|
B02BB
|
|
Fibrinogen
|
|
|
|
|
|
B02BB01
|
Human fibrinogen
|
|
|
|
|
B02BC
|
|
Local hemostatics
|
|
|
|
|
|
B02BC01
|
Absorbable gelatin sponge
|
|
|
|
|
|
B02BC02
|
Oxidized cellulose
|
|
|
|
|
|
B02BC03
|
Tetragalacturonic acid hydroxymethylester
|
|
|
|
|
|
B02BC05
|
Adrenalone
|
|
|
|
|
|
B02BC06
|
Thrombin
|
|
|
|
|
|
B02BC07
|
Collagen
|
|
|
|
|
|
B02BC08
|
Calcium alginate
|
|
|
|
|
|
B02BC09
|
Epinephrine
|
|
|
|
|
|
B02BC10
|
Fibrinogen, human
|
|
|
|
|
|
B02BC30
|
Combinations
|
|
|
|
|
B02BD
|
|
Blood coagulation factors
|
|
|
|
|
|
B02BD01
|
Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate)
|
|
|
|
|
|
B02BD02
|
Coagulation factor VIII
|
|
|
|
|
|
B02BD03
|
Factor VIII inhibitor bypassing activity
|
|
|
|
|
|
B02BD04
|
Coagulation factor IX
|
|
|
|
|
|
B02BD05
|
Coagulation factor VII
|
|
|
|
|
|
B02BD06
|
Von Willebrand factor and coagulation factor VIII in combination
|
|
|
|
|
|
B02BD07
|
Coagulation factor XIII
|
|
|
|
|
|
B02BD08
|
Eptacog alfa (activated)
|
|
|
|
|
|
B02BD09
|
Nonacog alfa
|
|
|
|
|
|
B02BD10
|
von Willebrand factor
|
|
|
|
|
|
B02BD11
|
Catridecacog
|
|
|
|
|
|
B02BD12
|
Trenonacog alfa
|
|
|
|
|
|
B02BD30
|
Thrombin
|
|
|
|
|
B02BX
|
|
Other systemic hemostatics
|
|
|
|
|
|
B02BX01
|
Etamsylate
|
|
|
|
|
|
B02BX02
|
Carbazochrome
|
|
|
|
|
|
B02BX03
|
Batroxobin
|
|
|
|
|
|
B02BX04
|
Romiplostim
|
|
|
|
|
|
B02BX05
|
Eltrombopag
|
|
|
B03
|
|
|
|
Antianemic preparations
|
|
|
|
B03A
|
|
|
Iron preparations
|
|
|
|
|
B03AA
|
|
Iron bivalent, oral preparations
|
|
|
|
|
|
B03AA01
|
Ferrous glycine sulfate
|
|
|
|
|
|
B03AA02
|
Ferrous fumarate
|
|
|
|
|
|
B03AA03
|
Ferrous gluconate
|
|
|
|
|
|
B03AA04
|
Ferrous carbonate
|
|
|
|
|
|
B03AA05
|
Ferrous chloride
|
|
|
|
|
|
B03AA06
|
Ferrous succinate
|
|
|
|
|
|
B03AA07
|
Ferrous sulfate
|
|
|
|
|
|
B03AA08
|
Ferrous tartrate
|
|
|
|
|
|
B03AA09
|
Ferrous aspartate
|
|
|
|
|
|
B03AA10
|
Ferrous ascorbate
|
|
|
|
|
|
B03AA11
|
Ferrous iodine
|
|
|
|
|
B03AB
|
|
Iron trivalent, oral preparations
|
|
|
|
|
|
B03AB01
|
Ferric sodium citrate
|
|
|
|
|
|
B03AB02
|
Saccharated iron oxide
|
|
|
|
|
|
B03AB03
|
Sodium feredetate
|
|
|
|
|
|
B03AB04
|
Ferric hydroxide
|
|
|
|
|
|
B03AB05
|
Ferric oxide polymaltose complexes
|
|
|
|
|
|
B03AB06
|
Ferric citrate
|
|
|
|
|
|
B03AB07
|
Chondroitin sulfate-iron complex
|
|
|
|
|
|
B03AB08
|
Ferric acetyl transferrin
|
|
|
|
|
|
B03AB09
|
Ferric proteinsuccinylate
|
|
|
|
|
B03AC
|
|
Iron trivalent, parenteral preparations
|
|
|
|
|
|
B03AC01
|
Ferric oxide polymaltose complexes
|
|
|
|
|
|
B03AC02
|
Saccharated iron oxide
|
|
|
|
|
|
B03AC03
|
Iron-sorbitol-citric acid complex
|
|
|
|
|
|
B03AC05
|
Ferric sorbitol gluconic acid complex
|
|
|
|
|
|
B03AC06
|
Ferric oxide dextran complexes
|
|
|
|
|
|
B03AC07
|
Ferric sodium gluconate complex
|
|
|
|
|
B03AD
|
|
Iron in combination with folic acid
|
|
|
|
|
|
B03AD01
|
Ferrous amino acid complex
|
|
|
|
|
|
B03AD02
|
Ferrous fumarate
|
|
|
|
|
|
B03AD03
|
Ferrous sulfate
|
|
|
|
|
|
B03AD04
|
Ferric oxide polymaltose complexes
|
|
|
|
|
B03AE
|
|
Iron in other combinations
|
|
|
|
|
|
B03AE01
|
Iron, vitamin B12 and folic acid
|
|
|
|
|
|
B03AE02
|
Iron, multivitamins and folic acid
|
|
|
|
|
|
B03AE03
|
Iron and multivitamins
|
|
|
|
|
|
B03AE04
|
Iron, multivitamins and minerals
|
|
|
|
|
|
B03AE10
|
Various combinations
|
|
|
|
B03B
|
|
|
Vitamin B12 and folic acid
|
|
|
|
|
B03BA
|
|
Vitamin B12 (cyanocobalamin and analogues)
|
|
|
|
|
|
B03BA01
|
Cyanocobalamin
|
|
|
|
|
|
B03BA02
|
Cyanocobalamin tannin complex
|
|
|
|
|
|
B03BA03
|
Hydroxocobalamin
|
|
|
|
|
|
B03BA04
|
Cobamamide
|
|
|
|
|
|
B03BA05
|
Mecobalamin
|
|
|
|
|
|
B03BA51
|
Cyanocobalamin, combinations
|
|
|
|
|
|
B03BA53
|
Hydroxocobalamin, combinations
|
|
|
|
|
B03BB
|
|
Folic acid and derivatives
|
|
|
|
|
|
B03BB01
|
Folic acid
|
|
|
|
|
|
B03BB51
|
Folic acid, combinations
|
|
|
|
B03X
|
|
|
Other antianemic preparations
|
|
|
|
|
B03XA
|
|
Other antianemic preparations
|
|
|
|
|
|
B03XA01
|
Erythropoietin
|
|
|
|
|
|
B03XA02
|
Darbepoetin alfa
|
|
|
|
|
|
B03XA03
|
Methoxy polyethylene glycol-epoetin beta
|
|
|
|
|
|
B03XA04
|
Peginesatide
|
|
|
B05
|
|
|
|
Blood substitutes and perfusion solutions
|
|
|
|
B05A
|
|
|
Blood and related products
|
|
|
|
|
B05AA
|
|
Blood substitutes and plasma protein fractions
|
|
|
|
|
|
B05AA01
|
Serum albumin
|
|
|
|
|
|
B05AA02
|
Other plasma protein fractions
|
|
|
|
|
|
B05AA03
|
Fluorocarbon blood substitutes
|
|
|
|
|
|
B05AA05
|
Dextran
|
|
|
|
|
|
B05AA06
|
Gelatin agents
|
|
|
|
|
|
B05AA07
|
Hydroxyethylstarch
|
|
|
|
|
|
B05AA08
|
Hemoglobin crosfumaril
|
|
|
|
|
|
B05AA09
|
Hemoglobin raffimer
|
|
|
|
|
|
B05AA10
|
Hemoglobin glutamer (bovine)
|
|
|
|
|
B05AX
|
|
Other blood products
|
|
|
|
|
|
B05AX01
|
Erythrocytes
|
|
|
|
|
|
B05AX02
|
Thrombocytes
|
|
|
|
|
|
B05AX03
|
Blood plasma
|
|
|
|
|
|
B05AX04
|
Stem cells from umbilical cord blood
|
|
|
|
B05B
|
|
|
I.v. solutions
|
|
|
|
|
B05BA
|
|
Solutions for parenteral nutrition
|
|
|
|
|
|
B05BA01
|
Amino acids
|
|
|
|
|
|
B05BA02
|
Fat emulsions
|
|
|
|
|
|
B05BA03
|
Carbohydrates
|
|
|
|
|
|
B05BA04
|
Protein hydrolysates
|
|
|
|
|
|
B05BA10
|
Combinations
|
|
|
|
|
B05BB
|
|
Solutions affecting the electrolyte balance
|
|
|
|
|
|
B05BB01
|
Electrolytes
|
|
|
|
|
|
B05BB02
|
Electrolytes with carbohydrates
|
|
|
|
|
|
B05BB03
|
Trometamol
|
|
|
|
|
|
B05BB04
|
Electrolytes in combination with other drugs
|
|
|
|
|
B05BC
|
|
Solutions producing osmotic diuresis
|
|
|
|
|
|
B05BC01
|
Mannitol
|
|
|
|
|
|
B05BC02
|
Carbamide
|
|
|
|
B05C
|
|
|
Irrigating solutions
|
|
|
|
|
B05CA
|
|
Antiinfectives
|
|
|
|
|
|
B05CA01
|
Cetylpyridinium
|
|
|
|
|
|
B05CA02
|
Chlorhexidine
|
|
|
|
|
|
B05CA03
|
Nitrofural
|
|
|
|
|
|
B05CA04
|
Sulfamethizole
|
|
|
|
|
|
B05CA05
|
Taurolidine
|
|
|
|
|
|
B05CA06
|
Mandelic acid
|
|
|
|
|
|
B05CA07
|
Noxytiolin
|
|
|
|
|
|
B05CA08
|
Ethacridine lactate
|
|
|
|
|
|
B05CA09
|
Neomycin
|
|
|
|
|
|
B05CA10
|
Combinations
|
|
|
|
|
B05CB
|
|
Salt solutions
|
|
|
|
|
|
B05CB01
|
Sodium chloride
|
|
|
|
|
|
B05CB02
|
Sodium citrate
|
|
|
|
|
|
B05CB03
|
Magnesium citrate
|
|
|
|
|
|
B05CB04
|
Sodium bicarbonate
|
|
|
|
|
|
B05CB10
|
Combinations
|
|
|
|
|
B05CX
|
|
Other irrigating solutions
|
|
|
|
|
|
B05CX01
|
Glucose
|
|
|
|
|
|
B05CX02
|
Sorbitol
|
|
|
|
|
|
B05CX03
|
Glycine
|
|
|
|
|
|
B05CX04
|
Mannitol
|
|
|
|
|
|
B05CX10
|
Combinations
|
|
|
|
B05D
|
|
|
Peritoneal dialytics
|
|
|
|
|
B05DA
|
|
Isotonic solutions
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05DB
|
|
Hypertonic solutions
|
|
|
|
|
|
|
empty
|
|
|
|
B05X
|
|
|
I.v. solution additives
|
|
|
|
|
B05XA
|
|
Electrolyte solutions
|
|
|
|
|
|
B05XA01
|
Potassium chloride
|
|
|
|
|
|
B05XA02
|
Sodium bicarbonate
|
|
|
|
|
|
B05XA03
|
Sodium chloride
|
|
|
|
|
|
B05XA04
|
Ammonium chloride
|
|
|
|
|
|
B05XA05
|
Magnesium sulfate
|
|
|
|
|
|
B05XA06
|
Potassium phosphate, including combinations with other potassium salts
|
|
|
|
|
|
B05XA07
|
Calcium chloride
|
|
|
|
|
|
B05XA08
|
Sodium acetate
|
|
|
|
|
|
B05XA09
|
Sodium phosphate
|
|
|
|
|
|
B05XA10
|
Magnesium phosphate
|
|
|
|
|
|
B05XA11
|
Magnesium chloride
|
|
|
|
|
|
B05XA12
|
Zinc chloride
|
|
|
|
|
|
B05XA13
|
Hydrochloric acid
|
|
|
|
|
|
B05XA14
|
Sodium glycerophosphate
|
|
|
|
|
|
B05XA15
|
Potassium lactate
|
|
|
|
|
|
B05XA16
|
Cardioplegia solutions
|
|
|
|
|
|
B05XA17
|
Potassium acetate
|
|
|
|
|
|
B05XA30
|
Combinations of electrolytes
|
|
|
|
|
|
B05XA31
|
Electrolytes in combination with other drugs
|
|
|
|
|
B05XB
|
|
Amino acids
|
|
|
|
|
|
B05XB01
|
Arginine hydrochloride
|
|
|
|
|
|
B05XB02
|
Alanyl glutamine
|
|
|
|
|
|
B05XB03
|
Lysine
|
|
|
|
|
B05XC
|
|
Vitamins
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05XX
|
|
Other i.v. solution additives
|
|
|
|
|
|
B05XX02
|
Trometamol
|
|
|
|
B05Z
|
|
|
Hemodialytics and hemofiltrates
|
|
|
|
|
B05ZA
|
|
Hemodialytics, concentrates
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05ZB
|
|
Hemofiltrates
|
|
|
|
|
|
|
empty
|
|
|
B06
|
|
|
|
Other hematological agents
|
|
|
|
B06A
|
|
|
Other hematological agents
|
|
|
|
|
B06AA
|
|
Enzymes
|
|
|
|
|
|
B06AA02
|
Fibrinolysin and desoxyribonuclease
|
|
|
|
|
|
B06AA03
|
Hyaluronidase
|
|
|
|
|
|
B06AA04
|
Chymotrypsin
|
|
|
|
|
|
B06AA07
|
Trypsin
|
|
|
|
|
|
B06AA10
|
Desoxyribonuclease
|
|
|
|
|
|
B06AA11
|
Bromelain
|
|
|
|
|
|
B06AA55
|
Streptokinase, combinations
|
|
|
|
|
B06AB
|
|
Other hematological products
|
|
|
|
|
|
B06AB01
|
Hematin
|
|
|
|
|
B06AC
|
|
Drugs used in hereditary angioedema
|
|
|
|
|
|
B06AC01
|
C1-inhibitor, plasma derived
|
|
|
|
|
|
B06AC02
|
Icatibant
|
|
|
|
|
|
B06AC03
|
Ecallantide
|
|
|
|
|
|
B06AC04
|
Conestat alfa
|
| C
|
|
|
|
|
Cardiovascular system
|
|
|
C01
|
|
|
|
Cardiac therapy
|
|
|
|
C01A
|
|
|
Cardiac glycosides
|
|
|
|
|
C01AA
|
|
Digitalis glycosides
|
|
|
|
|
|
C01AA01
|
Acetyldigitoxin
|
|
|
|
|
|
C01AA02
|
Acetyldigoxin
|
|
|
|
|
|
C01AA03
|
Digitalis leaves
|
|
|
|
|
|
C01AA04
|
Digitoxin
|
|
|
|
|
|
C01AA05
|
Digoxin
|
|
|
|
|
|
C01AA06
|
Lanatoside C
|
|
|
|
|
|
C01AA07
|
Deslanoside
|
|
|
|
|
|
C01AA08
|
Metildigoxin
|
|
|
|
|
|
C01AA09
|
Gitoformate
|
|
|
|
|
|
C01AA52
|
Acetyldigoxin, combinations
|
|
|
|
|
C01AB
|
|
Scilla glycosides
|
|
|
|
|
|
C01AB01
|
Proscillaridin
|
|
|
|
|
|
C01AB51
|
Proscillaridin, combinations
|
|
|
|
|
C01AC
|
|
Strophantus glycosides
|
|
|
|
|
|
C01AC01
|
G-strophanthin
|
|
|
|
|
|
C01AC03
|
Cymarin
|
|
|
|
|
C01AX
|
|
Other cardiac glycosides
|
|
|
|
|
|
C01AX02
|
Peruvoside
|
|
|
|
C01B
|
|
|
Antiarrhythmics, class I and III
|
|
|
|
|
C01BA
|
|
Antiarrhythmics, class Ia
|
|
|
|
|
|
C01BA01
|
Quinidine
|
|
|
|
|
|
C01BA02
|
Procainamide
|
|
|
|
|
|
C01BA03
|
Disopyramide
|
|
|
|
|
|
C01BA04
|
Sparteine
|
|
|
|
|
|
C01BA05
|
Ajmaline
|
|
|
|
|
|
C01BA08
|
Prajmaline
|
|
|
|
|
|
C01BA12
|
Lorajmine
|
|
|
|
|
|
C01BA51
|
Quinidine, combinations excluding psycholeptics
|
|
|
|
|
|
C01BA71
|
Quinidine, combinations with psycholeptics
|
|
|
|
|
C01BB
|
|
Antiarrhythmics, class Ib
|
|
|
|
|
|
C01BB01
|
Lidocaine
|
|
|
|
|
|
C01BB02
|
Mexiletine
|
|
|
|
|
|
C01BB03
|
Tocainide
|
|
|
|
|
|
C01BB04
|
Aprindine
|
|
|
|
|
C01BC
|
|
Antiarrhythmics, class Ic
|
|
|
|
|
|
C01BC03
|
Propafenone
|
|
|
|
|
|
C01BC04
|
Flecainide
|
|
|
|
|
|
C01BC07
|
Lorcainide
|
|
|
|
|
|
C01BC08
|
Encainide
|
|
|
|
|
|
C01BC09
|
Ethacizine
|
|
|
|
|
C01BD
|
|
Antiarrhythmics, class III
|
|
|
|
|
|
C01BD01
|
Amiodarone
|
|
|
|
|
|
C01BD02
|
Bretylium tosilate
|
|
|
|
|
|
C01BD03
|
Bunaftine
|
|
|
|
|
|
C01BD04
|
Dofetilide
|
|
|
|
|
|
C01BD05
|
Ibutilide
|
|
|
|
|
|
C01BD06
|
Tedisamil
|
|
|
|
|
|
C01BD07
|
Dronedarone
|
|
|
|
|
C01BG
|
|
Other antiarrhythmics, class I and III
|
|
|
|
|
|
C01BG01
|
Moracizine
|
|
|
|
|
|
C01BG07
|
Cibenzoline
|
|
|
|
|
|
C01BG11
|
Vernakalant
|
|
|
|
C01C
|
|
|
Cardiac stimulants excluding cardiac glycosides
|
|
|
|
|
C01CA
|
|
Adrenergic and dopaminergic agents
|
|
|
|
|
|
C01CA01
|
Etilefrine
|
|
|
|
|
|
C01CA02
|
Isoprenaline
|
|
|
|
|
|
C01CA03
|
Norepinephrine
|
|
|
|
|
|
C01CA04
|
Dopamine
|
|
|
|
|
|
C01CA05
|
Norfenefrine
|
|
|
|
|
|
C01CA06
|
Phenylephrine
|
|
|
|
|
|
C01CA07
|
Dobutamine
|
|
|
|
|
|
C01CA08
|
Oxedrine
|
|
|
|
|
|
C01CA09
|
Metaraminol
|
|
|
|
|
|
C01CA10
|
Methoxamine
|
|
|
|
|
|
C01CA11
|
Mephentermine
|
|
|
|
|
|
C01CA12
|
Dimetofrine
|
|
|
|
|
|
C01CA13
|
Prenalterol
|
|
|
|
|
|
C01CA14
|
Dopexamine
|
|
|
|
|
|
C01CA15
|
Gepefrine
|
|
|
|
|
|
C01CA16
|
Ibopamine
|
|
|
|
|
|
C01CA17
|
Midodrine
|
|
|
|
|
|
C01CA18
|
Octopamine
|
|
|
|
|
|
C01CA19
|
Fenoldopam
|
|
|
|
|
|
C01CA21
|
Cafedrine
|
|
|
|
|
|
C01CA22
|
Arbutamine
|
|
|
|
|
|
C01CA23
|
Theodrenaline
|
|
|
|
|
|
C01CA24
|
Epinephrine
|
|
|
|
|
|
C01CA25
|
Amezinium metilsulfate
|
|
|
|
|
|
C01CA26
|
Ephedrine
|
|
|
|
|
|
C01CA30
|
Combinations
|
|
|
|
|
|
C01CA51
|
Etilefrine, combinations
|
|
|
|
|
C01CE
|
|
Phosphodiesterase inhibitors
|
|
|
|
|
|
C01CE01
|
Amrinone
|
|
|
|
|
|
C01CE02
|
Milrinone
|
|
|
|
|
|
C01CE03
|
Enoximone
|
|
|
|
|
|
C01CE04
|
Bucladesine
|
|
|
|
|
C01CX
|
|
Other cardiac stimulants
|
|
|
|
|
|
C01CX06
|
Angiotensinamide
|
|
|
|
|
|
C01CX07
|
Xamoterol
|
|
|
|
|
|
C01CX08
|
Levosimendan
|
|
|
|
C01D
|
|
|
Vasodilators used in cardiac diseases
|
|
|
|
|
C01DA
|
|
Organic nitrates
|
|
|
|
|
|
C01DA02
|
Glyceryl trinitrate
|
|
|
|
|
|
C01DA04
|
Methylpropylpropanediol dinitrate
|
|
|
|
|
|
C01DA05
|
Pentaerithrityl tetranitrate
|
|
|
|
|
|
C01DA07
|
Propatylnitrate
|
|
|
|
|
|
C01DA08
|
Isosorbide dinitrate
|
|
|
|
|
|
C01DA09
|
Trolnitrate
|
|
|
|
|
|
C01DA13
|
Eritrityl tetranitrate
|
|
|
|
|
|
C01DA14
|
Isosorbide mononitrate
|
|
|
|
|
|
C01DA20
|
Organic nitrates in combination
|
|
|
|
|
|
C01DA38
|
Tenitramine
|
|
|
|
|
|
C01DA52
|
Glyceryl trinitrate, combinations
|
|
|
|
|
|
C01DA54
|
Methylpropylpropanediol dinitrate, combinations
|
|
|
|
|
|
C01DA55
|
Pentaerithrityl tetranitrate, combinations
|
|
|
|
|
|
C01DA57
|
Propatylnitrate, combinations
|
|
|
|
|
|
C01DA58
|
Isosorbide dinitrate, combinations
|
|
|
|
|
|
C01DA59
|
Trolnitrate, combinations
|
|
|
|
|
|
C01DA63
|
Eritrityl tetranitrate, combinations
|
|
|
|
|
|
C01DA70
|
Organic nitrates in combination with psycholeptics
|
|
|
|
|
C01DB
|
|
Quinolone vasodilators
|
|
|
|
|
|
C01DB01
|
Flosequinan
|
|
|
|
|
C01DX
|
|
Other vasodilators used in cardiac diseases
|
|
|
|
|
|
C01DX01
|
Itramin tosilate
|
|
|
|
|
|
C01DX02
|
Prenylamine
|
|
|
|
|
|
C01DX03
|
Oxyfedrine
|
|
|
|
|
|
C01DX04
|
Benziodarone
|
|
|
|
|
|
C01DX05
|
Carbocromen
|
|
|
|
|
|
C01DX06
|
Hexobendine
|
|
|
|
|
|
C01DX07
|
Etafenone
|
|
|
|
|
|
C01DX08
|
Heptaminol
|
|
|
|
|
|
C01DX09
|
Imolamine
|
|
|
|
|
|
C01DX10
|
Dilazep
|
|
|
|
|
|
C01DX11
|
Trapidil
|
|
|
|
|
|
C01DX12
|
Molsidomine
|
|
|
|
|
|
C01DX13
|
Efloxate
|
|
|
|
|
|
C01DX14
|
Cinepazet
|
|
|
|
|
|
C01DX15
|
Cloridarol
|
|
|
|
|
|
C01DX16
|
Nicorandil
|
|
|
|
|
|
C01DX18
|
Linsidomine
|
|
|
|
|
|
C01DX19
|
Nesiritide
|
|
|
|
|
|
C01DX51
|
Itramin tosilate, combinations
|
|
|
|
|
|
C01DX52
|
Prenylamine, combinations
|
|
|
|
|
|
C01DX53
|
Oxyfedrine, combinations
|
|
|
|
|
|
C01DX54
|
Benziodarone, combinations
|
|
|
|
C01E
|
|
|
Other cardiac preparations
|
|
|
|
|
C01EA
|
|
Prostaglandins
|
|
|
|
|
|
C01EA01
|
Alprostadil
|
|
|
|
|
C01EB
|
|
Other cardiac preparations
|
|
|
|
|
|
C01EB02
|
Camphor
|
|
|
|
|
|
C01EB03
|
Indometacin
|
|
|
|
|
|
C01EB04
|
Crataegus glycosides
|
|
|
|
|
|
C01EB05
|
Creatinolfosfate
|
|
|
|
|
|
C01EB06
|
Fosfocreatine
|
|
|
|
|
|
C01EB07
|
Fructose 1,6-diphosphate
|
|
|
|
|
|
C01EB09
|
Ubidecarenone
|
|
|
|
|
|
C01EB10
|
Adenosine
|
|
|
|
|
|
C01EB11
|
Tiracizine
|
|
|
|
|
|
C01EB13
|
Acadesine
|
|
|
|
|
|
C01EB15
|
Trimetazidine
|
|
|
|
|
|
C01EB16
|
Ibuprofen
|
|
|
|
|
|
C01EB17
|
Ivabradine
|
|
|
|
|
|
C01EB18
|
Ranolazine
|
|
|
|
|
|
C01EB21
|
Regadenoson
|
|
|
|
|
C01EX
|
|
Other cardiac combination products
|
|
|
|
|
|
|
empty
|
|
|
C02
|
|
|
|
Antihypertensives
|
|
|
|
C02A
|
|
|
Antiadrenergic agents, centrally acting
|
|
|
|
|
C02AA
|
|
Rauvolfia alkaloids
|
|
|
|
|
|
C02AA01
|
Rescinnamine
|
|
|
|
|
|
C02AA02
|
Reserpine
|
|
|
|
|
|
C02AA03
|
Combinations of rauwolfia alkaloids
|
|
|
|
|
|
C02AA04
|
Rauwolfia alkaloids, whole root
|
|
|
|
|
|
C02AA05
|
Deserpidine
|
|
|
|
|
|
C02AA06
|
Methoserpidine
|
|
|
|
|
|
C02AA07
|
Bietaserpine
|
|
|
|
|
|
C02AA52
|
Reserpine, combinations
|
|
|
|
|
|
C02AA53
|
Combinations of rauwolfia alkoloids, combinations
|
|
|
|
|
|
C02AA57
|
Bietaserpine, combinations
|
|
|
|
|
C02AB
|
|
Methyldopa
|
|
|
|
|
|
C02AB01
|
Methyldopa (levorotatory)
|
|
|
|
|
|
C02AB02
|
Methyldopa (racemic)
|
|
|
|
|
C02AC
|
|
Imidazoline receptor agonists
|
|
|
|
|
|
C02AC01
|
Clonidine
|
|
|
|
|
|
C02AC02
|
Guanfacine
|
|
|
|
|
|
C02AC04
|
Tolonidine
|
|
|
|
|
|
C02AC05
|
Moxonidine
|
|
|
|
|
|
C02AC06
|
Rilmenidine
|
|
|
|
C02B
|
|
|
Antiadrenergic agents, ganglion-blocking
|
|
|
|
|
C02BA
|
|
Sulfonium derivatives
|
|
|
|
|
|
C02BA01
|
Trimetaphan
|
|
|
|
|
C02BB
|
|
Secondary and tertiary amines
|
|
|
|
|
|
C02BB01
|
Mecamylamine
|
|
|
|
|
C02BC
|
|
Bisquaternary ammonium compounds
|
|
|
|
|
|
|
empty
|
|
|
|
C02C
|
|
|
Antiadrenergic agents, peripherally acting
|
|
|
|
|
C02CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
|
|
C02CA01
|
Prazosin
|
|
|
|
|
|
C02CA02
|
Indoramin
|
|
|
|
|
|
C02CA03
|
Trimazosin
|
|
|
|
|
|
C02CA04
|
Doxazosin
|
|
|
|
|
|
C02CA06
|
Urapidil
|
|
|
|
|
C02CC
|
|
Guanidine derivatives
|
|
|
|
|
|
C02CC01
|
Betanidine
|
|
|
|
|
|
C02CC02
|
Guanethidine
|
|
|
|
|
|
C02CC03
|
Guanoxan
|
|
|
|
|
|
C02CC04
|
Debrisoquine
|
|
|
|
|
|
C02CC05
|
Guanoclor
|
|
|
|
|
|
C02CC06
|
Guanazodine
|
|
|
|
|
|
C02CC07
|
Guanoxabenz
|
|
|
|
C02D
|
|
|
Arteriolar smooth muscle, agents acting on
|
|
|
|
|
C02DA
|
|
Thiazide derivatives
|
|
|
|
|
|
C02DA01
|
Diazoxide
|
|
|
|
|
C02DB
|
|
Hydrazinophthalazine derivatives
|
|
|
|
|
|
C02DB01
|
Dihydralazine
|
|
|
|
|
|
C02DB02
|
Hydralazine
|
|
|
|
|
|
C02DB03
|
Endralazine
|
|
|
|
|
|
C02DB04
|
Cadralazine
|
|
|
|
|
C02DC
|
|
Pyrimidine derivatives
|
|
|
|
|
|
C02DC01
|
Minoxidil
|
|
|
|
|
C02DD
|
|
Nitroferricyanide derivatives
|
|
|
|
|
|
C02DD01
|
Nitroprusside
|
|
|
|
|
C02DG
|
|
Guanidine derivatives
|
|
|
|
|
|
C02DG01
|
Pinacidil
|
|
|
|
C02K
|
|
|
Other antihypertensives
|
|
|
|
|
C02KA
|
|
Alkaloids, excluding rauwolfia
|
|
|
|
|
|
C02KA01
|
Veratrum
|
|
|
|
|
C02KB
|
|
Tyrosine hydroxylase inhibitors
|
|
|
|
|
|
C02KB01
|
Metirosine
|
|
|
|
|
C02KC
|
|
MAO inhibitors
|
|
|
|
|
|
C02KC01
|
Pargyline
|
|
|
|
|
C02KD
|
|
Serotonin antagonists
|
|
|
|
|
|
C02KD01
|
Ketanserin
|
|
|
|
|
C02KX
|
|
Other antihypertensives
|
|
|
|
|
|
C02KX01
|
Bosentan
|
|
|
|
|
|
C02KX02
|
Ambrisentan
|
|
|
|
|
|
C02KX03
|
Sitaxentan
|
|
|
|
C02L
|
|
|
Antihypertensives and diuretics in combination
|
|
|
|
|
C02LA
|
|
Rauwolfia alkaloids and diuretics in combination
|
|
|
|
|
|
C02LA01
|
Reserpine and diuretics
|
|
|
|
|
|
C02LA02
|
Rescinnamine and diuretics
|
|
|
|
|
|
C02LA03
|
Deserpidine and diuretics
|
|
|
|
|
|
C02LA04
|
Methoserpidine and diuretics
|
|
|
|
|
|
C02LA07
|
Bietaserpine and diuretics
|
|
|
|
|
|
C02LA08
|
Rauwolfia alkaloids, whole root and diuretics
|
|
|
|
|
|
C02LA09
|
Syrosingopine and diuretics
|
|
|
|
|
|
C02LA50
|
Combinations of rauwolfia alkaloids and diuretics including other combinations
|
|
|
|
|
|
C02LA51
|
Reserpine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LA52
|
Rescinnamine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LA71
|
Reserpine and diuretics, combinations with psycholeptics
|
|
|
|
|
C02LB
|
|
Methyldopa and diuretics in combination
|
|
|
|
|
|
C02LB01
|
Methyldopa (levorotatory) and diuretics
|
|
|
|
|
C02LC
|
|
Imidazoline receptor agonists in combination with diuretics
|
|
|
|
|
|
C02LC01
|
Clonidine and diuretics
|
|
|
|
|
|
C02LC05
|
Moxonidine and diuretics
|
|
|
|
|
|
C02LC51
|
Clonidine and diuretics, combinations with other drugs
|
|
|
|
|
C02LE
|
|
Alpha-adrenoreceptor antagonists and diuretics
|
|
|
|
|
|
C02LE01
|
Prazosin and diuretics
|
|
|
|
|
C02LF
|
|
Guanidine derivatives and diuretics
|
|
|
|
|
|
C02LF01
|
Guanethidine and diuretics
|
|
|
|
|
C02LG
|
|
Hydrazinophthalazine derivatives and diuretics
|
|
|
|
|
|
C02LG01
|
Dihydralazine and diuretics
|
|
|
|
|
|
C02LG02
|
Hydralazine and diuretics
|
|
|
|
|
|
C02LG03
|
Picodralazine and diuretics
|
|
|
|
|
|
C02LG51
|
Dihydralazine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LG73
|
Picodralazine and diuretics, combinations with psycholeptics
|
|
|
|
|
C02LK
|
|
Alkaloids, excluding rauwolfia, in combination with diuretics
|
|
|
|
|
|
C02LK01
|
Veratrum and diuretics
|
|
|
|
|
C02LL
|
|
MAO inhibitors and diuretics
|
|
|
|
|
|
C02LL01
|
Pargyline and diuretics
|
|
|
|
C02LN
|
|
|
Serotonin antagonists and diuretics
|
|
|
|
|
|
|
empty
|
|
|
|
C02LX
|
|
|
Other antihypertensives and diuretics
|
|
|
|
|
|
C02LX01
|
Pinacidil and diuretics
|
|
|
|
C02N
|
|
|
Combinations of antihypertensives in ATC-group C02
|
|
|
|
|
|
|
empty
|
|
|
C03
|
|
|
|
Diuretics
|
|
|
|
C03A
|
|
|
Low-ceiling diuretics, thiazides
|
|
|
|
|
C03AA
|
|
Thiazides, plain
|
|
|
|
|
|
C03AA01
|
Bendroflumethiazide
|
|
|
|
|
|
C03AA02
|
Hydroflumethiazide
|
|
|
|
|
|
C03AA03
|
Hydrochlorothiazide
|
|
|
|
|
|
C03AA04
|
Chlorothiazide
|
|
|
|
|
|
C03AA05
|
Polythiazide
|
|
|
|
|
|
C03AA06
|
Trichlormethiazide
|
|
|
|
|
|
C03AA07
|
Cyclopenthiazide
|
|
|
|
|
|
C03AA08
|
Methyclothiazide
|
|
|
|
|
|
C03AA09
|
Cyclothiazide
|
|
|
|
|
|
C03AA13
|
Mebutizide
|
|
|
|
|
C03AB
|
|
Thiazides and potassium in combination
|
|
|
|
|
|
C03AB01
|
Bendroflumethiazide and potassium
|
|
|
|
|
|
C03AB02
|
Hydroflumethiazide and potassium
|
|
|
|
|
|
C03AB03
|
Hydrochlorothiazide and potassium
|
|
|
|
|
|
C03AB04
|
Chlorothiazide and potassium
|
|
|
|
|
|
C03AB05
|
Polythiazide and potassium
|
|
|
|
|
|
C03AB06
|
Trichlormethiazide and potassium
|
|
|
|
|
|
C03AB07
|
Cyclopenthiazide and potassium
|
|
|
|
|
|
C03AB08
|
Methyclothiazide and potassium
|
|
|
|
|
|
C03AB09
|
Cyclothiazide and potassium
|
|
|
|
|
C03AH
|
|
Thiazides, combinations with psycholeptics and/or analgesics
|
|
|
|
|
|
C03AH01
|
Chlorothiazide, combinations
|
|
|
|
|
|
C03AH02
|
Hydroflumethiazide, combinations
|
|
|
|
|
C03AX
|
|
Thiazides, combinations with other drugs
|
|
|
|
|
|
C03AX01
|
Hydrochlorothiazide, combinations
|
|
|
|
C03B
|
|
|
Low-ceiling diuretics, excluding thiazides
|
|
|
|
|
C03BA
|
|
Sulfonamides, plain
|
|
|
|
|
|
C03BA02
|
Quinethazone
|
|
|
|
|
|
C03BA03
|
Clopamide
|
|
|
|
|
|
C03BA04
|
Chlortalidone
|
|
|
|
|
|
C03BA05
|
Mefruside
|
|
|
|
|
|
C03BA07
|
Clofenamide
|
|
|
|
|
|
C03BA08
|
Metolazone
|
|
|
|
|
|
C03BA09
|
Meticrane
|
|
|
|
|
|
C03BA10
|
Xipamide
|
|
|
|
|
|
C03BA11
|
Indapamide
|
|
|
|
|
|
C03BA12
|
Clorexolone
|
|
|
|
|
|
C03BA13
|
Fenquizone
|
|
|
|
|
|
C03BA82
|
Clorexolone, combinations with psycholeptics
|
|
|
|
|
C03BB
|
|
Sulfonamides and potassium in combination
|
|
|
|
|
|
C03BB02
|
Quinethazone and potassium
|
|
|
|
|
|
C03BB03
|
Clopamide and potassium
|
|
|
|
|
|
C03BB04
|
Chlortalidone and potassium
|
|
|
|
|
|
C03BB05
|
Mefruside and potassium
|
|
|
|
|
|
C03BB07
|
Clofenamide and potassium
|
|
|
|
|
C03BC
|
|
Mercurial diuretics
|
|
|
|
|
|
C03BC01
|
Mersalyl
|
|
|
|
|
C03BD
|
|
Xanthine derivatives
|
|
|
|
|
|
C03BD01
|
Theobromine
|
|
|
|
|
C03BK
|
|
Sulfonamides, combinations with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
|
C03BX
|
|
Other low-ceiling diuretics
|
|
|
|
|
|
C03BX03
|
Cicletanine
|
|
|
|
C03C
|
|
|
High-ceiling diuretics
|
|
|
|
|
C03CA
|
|
Sulfonamides, plain
|
|
|
|
|
|
C03CA01
|
Furosemide
|
|
|
|
|
|
C03CA02
|
Bumetanide
|
|
|
|
|
|
C03CA03
|
Piretanide
|
|
|
|
|
|
C03CA04
|
Torasemide
|
|
|
|
|
C03CB
|
|
Sulfonamides and potassium in combination
|
|
|
|
|
|
C03CB01
|
Furosemide and potassium
|
|
|
|
|
|
C03CB02
|
Bumetanide and potassium
|
|
|
|
|
C03CC
|
|
Aryloxyacetic acid derivatives
|
|
|
|
|
|
C03CC01
|
Etacrynic acid
|
|
|
|
|
|
C03CC02
|
Tienilic acid
|
|
|
|
|
C03CD
|
|
Pyrazolone derivatives
|
|
|
|
|
|
C03CD01
|
Muzolimine
|
|
|
|
|
C03CX
|
|
Other high-ceiling diuretics
|
|
|
|
|
|
C03CX01
|
Etozolin
|
|
|
|
C03D
|
|
|
Potassium-sparing agents
|
|
|
|
|
C03DA
|
|
Aldosterone antagonists
|
|
|
|
|
|
C03DA01
|
Spironolactone
|
|
|
|
|
|
C03DA02
|
Potassium canrenoate
|
|
|
|
|
|
C03DA03
|
Canrenone
|
|
|
|
|
|
C03DA04
|
Eplerenone
|
|
|
|
|
C03DB
|
|
Other potassium-sparing agents
|
|
|
|
|
|
C03DB01
|
Amiloride
|
|
|
|
|
|
C03DB02
|
Triamterene
|
|
|
|
C03E
|
|
|
Diuretics and potassium-sparing agents in combination
|
|
|
|
|
C03EA
|
|
Low-ceiling diuretics and potassium-sparing agents
|
|
|
|
|
|
C03EA01
|
Hydrochlorothiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA02
|
Trichlormethiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA03
|
Epitizide and potassium-sparing agents
|
|
|
|
|
|
C03EA04
|
Altizide and potassium-sparing agents
|
|
|
|
|
|
C03EA05
|
Mebutizide and potassium-sparing agents
|
|
|
|
|
|
C03EA06
|
Chlortalidone and potassium-sparing agents
|
|
|
|
|
|
C03EA07
|
Cyclopenthiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA12
|
Metolazone and potassium-sparing agents
|
|
|
|
|
|
C03EA13
|
Bendroflumethiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA14
|
Butizide and potassium-sparing agents
|
|
|
|
|
C03EB
|
|
High-ceiling diuretics and potassium-sparing agents
|
|
|
|
|
|
C03EB01
|
Furosemide and potassium-sparing agents
|
|
|
|
|
|
C03EB02
|
Bumetanide and potassium-sparing agents
|
|
|
|
C03X
|
|
|
Other diuretics
|
|
|
|
|
C03XA
|
|
Vasopressin antagonists
|
|
|
|
|
|
C03XA01
|
Tolvaptan
|
|
|
|
|
|
C03XA02
|
Conivaptan
|
|
|
C04
|
|
|
|
Peripheral vasodilators
|
|
|
|
C04A
|
|
|
Peripheral vasodilators
|
|
|
|
|
C04AA
|
|
2-amino-1-phenylethanol derivatives
|
|
|
|
|
|
C04AA01
|
Isoxsuprine
|
|
|
|
|
|
C04AA02
|
Buphenine
|
|
|
|
|
|
C04AA31
|
Bamethan
|
|
|
|
|
C04AB
|
|
Imidazoline derivatives
|
|
|
|
|
|
C04AB01
|
Phentolamine
|
|
|
|
|
|
C04AB02
|
Tolazoline
|
|
|
|
|
C04AC
|
|
Nicotinic acid and derivatives
|
|
|
|
|
|
C04AC01
|
Nicotinic acid
|
|
|
|
|
|
C04AC02
|
Nicotinyl alcohol (pyridylcarbinol)
|
|
|
|
|
|
C04AC03
|
Inositol nicotinate
|
|
|
|
|
|
C04AC07
|
Ciclonicate
|
|
|
|
|
C04AD
|
|
Purine derivatives
|
|
|
|
|
|
C04AD01
|
Pentifylline
|
|
|
|
|
|
C04AD02
|
Xantinol nicotinate
|
|
|
|
|
|
C04AD03
|
Pentoxifylline
|
|
|
|
|
|
C04AD04
|
Etofylline nicotinate
|
|
|
|
|
C04AE
|
|
Ergot alkaloids
|
|
|
|
|
|
C04AE01
|
Ergoloid mesylates
|
|
|
|
|
|
C04AE02
|
Nicergoline
|
|
|
|
|
|
C04AE04
|
Dihydroergocristine
|
|
|
|
|
|
C04AE51
|
Ergoloid mesylates, combinations
|
|
|
|
|
|
C04AE54
|
Dihydroergocristine, combinations
|
|
|
|
|
C04AF
|
|
Enzymes
|
|
|
|
|
|
C04AF01
|
Kallidinogenase
|
|
|
|
|
C04AX
|
|
Other peripheral vasodilators
|
|
|
|
|
|
C04AX01
|
Cyclandelate
|
|
|
|
|
|
C04AX02
|
Phenoxybenzamine
|
|
|
|
|
|
C04AX07
|
Vincamine
|
|
|
|
|
|
C04AX10
|
Moxisylyte
|
|
|
|
|
|
C04AX11
|
Bencyclane
|
|
|
|
|
|
C04AX17
|
Vinburnine
|
|
|
|
|
|
C04AX19
|
Sulcotidil
|
|
|
|
|
|
C04AX20
|
Buflomedil
|
|
|
|
|
|
C04AX21
|
Naftidrofuryl
|
|
|
|
|
|
C04AX23
|
Butalamine
|
|
|
|
|
|
C04AX24
|
Visnadine
|
|
|
|
|
|
C04AX26
|
Cetiedil
|
|
|
|
|
|
C04AX27
|
Cinepazide
|
|
|
|
|
|
C04AX28
|
Ifenprodil
|
|
|
|
|
|
C04AX30
|
Azapetine
|
|
|
|
|
|
C04AX32
|
Fasudil
|
|
|
C05
|
|
|
|
Vasoprotectives
|
|
|
|
C05A
|
|
|
Agents for treatment of hemorrhoids and anal fissures for topical use
|
|
|
|
|
C05AA
|
|
Corticosteroids
|
|
|
|
|
|
C05AA01
|
Hydrocortisone
|
|
|
|
|
|
C05AA04
|
Prednisolone
|
|
|
|
|
|
C05AA05
|
Betamethasone
|
|
|
|
|
|
C05AA06
|
Fluorometholone
|
|
|
|
|
|
C05AA08
|
Fluocortolone
|
|
|
|
|
|
C05AA09
|
Dexamethasone
|
|
|
|
|
|
C05AA10
|
Fluocinolone acetonide
|
|
|
|
|
|
C05AA11
|
Fluocinonide
|
|
|
|
|
|
C05AA12
|
Triamcinolone
|
|
|
|
|
C05AB
|
|
Antibiotics
|
|
|
|
|
|
|
empty
|
|
|
|
|
C05AD
|
|
Local anesthetics
|
|
|
|
|
|
C05AD01
|
Lidocaine
|
|
|
|
|
|
C05AD02
|
Tetracaine
|
|
|
|
|
|
C05AD03
|
Benzocaine
|
|
|
|
|
|
C05AD04
|
Cinchocaine
|
|
|
|
|
|
C05AD05
|
Procaine
|
|
|
|
|
|
C05AD06
|
Oxetacaine
|
|
|
|
|
|
C05AD07
|
Pramocaine
|
|
|
|
|
C05AE
|
|
Muscle relaxants
|
|
|
|
|
|
C05AE01
|
Glyceryl trinitrate
|
|
|
|
|
|
C05AE02
|
Isosorbide dinitrate
|
|
|
|
|
C05AX
|
|
Other agents for treatment of hemorrhoids and anal fissures for topical use
|
|
|
|
|
|
C05AX01
|
Aluminium preparations
|
|
|
|
|
|
C05AX02
|
Bismuth preparations, combinations
|
|
|
|
|
|
C05AX03
|
Other preparations, combinations
|
|
|
|
|
|
C05AX04
|
Zinc preparations
|
|
|
|
|
|
C05AX05
|
Tribenoside
|
|
|
|
C05B
|
|
|
Antivaricose therapy
|
|
|
|
|
C05BA
|
|
Heparins or heparinoids for topical use
|
|
|
|
|
|
C05BA01
|
Organo-heparinoid
|
|
|
|
|
|
C05BA02
|
Sodium apolate
|
|
|
|
|
|
C05BA03
|
Heparin
|
|
|
|
|
|
C05BA04
|
Pentosan polysulfate sodium
|
|
|
|
|
|
C05BA51
|
Heparinoid, combinations
|
|
|
|
|
|
C05BA53
|
Heparin, combinations
|
|
|
|
|
C05BB
|
|
Sclerosing agents for local injection
|
|
|
|
|
|
C05BB01
|
Monoethanolamine oleate
|
|
|
|
|
|
C05BB02
|
Polidocanol
|
|
|
|
|
|
C05BB03
|
Invert sugar
|
|
|
|
|
|
C05BB04
|
Sodium tetradecyl sulfate
|
|
|
|
|
|
C05BB05
|
Phenol
|
|
|
|
|
|
C05BB56
|
Glucose, combinations
|
|
|
|
|
C05BX
|
|
Other sclerosing agents
|
|
|
|
|
|
C05BX01
|
Calcium dobesilate
|
|
|
|
|
|
C05BX51
|
Calcium dobesilate, combinations
|
|
|
|
C05C
|
|
|
Capillary stabilising agents
|
|
|
|
|
C05CA
|
|
Bioflavonoids
|
|
|
|
|
|
C05CA01
|
Rutoside
|
|
|
|
|
|
C05CA02
|
Monoxerutin
|
|
|
|
|
|
C05CA03
|
Diosmin
|
|
|
|
|
|
C05CA04
|
Troxerutin
|
|
|
|
|
|
C05CA05
|
Hidrosmin
|
|
|
|
|
|
C05CA51
|
Rutoside, combinations
|
|
|
|
|
|
C05CA53
|
Diosmin, combinations
|
|
|
|
|
|
C05CA54
|
Troxerutin, combinations
|
|
|
|
|
C05CX
|
|
Other capillary stabilising agents
|
|
|
|
|
|
C05CX01
|
Tribenoside
|
|
|
|
|
|
C05CX02
|
Naftazone
|
|
|
|
|
|
C05CX03
|
Hippocastani semen
|
|
|
C07
|
|
|
|
Beta blocking agents
|
|
|
|
C07A
|
|
|
Beta blocking agents
|
|
|
|
|
C07AA
|
|
Beta blocking agents, non-selective
|
|
|
|
|
|
C07AA01
|
Alprenolol
|
|
|
|
|
|
C07AA02
|
Oxprenolol
|
|
|
|
|
|
C07AA03
|
Pindolol
|
|
|
|
|
|
C07AA05
|
Propranolol
|
|
|
|
|
|
C07AA06
|
Timolol
|
|
|
|
|
|
C07AA07
|
Sotalol
|
|
|
|
|
|
C07AA12
|
Nadolol
|
|
|
|
|
|
C07AA14
|
Mepindolol
|
|
|
|
|
|
C07AA15
|
Carteolol
|
|
|
|
|
|
C07AA16
|
Tertatolol
|
|
|
|
|
|
C07AA17
|
Bopindolol
|
|
|
|
|
|
C07AA19
|
Bupranolol
|
|
|
|
|
|
C07AA23
|
Penbutolol
|
|
|
|
|
|
C07AA27
|
Cloranolol
|
|
|
|
|
|
C07AA57
|
Sotalol, combinations
|
|
|
|
|
C07AB
|
|
Beta blocking agents, selective
|
|
|
|
|
|
C07AB01
|
Practolol
|
|
|
|
|
|
C07AB02
|
Metoprolol
|
|
|
|
|
|
C07AB03
|
Atenolol
|
|
|
|
|
|
C07AB04
|
Acebutolol
|
|
|
|
|
|
C07AB05
|
Betaxolol
|
|
|
|
|
|
C07AB06
|
Bevantolol
|
|
|
|
|
|
C07AB07
|
Bisoprolol
|
|
|
|
|
|
C07AB08
|
Celiprolol
|
|
|
|
|
|
C07AB09
|
Esmolol
|
|
|
|
|
|
C07AB10
|
Epanolol
|
|
|
|
|
|
C07AB11
|
S-atenolol
|
|
|
|
|
|
C07AB12
|
Nebivolol
|
|
|
|
|
|
C07AB13
|
Talinolol
|
|
|
|
|
|
C07AB52
|
Metoprolol, combinations
|
|
|
|
|
|
C07AB57
|
Bisoprolol, combinations
|
|
|
|
|
C07AG
|
|
Alpha and beta blocking agents
|
|
|
|
|
|
C07AG01
|
Labetalol
|
|
|
|
|
|
C07AG02
|
Carvedilol
|
|
|
|
C07B
|
|
|
Beta blocking agents and thiazides
|
|
|
|
|
C07BA
|
|
Beta blocking agents, non-selective, and thiazides
|
|
|
|
|
|
C07BA02
|
Oxprenolol and thiazides
|
|
|
|
|
|
C07BA05
|
Propranolol and thiazides
|
|
|
|
|
|
C07BA06
|
Timolol and thiazides
|
|
|
|
|
|
C07BA07
|
Sotalol and thiazides
|
|
|
|
|
|
C07BA12
|
Nadolol and thiazides
|
|
|
|
|
|
C07BA68
|
Metipranolol and thiazides, combinations
|
|
|
|
|
C07BB
|
|
Beta blocking agents, selective, and thiazides
|
|
|
|
|
|
C07BB02
|
Metoprolol and thiazides
|
|
|
|
|
|
C07BB03
|
Atenolol and thiazides
|
|
|
|
|
|
C07BB04
|
Acebutolol and thiazides
|
|
|
|
|
|
C07BB06
|
Bevantolol and thiazides
|
|
|
|
|
|
C07BB07
|
Bisoprolol and thiazides
|
|
|
|
|
|
C07BB12
|
Nebivolol and thiazides
|
|
|
|
|
|
C07BB52
|
Metoprolol and thiazides, combinations
|
|
|
|
|
C07BG
|
|
Alpha and beta blocking agents and thiazides
|
|
|
|
|
|
C07BG01
|
Labetalol and thiazides
|
|
|
|
C07C
|
|
|
Beta blocking agents and other diuretics
|
|
|
|
|
C07CA
|
|
Beta blocking agents, non-selective, and other diuretics
|
|
|
|
|
|
C07CA02
|
Oxprenolol and other diuretics
|
|
|
|
|
|
C07CA03
|
Pindolol and other diuretics
|
|
|
|
|
|
C07CA17
|
Bopindolol and other diuretics
|
|
|
|
|
|
C07CA23
|
Penbutolol and other diuretics
|
|
|
|
|
C07CB
|
|
Beta blocking agents, selective, and other diuretics
|
|
|
|
|
|
C07CB02
|
Metoprolol and other diuretics
|
|
|
|
|
|
C07CB03
|
Atenolol and other diuretics
|
|
|
|
|
|
C07CB53
|
Atenolol and other diuretics, combinations
|
|
|
|
|
C07CG
|
|
Alpha and beta blocking agents and other diuretics
|
|
|
|
|
|
C07CG01
|
Labetalol and other diuretics
|
|
|
|
C07D
|
|
|
Beta blocking agents, thiazides and other diuretics
|
|
|
|
|
C07DA
|
|
Beta blocking agents, non-selective, thiazides and other diuretics
|
|
|
|
|
|
C07DA06
|
Timolol, thiazides and other diuretics
|
|
|
|
|
C07DB
|
|
Beta blocking agents, selective, thiazides and other diuretics
|
|
|
|
|
|
C07DB01
|
Atenolol, thiazides and other diuretics
|
|
|
|
C07E
|
|
|
Beta blocking agents and vasodilators
|
|
|
|
|
C07EA
|
|
Beta blocking agents, non-selective, and vasodilators
|
|
|
|
|
|
|
empty
|
|
|
|
|
C07EB
|
|
Beta blocking agents, selective, and vasodilators
|
|
|
|
|
|
|
empty
|
|
|
|
C07F
|
|
|
Beta blocking agents and other antihypertensives
|
|
|
|
|
C07FA
|
|
Beta blocking agents, non-selective, and other antihypertensives
|
|
|
|
|
|
C07FA05
|
Propranolol and other antihypertensives
|
|
|
|
|
C07FB
|
|
Beta blocking agents, selective, and other antihypertensives
|
|
|
|
|
|
C07FB02
|
Metoprolol and other antihypertensives
|
|
|
|
|
|
C07FB03
|
Atenolol and other antihypertensives
|
|
|
|
|
|
C07FB07
|
Bisoprolol and other antihypertensives
|
|
|
C08
|
|
|
|
Calcium channel blockers
|
|
|
|
C08C
|
|
|
Selective calcium channel blockers with mainly vascular effects
|
|
|
|
|
C08CA
|
|
Dihydropyridine derivatives
|
|
|
|
|
|
C08CA01
|
Amlodipine
|
|
|
|
|
|
C08CA02
|
Felodipine
|
|
|
|
|
|
C08CA03
|
Isradipine
|
|
|
|
|
|
C08CA04
|
Nicardipine
|
|
|
|
|
|
C08CA05
|
Nifedipine
|
|
|
|
|
|
C08CA06
|
Nimodipine
|
|
|
|
|
|
C08CA07
|
Nisoldipine
|
|
|
|
|
|
C08CA08
|
Nitrendipine
|
|
|
|
|
|
C08CA09
|
Lacidipine
|
|
|
|
|
|
C08CA10
|
Nilvadipine
|
|
|
|
|
|
C08CA11
|
Manidipine
|
|
|
|
|
|
C08CA12
|
Barnidipine
|
|
|
|
|
|
C08CA13
|
Lercanidipine
|
|
|
|
|
|
C08CA14
|
Cilnidipine
|
|
|
|
|
|
C08CA15
|
Benidipine
|
|
|
|
|
|
C08CA16
|
Clevidipine
|
|
|
|
|
|
C08CA55
|
Nifedipine, combinations
|
|
|
|
|
C08CX
|
|
Other selective calcium channel blockers with mainly vascular effects
|
|
|
|
|
|
C08CX01
|
Mibefradil
|
|
|
|
C08D
|
|
|
Selective calcium channel blockers with direct cardiac effects
|
|
|
|
|
C08DA
|
|
Phenylalkylamine derivatives
|
|
|
|
|
|
C08DA01
|
Verapamil
|
|
|
|
|
|
C08DA02
|
Gallopamil
|
|
|
|
|
|
C08DA51
|
Verapamil, combinations
|
|
|
|
|
C08DB
|
|
Benzothiazepine derivatives
|
|
|
|
|
|
C08DB01
|
Diltiazem
|
|
|
|
C08E
|
|
|
Non-selective calcium channel blockers
|
|
|
|
|
C08EA
|
|
Phenylalkylamine derivatives
|
|
|
|
|
|
C08EA01
|
Fendiline
|
|
|
|
|
|
C08EA02
|
Bepridil
|
|
|
|
|
C08EX
|
|
Other non-selective calcium channel blockers
|
|
|
|
|
|
C08EX01
|
Lidoflazine
|
|
|
|
|
|
C08EX02
|
Perhexiline
|
|
|
|
C08G
|
|
|
Calcium channel blockers and diuretics
|
|
|
|
|
C08GA
|
|
Calcium channel blockers and diuretics
|
|
|
|
|
|
C08GA01
|
Nifedipine and diuretics
|
|
|
C09
|
|
|
|
Agents acting on the renin-angiotensin system
|
|
|
|
C09A
|
|
|
ACE inhibitors, plain
|
|
|
|
|
C09AA
|
|
ACE inhibitors, plain
|
|
|
|
|
|
C09AA01
|
Captopril
|
|
|
|
|
|
C09AA02
|
Enalapril
|
|
|
|
|
|
C09AA03
|
Lisinopril
|
|
|
|
|
|
C09AA04
|
Perindopril
|
|
|
|
|
|
C09AA05
|
Ramipril
|
|
|
|
|
|
C09AA06
|
Quinaprl
|
|
|
|
|
|
C09AA07
|
Benazepril
|
|
|
|
|
|
C09AA08
|
Cilazapril
|
|
|
|
|
|
C09AA09
|
Fosinopril
|
|
|
|
|
|
C09AA10
|
Trandolapril
|
|
|
|
|
|
C09AA11
|
Spirapril
|
|
|
|
|
|
C09AA12
|
Delapril
|
|
|
|
|
|
C09AA13
|
Moexipril
|
|
|
|
|
|
C09AA14
|
Temocapril
|
|
|
|
|
|
C09AA15
|
Zofenopril
|
|
|
|
|
|
C09AA16
|
Imidapril
|
|
|
|
C09B
|
|
|
ACE inhibitors, combinations
|
|
|
|
|
C09BA
|
|
ACE inhibitors and diuretics
|
|
|
|
|
|
C09BA01
|
Captopril and diuretics
|
|
|
|
|
|
C09BA02
|
Enalapril and diuretics
|
|
|
|
|
|
C09BA03
|
Lisinopril and diuretics
|
|
|
|
|
|
C09BA04
|
Perindopril and diuretics
|
|
|
|
|
|
C09BA05
|
Ramipril and diuretics
|
|
|
|
|
|
C09BA06
|
Quinapril and diuretics
|
|
|
|
|
|
C09BA07
|
Benazepril and diuretics
|
|
|
|
|
|
C09BA08
|
Cilazapril and diuretics
|
|
|
|
|
|
C09BA09
|
Fosinopril and diuretics
|
|
|
|
|
|
C09BA12
|
Delapril and diuretics
|
|
|
|
|
|
C09BA13
|
Moexipril and diuretics
|
|
|
|
|
|
C09BA15
|
Zofenopril and diuretics
|
|
|
|
|
C09BB
|
|
ACE inhibitors and calcium channel blockers
|
|
|
|
|
|
C09BB02
|
Enalapril and lercanidipine
|
|
|
|
|
|
C09BB03
|
Lisinopril and amlodipine
|
|
|
|
|
|
C09BB04
|
Perindopril and amlodipine
|
|
|
|
|
|
C09BB05
|
Ramipril and felodipine
|
|
|
|
|
|
C09BB06
|
Enalapril and nitrendipine
|
|
|
|
|
|
C09BB07
|
Ramipril and amlodipine
|
|
|
|
|
|
C09BB10
|
Trandolapril and verapamil
|
|
|
|
|
|
C09BB12
|
Delapril and manidipine
|
|
|
|
C09C
|
|
|
Angiotensin II antagonists, plain
|
|
|
|
|
C09CA
|
|
Angiotensin II antagonists, plain
|
|
|
|
|
|
C09CA01
|
Losartan
|
|
|
|
|
|
C09CA02
|
Eprosartan
|
|
|
|
|
|
C09CA03
|
Valsartan
|
|
|
|
|
|
C09CA04
|
Irbesartan
|
|
|
|
|
|
C09CA05
|
Tasosartan
|
|
|
|
|
|
C09CA06
|
Candesartan
|
|
|
|
|
|
C09CA07
|
Telmisartan
|
|
|
|
|
|
C09CA08
|
Olmesartan medoxomil
|
|
|
|
|
|
C09CA09
|
Azilsartan medoxomil
|
|
|
|
C09D
|
|
|
Angiotensin II antagonists, combinations
|
|
|
|
|
C09DA
|
|
Angiotensin II antagonists and diuretics
|
|
|
|
|
|
C09DA01
|
Losartan and diuretics
|
|
|
|
|
|
C09DA02
|
Eprosartan and diuretics
|
|
|
|
|
|
C09DA03
|
Valsartan and diuretics
|
|
|
|
|
|
C09DA04
|
Irbesartan and diuretics
|
|
|
|
|
|
C09DA06
|
Candesartan and diuretics
|
|
|
|
|
|
C09DA07
|
Telmisartan and diuretics
|
|
|
|
|
|
C09DA08
|
Olmesartan medoxomil and diuretics
|
|
|
|
|
C09DB
|
|
Angiotensin II antagonists and calcium channel blockers
|
|
|
|
|
|
C09DB01
|
Valsartan and amlodipine
|
|
|
|
|
|
C09DB02
|
Olmesartan medoxomil and amlodipine
|
|
|
|
|
|
C09DB04
|
Telmisartan and amlodipine
|
|
|
|
|
|
C09DB05
|
Irbesartan and amlodipine
|
|
|
|
|
|
C09DB06
|
Losartan and amlodipine
|
|
|
|
|
C09DX
|
|
Angiotensin II antagonists, other combinations
|
|
|
|
C09X
|
|
|
Other agents acting on the renin-angiotensin system
|
|
|
|
|
|
C09DX01
|
Valsartan, amlodipine and hydrochlorothiazide
|
|
|
|
|
|
C09DX02
|
Valsartan and aliskiren
|
|
|
|
|
|
C09DX03
|
Olmesartan medoxomil, amlodipine and hydrochlorothiazide
|
|
|
|
|
C09XA
|
|
Renin-inhibitors
|
|
|
|
|
|
C09XA01
|
Remikiren
|
|
|
|
|
|
C09XA02
|
Aliskiren
|
|
|
|
|
|
C09XA52
|
Aliskiren and hydrochlorothiazide
|
|
|
|
|
|
C09XA53
|
Aliskiren and amlodipine
|
|
|
|
|
|
C09XA54
|
Aliskiren, amlodipine and hydrochlorothiazide
|
|
|
C10
|
|
|
|
Lipid modifying agents
|
|
|
|
C10A
|
|
|
Lipid modifying agents, plain
|
|
|
|
|
C10AA
|
|
HMG CoA reductase inhibitors
|
|
|
|
|
|
C10AA01
|
Simvastatin
|
|
|
|
|
|
C10AA02
|
Lovastatin
|
|
|
|
|
|
C10AA03
|
Pravastatin
|
|
|
|
|
|
C10AA04
|
Fluvastatin
|
|
|
|
|
|
C10AA05
|
Atorvastatin
|
|
|
|
|
|
C10AA06
|
Cerivastatin
|
|
|
|
|
|
C10AA07
|
Rosuvastatin
|
|
|
|
|
|
C10AA08
|
Pitavastatin
|
|
|
|
|
C10AB
|
|
Fibrates
|
|
|
|
|
|
C10AB01
|
Clofibrate
|
|
|
|
|
|
C10AB02
|
Bezafibrate
|
|
|
|
|
|
C10AB03
|
Aluminium clofibrate
|
|
|
|
|
|
C10AB04
|
Gemfibrozil
|
|
|
|
|
|
C10AB05
|
Fenofibrate
|
|
|
|
|
|
C10AB06
|
Simfibrate
|
|
|
|
|
|
C10AB07
|
Ronifibrate
|
|
|
|
|
|
C10AB08
|
Ciprofibrate
|
|
|
|
|
|
C10AB09
|
Etofibrate
|
|
|
|
|
|
C10AB10
|
Clofibride
|
|
|
|
|
|
C10AB11
|
Choline fenofibrate
|
|
|
|
|
C10AC
|
|
Bile acid sequestrants
|
|
|
|
|
|
C10AC01
|
Colestyramine
|
|
|
|
|
|
C10AC02
|
Colestipol
|
|
|
|
|
|
C10AC03
|
Colextran
|
|
|
|
|
|
C10AC04
|
Colesevelam
|
|
|
|
|
C10AD
|
|
Nicotinic acid and derivatives
|
|
|
|
|
|
C10AD01
|
Niceritrol
|
|
|
|
|
|
C10AD02
|
Nicotinic acid
|
|
|
|
|
|
C10AD03
|
Nicofuranose
|
|
|
|
|
|
C10AD04
|
Aluminium nicotinate
|
|
|
|
|
|
C10AD05
|
Nicotinyl alcohol (pyridylcarbinol)
|
|
|
|
|
|
C10AD06
|
Acipimox
|
|
|
|
|
|
C10AD52
|
Nicotinic acid, combinations
|
|
|
|
|
C10AX
|
|
Other lipid modifying agents
|
|
|
|
|
|
C10AX01
|
Dextrothyroxine
|
|
|
|
|
|
C10AX02
|
Probucol
|
|
|
|
|
|
C10AX03
|
Tiadenol
|
|
|
|
|
|
C10AX05
|
Meglutol
|
|
|
|
|
|
C10AX06
|
Omega-3-triglycerides
|
|
|
|
|
|
C10AX07
|
Magnesium pyridoxal 5-phosphate glutamate
|
|
|
|
|
|
C10AX08
|
Policosanol
|
|
|
|
|
|
C10AX09
|
Ezetimibe
|
|
|
|
|
|
C10AX10
|
Alipogene tiparvovec
|
|
|
|
|
|
C10AX11
|
Mipomersen
|
|
|
|
|
|
C10AX12
|
Lomitapide
|
|
|
|
C10B
|
|
|
Lipid modifying agents, combinations
|
|
|
|
|
C10BA
|
|
HMG CoA reductase inhibitors in combination with other lipid modifying agents
|
|
|
|
|
|
C10BA01
|
Lovastatin and nicotinic acid
|
|
|
|
|
|
C10BA02
|
Simvastatin and ezetimibe
|
|
|
|
|
|
C10BA03
|
Pravastatin and fenofibrate
|
|
|
|
|
|
C10BA04
|
Simvastatin and fenofibrate
|
|
|
|
|
|
C10BA05
|
Atorvastatin and ezetimibe
|
|
|
|
|
C10BX
|
|
HMG CoA reductase inhibitors, other combinations
|
|
|
|
|
|
C10BX01
|
Simvastatin and acetylsalicylic acid
|
|
|
|
|
|
C10BX02
|
Pravastatin and acetylsalicylic acid
|
|
|
|
|
|
C10BX03
|
Atorvastatin and amlodipine
|
|
|
|
|
|
C10BX04
|
Simvastatin, acetylsalicylic acid and ramipril
|
| D
|
|
|
|
|
Dermatologicals
|
|
|
D01
|
|
|
|
Antifungals for dermatological use
|
|
|
|
D01A
|
|
|
Antifungals for topical use
|
|
|
|
|
D01AA
|
|
Antibiotics
|
|
|
|
|
|
D01AA01
|
Nystatin
|
|
|
|
|
|
D01AA02
|
Natamycin
|
|
|
|
|
|
D01AA03
|
Hachimycin
|
|
|
|
|
|
D01AA04
|
Pecilocin
|
|
|
|
|
|
D01AA06
|
Mepartricin
|
|
|
|
|
|
D01AA07
|
Pyrrolnitrin
|
|
|
|
|
|
D01AA08
|
Griseofulvin
|
|
|
|
|
|
D01AA20
|
Combinations
|
|
|
|
|
D01AC
|
|
Imidazole and triazole derivatives
|
|
|
|
|
|
D01AC01
|
Clotrimazole
|
|
|
|
|
|
D01AC02
|
Miconazole
|
|
|
|
|
|
D01AC03
|
Econazole
|
|
|
|
|
|
D01AC04
|
Clomidazole
|
|
|
|
|
|
D01AC05
|
Isoconazole
|
|
|
|
|
|
D01AC06
|
Tiabendazole
|
|
|
|
|
|
D01AC07
|
Tioconazole
|
|
|
|
|
|
D01AC08
|
Ketoconazole
|
|
|
|
|
|
D01AC09
|
Sulconazole
|
|
|
|
|
|
D01AC10
|
Bifonazole
|
|
|
|
|
|
D01AC11
|
Oxiconazole
|
|
|
|
|
|
D01AC12
|
Fenticonazole
|
|
|
|
|
|
D01AC13
|
Omoconazole
|
|
|
|
|
|
D01AC14
|
Sertaconazole
|
|
|
|
|
|
D01AC15
|
Fluconazole
|
|
|
|
|
|
D01AC16
|
Flutrimazole
|
|
|
|
|
|
D01AC17
|
Eberconazole
|
|
|
|
|
|
D01AC20
|
Combinations
|
|
|
|
|
|
D01AC52
|
Miconazole, combinations
|
|
|
|
|
|
D01AC60
|
Bifonazole, combinations
|
|
|
|
|
D01AE
|
|
Other antifungals for topical use
|
|
|
|
|
|
D01AE01
|
Bromochlorosalicylanilide
|
|
|
|
|
|
D01AE02
|
Methylrosaniline
|
|
|
|
|
|
D01AE03
|
Tribromometacresol
|
|
|
|
|
|
D01AE04
|
Undecylenic acid
|
|
|
|
|
|
D01AE05
|
Polynoxylin
|
|
|
|
|
|
D01AE06
|
2-(4-chlorphenoxy)-ethanol
|
|
|
|
|
|
D01AE07
|
Chlorphenesin
|
|
|
|
|
|
D01AE08
|
Ticlatone
|
|
|
|
|
|
D01AE09
|
Sulbentine
|
|
|
|
|
|
D01AE10
|
Ethyl hydroxybenzoate
|
|
|
|
|
|
D01AE11
|
Haloprogin
|
|
|
|
|
|
D01AE12
|
Salicylic acid
|
|
|
|
|
|
D01AE13
|
Selenium sulfide
|
|
|
|
|
|
D01AE14
|
Ciclopirox
|
|
|
|
|
|
D01AE15
|
Terbinafine
|
|
|
|
|
|
D01AE16
|
Amorolfine
|
|
|
|
|
|
D01AE17
|
Dimazole
|
|
|
|
|
|
D01AE18
|
Tolnaftate
|
|
|
|
|
|
D01AE19
|
Tolciclate
|
|
|
|
|
|
D01AE20
|
Combinations
|
|
|
|
|
|
D01AE21
|
Flucytosine
|
|
|
|
|
|
D01AE22
|
Naftifine
|
|
|
|
|
|
D01AE23
|
Butenafine
|
|
|
|
|
|
D01AE54
|
Undecylenic acid, combinations
|
|
|
|
D01B
|
|
|
Antifungals for systemic use
|
|
|
|
|
D01BA
|
|
Antifungals for systemic use
|
|
|
|
|
|
D01BA01
|
Griseofulvin
|
|
|
|
|
|
D01BA02
|
Terbinafine
|
|
|
D02
|
|
|
|
Emollients and protectives
|
|
|
|
D02A
|
|
|
Emollients and protectives
|
|
|
|
|
D02AA
|
|
Silicone products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AB
|
|
Zinc products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AC
|
|
Soft paraffin and fat products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AD
|
|
Liquid plasters
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AE
|
|
Carbamide products
|
|
|
|
|
|
D02AE01
|
Carbamide
|
|
|
|
|
|
D02AE51
|
Carbamide, combinations
|
|
|
|
|
D02AF
|
|
Salicylic acid preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AX
|
|
Other emollients and protectives
|
|
|
|
|
|
|
empty
|
|
|
|
D02B
|
|
|
Protectives against UV-radiation
|
|
|
|
|
D02BA
|
|
Protectives against UV-radiation for topical use
|
|
|
|
|
|
D02BA01
|
Aminobenzoic acid
|
|
|
|
|
|
D02BA02
|
Octinoxate
|
|
|
|
|
D02BB
|
|
Protectives against UV-radiation for systemic use
|
|
|
|
|
|
D02BB01
|
Betacarotene
|
|
|
D03
|
|
|
|
Preparations for treatment of wounds and ulcers
|
|
|
|
D03A
|
|
|
Cicatrizants
|
|
|
|
|
D03AA
|
|
Cod-liver oil ointments
|
|
|
|
|
|
|
empty
|
|
|
|
|
D03AX
|
|
Other cicatrizants
|
|
|
|
|
|
D03AX01
|
Cadexomer iodine
|
|
|
|
|
|
D03AX02
|
Dextranomer
|
|
|
|
|
|
D03AX03
|
Dexpanthenol
|
|
|
|
|
|
D03AX04
|
Calcium pantothenate
|
|
|
|
|
|
D03AX05
|
Hyaluronic acid
|
|
|
|
|
|
D03AX06
|
Becaplermin
|
|
|
|
|
|
D03AX09
|
Crilanomer
|
|
|
|
|
|
D03AX10
|
Enoxolone
|
|
|
|
|
|
D03AX11
|
Sodium chlorite (tetrachlorodecaoxide)
|
|
|
|
D03B
|
|
|
Enzymes
|
|
|
|
|
D03BA
|
|
Proteolytic enzymes
|
|
|
|
|
|
D03BA01
|
Trypsin
|
|
|
|
|
|
D03BA02
|
Clostridiopeptidase
|
|
|
|
|
|
D03BA52
|
Clostridiopeptidase, combinations
|
|
|
D04
|
|
|
|
Antipruritics, including antihistamines, anesthetics, etc
|
|
|
|
D04A
|
|
|
Antipruritics, including antihistamines, anesthetics, etc.
|
|
|
|
|
D04AA
|
|
Antihistamines for topical use
|
|
|
|
|
|
D04AA01
|
Thonzylamine
|
|
|
|
|
|
D04AA02
|
Mepyramine
|
|
|
|
|
|
D04AA03
|
Thenalidine
|
|
|
|
|
|
D04AA04
|
Tripelennamine
|
|
|
|
|
|
D04AA09
|
Chloropyramine
|
|
|
|
|
|
D04AA10
|
Promethazine
|
|
|
|
|
|
D04AA12
|
Tolpropamine
|
|
|
|
|
|
D04AA13
|
Dimetindene
|
|
|
|
|
|
D04AA14
|
Clemastine
|
|
|
|
|
|
D04AA15
|
Bamipine
|
|
|
|
|
|
D04AA22
|
Isothipendyl
|
|
|
|
|
|
D04AA32
|
Diphenhydramine
|
|
|
|
|
|
D04AA33
|
Diphenhydramine methylbromide
|
|
|
|
|
|
D04AA34
|
Chlorphenoxamine
|
|
|
|
|
D04AB
|
|
Anesthetics for topical use
|
|
|
|
|
|
D04AB01
|
Lidocaine
|
|
|
|
|
|
D04AB02
|
Cinchocaine
|
|
|
|
|
|
D04AB03
|
Oxybuprocaine
|
|
|
|
|
|
D04AB04
|
Benzocaine
|
|
|
|
|
|
D04AB05
|
Quinisocaine
|
|
|
|
|
|
D04AB06
|
Tetracaine
|
|
|
|
|
|
D04AB07
|
Pramocaine
|
|
|
|
|
D04AX
|
|
Other antipruritics
|
|
|
|
|
|
|
empty
|
|
|
D05
|
|
|
|
Antipsoriatics
|
|
|
|
D05A
|
|
|
Antipsoriatics for topical use
|
|
|
|
|
D05AA
|
|
Tars
|
|
|
|
|
|
|
empty
|
|
|
|
|
D05AC
|
|
Antracen derivatives
|
|
|
|
|
|
D05AC01
|
Dithranol
|
|
|
|
|
|
D05AC51
|
Dithranol, combinations
|
|
|
|
|
D05AD
|
|
Psoralens for topical use
|
|
|
|
|
|
D05AD01
|
Trioxysalen
|
|
|
|
|
|
D05AD02
|
Methoxsalen
|
|
|
|
|
D05AX
|
|
Other antipsoriatics for topical use
|
|
|
|
|
|
D05AX01
|
Fumaric acid
|
|
|
|
|
|
D05AX02
|
Calcipotriol
|
|
|
|
|
|
D05AX03
|
Calcitriol
|
|
|
|
|
|
D05AX04
|
Tacalcitol
|
|
|
|
|
|
D05AX05
|
Tazarotene
|
|
|
|
|
|
D05AX52
|
Calcipotriol, combinations
|
|
|
|
D05B
|
|
|
Antipsoriatics for systemic use
|
|
|
|
|
D05BA
|
|
Psoralens for systemic use
|
|
|
|
|
|
D05BA01
|
Trioxysalen
|
|
|
|
|
|
D05BA02
|
Methoxsalen
|
|
|
|
|
|
D05BA03
|
Bergapten
|
|
|
|
|
D05BB
|
|
Retinoids for treatment of psoriasis
|
|
|
|
|
|
D05BB01
|
Etretinate
|
|
|
|
|
|
D05BB02
|
Acitretin
|
|
|
|
|
D05BX
|
|
Other antipsoriatics for systemic use
|
|
|
|
|
|
D05BX51
|
Fumaric acid derivatives, combinations
|
|
|
D06
|
|
|
|
Antibiotics and chemotherapeutics for dermatological use
|
|
|
|
D06A
|
|
|
Antibiotics for topical use
|
|
|
|
|
D06AA
|
|
Tetracycline and derivatives
|
|
|
|
|
|
D06AA01
|
Demeclocycline
|
|
|
|
|
|
D06AA02
|
Chlortetracycline
|
|
|
|
|
|
D06AA03
|
Oxytetracycline
|
|
|
|
|
|
D06AA04
|
Tetracycline
|
|
|
|
|
D06AX
|
|
Other antibiotics for topical use
|
|
|
|
|
|
D06AX01
|
Fusidic acid
|
|
|
|
|
|
D06AX02
|
Chloramphenicol
|
|
|
|
|
|
D06AX04
|
Neomycin
|
|
|
|
|
|
D06AX05
|
Bacitracin
|
|
|
|
|
|
D06AX07
|
Gentamicin
|
|
|
|
|
|
D06AX08
|
Tyrothricin
|
|
|
|
|
|
D06AX09
|
Mupirocin
|
|
|
|
|
|
D06AX10
|
Virginiamycin
|
|
|
|
|
|
D06AX11
|
Rifaximin
|
|
|
|
|
|
D06AX12
|
Amikacin
|
|
|
|
|
|
D06AX13
|
Retapamulin
|
|
|
|
D06B
|
|
|
Chemotherapeutics for topical use
|
|
|
|
|
D06BA
|
|
Sulfonamides
|
|
|
|
|
|
D06BA01
|
Silver sulfadiazine
|
|
|
|
|
|
D06BA02
|
Sulfathiazole
|
|
|
|
|
|
D06BA03
|
Mafenide
|
|
|
|
|
|
D06BA04
|
Sulfamethizole
|
|
|
|
|
|
D06BA05
|
Sulfanilamide
|
|
|
|
|
|
D06BA06
|
Sulfamerazine
|
|
|
|
|
D06BB
|
|
Antivirals
|
|
|
|
|
|
D06BB01
|
Idoxuridine
|
|
|
|
|
|
D06BB02
|
Tromantadine
|
|
|
|
|
|
D06BB03
|
Aciclovir
|
|
|
|
|
|
D06BB04
|
Podophyllotoxin
|
|
|
|
|
|
D06BB05
|
Inosine
|
|
|
|
|
|
D06BB06
|
Penciclovir
|
|
|
|
|
|
D06BB07
|
Lysozyme
|
|
|
|
|
|
D06BB08
|
Ibacitabine
|
|
|
|
|
|
D06BB09
|
Edoxudine
|
|
|
|
|
|
D06BB10
|
Imiquimod
|
|
|
|
|
|
D06BB11
|
Docosanol
|
|
|
|
|
|
D06BB12
|
Sinecatechins
|
|
|
|
|
|
D06BB53
|
Aciclovir, combinations
|
|
|
|
|
D06BX
|
|
Other chemotherapeutics
|
|
|
|
|
|
D06BX01
|
Metronidazole
|
|
|
|
|
|
D06BX02
|
Ingenol mebutate
|
|
|
|
D06C
|
|
|
Antibiotics and chemotherapeutics, combinations
|
|
|
|
|
|
|
empty
|
|
|
D07
|
|
|
|
Corticosteroids, dermatological preparations
|
|
|
|
D07A
|
|
|
Corticosteroids, plain
|
|
|
|
|
D07AA
|
|
Corticosteroids, weak (group I)
|
|
|
|
|
|
D07AA01
|
Methylprednisolone
|
|
|
|
|
|
D07AA02
|
Hydrocortisone
|
|
|
|
|
|
D07AA03
|
Prednisolone
|
|
|
|
|
D07AB
|
|
Corticosteroids, moderately potent (group II)
|
|
|
|
|
|
D07AB01
|
Clobetasone
|
|
|
|
|
|
D07AB02
|
Hydrocortisone butyrate
|
|
|
|
|
|
D07AB03
|
Flumetasone
|
|
|
|
|
|
D07AB04
|
Fluocortin
|
|
|
|
|
|
D07AB05
|
Fluperolone
|
|
|
|
|
|
D07AB06
|
Fluorometholone
|
|
|
|
|
|
D07AB07
|
Fluprednidene
|
|
|
|
|
|
D07AB08
|
Desonide
|
|
|
|
|
|
D07AB09
|
Triamcinolone
|
|
|
|
|
|
D07AB10
|
Alclometasone
|
|
|
|
|
|
D07AB11
|
Hydrocortisone buteprate
|
|
|
|
|
|
D07AB19
|
Dexamethasone
|
|
|
|
|
|
D07AB21
|
Clocortolone
|
|
|
|
|
|
D07AB30
|
Combinations of corticosteroids
|
|
|
|
|
D07AC
|
|
Corticosteroids, potent (group III)
|
|
|
|
|
|
D07AC01
|
Betamethasone
|
|
|
|
|
|
D07AC02
|
Fluclorolone
|
|
|
|
|
|
D07AC03
|
Desoximetasone
|
|
|
|
|
|
D07AC04
|
Fluocinolone acetonide
|
|
|
|
|
|
D07AC05
|
Fluocortolone
|
|
|
|
|
|
D07AC06
|
Diflucortolone
|
|
|
|
|
|
D07AC07
|
Fludroxycortide
|
|
|
|
|
|
D07AC08
|
Fluocinonide
|
|
|
|
|
|
D07AC09
|
Budesonide
|
|
|
|
|
|
D07AC10
|
Diflorasone
|
|
|
|
|
|
D07AC11
|
Amcinonide
|
|
|
|
|
|
D07AC12
|
Halometasone
|
|
|
|
|
|
D07AC13
|
Mometasone furoate
|
|
|
|
|
|
D07AC14
|
Methylprednisolone aceponate
|
|
|
|
|
|
D07AC15
|
Beclometasone
|
|
|
|
|
|
D07AC16
|
Hydrocortisone aceponate
|
|
|
|
|
|
D07AC17
|
Fluticasone
|
|
|
|
|
|
D07AC18
|
Prednicarbate
|
|
|
|
|
|
D07AC19
|
Difluprednate
|
|
|
|
|
|
D07AC21
|
Ulobetasol
|
|
|
|
|
D07AD
|
|
Corticosteroids, very potent (group IV)
|
|
|
|
|
|
D07AD01
|
Clobetasol
|
|
|
|
|
|
D07AD02
|
Halcinonide
|
|
|
|
D07B
|
|
|
Corticosteroids, combinations with antiseptics
|
|
|
|
|
D07BA
|
|
Corticosteroids, weak, combinations with antiseptics
|
|
|
|
|
|
D07BA01
|
Prednisolone and antiseptics
|
|
|
|
|
|
D07BA04
|
Hydrocortisone and antiseptics
|
|
|
|
|
D07BB
|
|
Corticosteroids, moderately potent, combinations with antiseptics
|
|
|
|
|
|
D07BB01
|
Flumetasone and antiseptics
|
|
|
|
|
|
D07BB02
|
Desonide and antiseptics
|
|
|
|
|
|
D07BB03
|
Triamcinolone and antiseptics
|
|
|
|
|
|
D07BB04
|
Hydrocortisone butyrate and antiseptics
|
|
|
|
|
D07BC
|
|
Corticosteroids, potent, combinations with antiseptics
|
|
|
|
|
|
D07BC01
|
Betamethasone and antiseptics
|
|
|
|
|
|
D07BC02
|
Fluocinolone acetonide and antiseptics
|
|
|
|
|
|
D07BC03
|
Fluocortolone and antiseptics
|
|
|
|
|
|
D07BC04
|
Diflucortolone and antiseptics
|
|
|
|
|
D07BD
|
|
Corticosteroids, very potent, combinations with antiseptics
|
|
|
|
|
|
|
empty
|
|
|
|
D07C
|
|
|
Corticosteroids, combinations with antibiotics
|
|
|
|
|
D07CA
|
|
Corticosteroids, weak, combinations with antibiotics
|
|
|
|
|
|
D07CA01
|
Hydrocortisone and antibiotics
|
|
|
|
|
|
D07CA02
|
Methylprednisolone and antibiotics
|
|
|
|
|
|
D07CA03
|
Prednisolone and antibiotics
|
|
|
|
|
D07CB
|
|
Corticosteroids, moderately potent, combinations with antibiotics
|
|
|
|
|
|
D07CB01
|
Triamcinolone and antibiotics
|
|
|
|
|
|
D07CB02
|
Fluprednidene and antibiotics
|
|
|
|
|
|
D07CB03
|
Fluorometholone and antibiotics
|
|
|
|
|
|
D07CB04
|
Dexamethasone and antibiotics
|
|
|
|
|
|
D07CB05
|
Flumetasone and antibiotics
|
|
|
|
|
D07CC
|
|
Corticosteroids, potent, combinations with antibiotics
|
|
|
|
|
|
D07CC01
|
Betamethasone and antibiotics
|
|
|
|
|
|
D07CC02
|
Fluocinolone acetonide and antibiotics
|
|
|
|
|
|
D07CC03
|
Fludroxycortide and antibiotics
|
|
|
|
|
|
D07CC04
|
Beclometasone and antibiotics
|
|
|
|
|
|
D07CC05
|
Fluocinonide and antibiotics
|
|
|
|
|
|
D07CC06
|
Fluocortolone and antibiotics
|
|
|
|
|
D07CD
|
|
Corticosteroids, very potent, combinations with antibiotics
|
|
|
|
|
|
D07CD01
|
Clobetasol and antibiotics
|
|
|
|
D07X
|
|
|
Corticosteroids, other combinations
|
|
|
|
|
D07XA
|
|
Corticosteroids, weak, other combinations
|
|
|
|
|
|
D07XA01
|
Hydrocortisone
|
|
|
|
|
|
D07XA02
|
Prednisolone
|
|
|
|
|
D07XB
|
|
Corticosteroids, moderately potent, other combinations
|
|
|
|
|
|
D07XB01
|
Flumetasone
|
|
|
|
|
|
D07XB02
|
Triamcinolone
|
|
|
|
|
|
D07XB03
|
Fluprednidene
|
|
|
|
|
|
D07XB04
|
Fluorometholone
|
|
|
|
|
|
D07XB05
|
Dexamethasone
|
|
|
|
|
|
D07XB30
|
Combinations of corticosteroids
|
|
|
|
|
D07XC
|
|
Corticosteroids, potent, other combinations
|
|
|
|
|
|
D07XC01
|
Betamethasone
|
|
|
|
|
|
D07XC02
|
Desoximetasone
|
|
|
|
|
|
D07XC03
|
Mometasone
|
|
|
|
|
|
D07XC04
|
Diflucortolone
|
|
|
|
|
D07XD
|
|
Corticosteroids, very potent, other combinations
|
|
|
|
|
|
|
empty
|
|
|
D08
|
|
|
|
Antiseptics and disinfectants
|
|
|
|
D08A
|
|
|
Antiseptics and disinfectants
|
|
|
|
|
D08AA
|
|
Acridine derivatives
|
|
|
|
|
|
D08AA01
|
Ethacridine lactate
|
|
|
|
|
|
D08AA02
|
Aminoacridine
|
|
|
|
|
|
D08AA03
|
Euflavine
|
|
|
|
|
D08AB
|
|
Aluminium agents
|
|
|
|
|
|
|
empty
|
|
|
|
|
D08AC
|
|
Biguanides and amidines
|
|
|
|
|
|
D08AC01
|
Dibrompropamidine
|
|
|
|
|
|
D08AC02
|
Chlorhexidine
|
|
|
|
|
|
D08AC03
|
Propamidine
|
|
|
|
|
|
D08AC04
|
Hexamidine
|
|
|
|
|
|
D08AC05
|
Polihexanide
|
|
|
|
|
|
D08AC52
|
Chlorhexidine, combinations
|
|
|
|
|
D08AD
|
|
Boric acid products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D08AE
|
|
Phenol and derivatives
|
|
|
|
|
|
D08AE01
|
Hexachlorophene
|
|
|
|
|
|
D08AE02
|
Policresulen
|
|
|
|
|
|
D08AE03
|
Phenol
|
|
|
|
|
|
D08AE04
|
Triclosan
|
|
|
|
|
|
D08AE05
|
Chloroxylenol
|
|
|
|
|
|
D08AE06
|
Biphenylol
|
|
|
|
|
D08AF
|
|
Nitrofuran derivatives
|
|
|
|
|
|
D08AF01
|
Nitrofural
|
|
|
|
|
D08AG
|
|
Iodine products
|
|
|
|
|
|
D08AG01
|
Iodine/octylphenoxypolyglycolether
|
|
|
|
|
|
D08AG02
|
Povidone-iodine
|
|
|
|
|
|
D08AG03
|
Iodine
|
|
|
|
|
|
D08AG04
|
Diiodohydroxypropane
|
|
|
|
|
D08AH
|
|
Quinoline derivatives
|
|
|
|
|
|
D08AH01
|
Dequalinium
|
|
|
|
|
|
D08AH02
|
Chlorquinaldol
|
|
|
|
|
|
D08AH03
|
Oxyquinoline
|
|
|
|
|
|
D08AH30
|
Clioquinol
|
|
|
|
|
D08AJ
|
|
Quaternary ammonium compounds
|
|
|
|
|
|
D08AJ01
|
Benzalkonium
|
|
|
|
|
|
D08AJ02
|
Cetrimonium
|
|
|
|
|
|
D08AJ03
|
Cetylpyridinium
|
|
|
|
|
|
D08AJ04
|
Cetrimide
|
|
|
|
|
|
D08AJ05
|
Benzoxonium chloride
|
|
|
|
|
|
D08AJ06
|
Didecyldimethylammonium chloride
|
|
|
|
|
|
D08AJ08
|
Benzethonium chloride
|
|
|
|
|
|
D08AJ57
|
Octenidine, combinations
|
|
|
|
|
|
D08AJ58
|
Benzethonium chloride, combinations
|
|
|
|
|
|
D08AJ59
|
Dodeclonium bromide, combinations
|
|
|
|
|
D08AK
|
|
Mercurial products
|
|
|
|
|
|
D08AK01
|
Mercuric amidochloride
|
|
|
|
|
|
D08AK02
|
Phenylmercuric borate
|
|
|
|
|
|
D08AK03
|
Mercuric chloride
|
|
|
|
|
|
D08AK04
|
Mercurochrome
|
|
|
|
|
|
D08AK05
|
Mercury, metallic
|
|
|
|
|
|
D08AK06
|
Thiomersal
|
|
|
|
|
|
D08AK30
|
Mercuric iodide
|
|
|
|
|
D08AL
|
|
Silver compounds
|
|
|
|
|
|
D08AL01
|
Silver nitrate
|
|
|
|
|
|
D08AL30
|
Silver
|
|
|
|
|
D08AX
|
|
Other antiseptics and disinfectants
|
|
|
|
|
|
D08AX01
|
Hydrogen peroxide
|
|
|
|
|
|
D08AX02
|
Eosin
|
|
|
|
|
|
D08AX03
|
Propanol
|
|
|
|
|
|
D08AX04
|
Tosylchloramide sodium
|
|
|
|
|
|
D08AX05
|
Isopropanol
|
|
|
|
|
|
D08AX06
|
Potassium permanganate
|
|
|
|
|
|
D08AX07
|
Sodium hypochlorite
|
|
|
|
|
|
D08AX08
|
Ethanol
|
|
|
|
|
|
D08AX53
|
Propanol, combinations
|
|
|
D09
|
|
|
|
Medicated dressings
|
|
|
|
D09A
|
|
|
Medicated dressings
|
|
|
|
|
D09AA
|
|
Medicated dressings with antiinfectives
|
|
|
|
|
|
D09AA01
|
Framycetin
|
|
|
|
|
|
D09AA02
|
Fusidic acid
|
|
|
|
|
|
D09AA03
|
Nitrofural
|
|
|
|
|
|
D09AA04
|
Phenylmercuric nitrate
|
|
|
|
|
|
D09AA05
|
Benzododecinium
|
|
|
|
|
|
D09AA06
|
Triclosan
|
|
|
|
|
|
D09AA07
|
Cetylpyridinium
|
|
|
|
|
|
D09AA08
|
Aluminium chlorohydrate
|
|
|
|
|
|
D09AA09
|
Povidone-iodine
|
|
|
|
|
|
D09AA10
|
Clioquinol
|
|
|
|
|
|
D09AA11
|
Benzalkonium
|
|
|
|
|
|
D09AA12
|
Chlorhexidine
|
|
|
|
|
|
D09AA13
|
Iodoform
|
|
|
|
|
D09AB
|
|
Zinc bandages
|
|
|
|
|
|
D09AB01
|
Zinc bandage without supplements
|
|
|
|
|
|
D09AB02
|
Zinc bandage with supplements
|
|
|
|
|
D09AX
|
|
Soft paraffin dressings
|
|
|
|
|
|
|
empty
|
|
|
D10
|
|
|
|
Anti-acne preparations
|
|
|
|
D10A
|
|
|
Anti-acne preparations for topical use
|
|
|
|
|
D10AA
|
|
Corticosteroids, combinations for treatment of acne
|
|
|
|
|
|
D10AA01
|
Fluorometholone
|
|
|
|
|
|
D10AA02
|
Methylprednisolone
|
|
|
|
|
|
D10AA03
|
Dexamethasone
|
|
|
|
|
D10AB
|
|
Preparations containing sulfur
|
|
|
|
|
|
D10AB01
|
Bithionol
|
|
|
|
|
|
D10AB02
|
Sulfur
|
|
|
|
|
|
D10AB03
|
Tioxolone
|
|
|
|
|
|
D10AB05
|
Mesulfen
|
|
|
|
|
D10AD
|
|
Retinoids for topical use in acne
|
|
|
|
|
|
D10AD01
|
Tretinoin
|
|
|
|
|
|
D10AD02
|
Retinol
|
|
|
|
|
|
D10AD03
|
Adapalene
|
|
|
|
|
|
D10AD04
|
Isotretinoin
|
|
|
|
|
|
D10AD05
|
Motretinide
|
|
|
|
|
|
D10AD51
|
Tretinoin, combinations
|
|
|
|
|
|
D10AD53
|
Adapalene, combinations
|
|
|
|
|
|
D10AD54
|
Isotretinoin, combinations
|
|
|
|
|
D10AE
|
|
Peroxides
|
|
|
|
|
|
D10AE01
|
Benzoyl peroxide
|
|
|
|
|
|
D10AE51
|
Benzoyl peroxide, combinations
|
|
|
|
|
D10AF
|
|
Anti-infectives for treatment of acne
|
|
|
|
|
|
D10AF01
|
Clindamycin
|
|
|
|
|
|
D10AF02
|
Erythromycin
|
|
|
|
|
|
D10AF03
|
Chloramphenicol
|
|
|
|
|
|
D10AF04
|
Meclocycline
|
|
|
|
|
|
D10AF51
|
Clindamycin, combinations
|
|
|
|
|
|
D10AF52
|
Erythromycin, combinations
|
|
|
|
|
D10AX
|
|
Other anti-acne preparations for topical use
|
|
|
|
|
|
D10AX01
|
Aluminium chloride
|
|
|
|
|
|
D10AX02
|
Resorcinol
|
|
|
|
|
|
D10AX03
|
Azelaic acid
|
|
|
|
|
|
D10AX04
|
Aluminium oxide
|
|
|
|
|
|
D10AX05
|
Dapsone
|
|
|
|
|
|
D10AX30
|
Various combinations
|
|
|
|
D10B
|
|
|
Anti-acne preparations for systemic use
|
|
|
|
|
D10BA
|
|
Retinoids for treatment of acne
|
|
|
|
|
|
D10BA01
|
Isotretinoin
|
|
|
|
|
D10BX
|
|
Other anti-acne preparations for systemic use
|
|
|
|
|
|
D10BX01
|
Ichtasol
|
|
|
D11
|
|
|
|
Other dermatological preparations
|
|
|
|
D11A
|
|
|
Other dermatological preparations
|
|
|
|
|
D11AA
|
|
Antihidrotics
|
|
|
|
|
|
|
empty
|
|
|
|
|
D11AC
|
|
Medicated shampoos
|
|
|
|
|
|
D11AC01
|
Cetrimide
|
|
|
|
|
|
D11AC02
|
Cadmium compounds
|
|
|
|
|
|
D11AC03
|
Selenium compounds
|
|
|
|
|
|
D11AC06
|
Povidone-iodine
|
|
|
|
|
|
D11AC08
|
Sulfur compounds
|
|
|
|
|
|
D11AC09
|
Xenysalate
|
|
|
|
|
|
D11AC30
|
Others
|
|
|
|
|
D11AE
|
|
Androgens for topical use
|
|
|
|
|
|
D11AE01
|
Metandienone
|
|
|
|
|
D11AF
|
|
Wart and anti-corn preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
D11AH
|
|
Agents for dermatitis, excluding corticosteroids
|
|
|
|
|
|
D11AH01
|
Tacrolimus
|
|
|
|
|
|
D11AH02
|
Pimecrolimus
|
|
|
|
|
|
D11AH03
|
Cromoglicic acid
|
|
|
|
|
|
D11AH04
|
Alitretinoin
|
|
|
|
|
D11AX
|
|
Other dermatologicals
|
|
|
|
|
|
D11AX01
|
Minoxidil
|
|
|
|
|
|
D11AX02
|
Gamolenic acid
|
|
|
|
|
|
D11AX03
|
Calcium gluconate
|
|
|
|
|
|
D11AX04
|
Lithium succinate
|
|
|
|
|
|
D11AX05
|
Magnesium sulfate
|
|
|
|
|
|
D11AX06
|
Mequinol
|
|
|
|
|
|
D11AX08
|
Tiratricol
|
|
|
|
|
|
D11AX09
|
Oxaceprol
|
|
|
|
|
|
D11AX10
|
Finasteride
|
|
|
|
|
|
D11AX11
|
Hydroquinone
|
|
|
|
|
|
D11AX12
|
Pyrithione zinc
|
|
|
|
|
|
D11AX13
|
Monobenzone
|
|
|
|
|
|
D11AX16
|
Eflornithine
|
|
|
|
|
|
D11AX18
|
Diclofenac
|
|
|
|
|
|
D11AX52
|
Gamolenic acid, combinations
|
|
|
|
|
|
D11AX57
|
Collagen, combinations
|
| G
|
|
|
|
|
Genito-urinary system and sex hormones
|
|
|
G01
|
|
|
|
Gynecological antiinfectives and antiseptics
|
|
|
|
G01A
|
|
|
Antiinfectives and antiseptics, excluding combinations with corticosteroids
|
|
|
|
|
G01AA
|
|
Antibiotics
|
|
|
|
|
|
G01AA01
|
Nystatin
|
|
|
|
|
|
G01AA02
|
Natamycin
|
|
|
|
|
|
G01AA03
|
Amphotericin B
|
|
|
|
|
|
G01AA04
|
Candicidin
|
|
|
|
|
|
G01AA05
|
Chloramphenicol
|
|
|
|
|
|
G01AA06
|
Hachimycin
|
|
|
|
|
|
G01AA07
|
Oxytetracycline
|
|
|
|
|
|
G01AA08
|
Carfecillin
|
|
|
|
|
|
G01AA09
|
Mepartricin
|
|
|
|
|
|
G01AA10
|
Clindamycin
|
|
|
|
|
|
G01AA11
|
Pentamycin
|
|
|
|
|
|
G01AA51
|
Nystatin, combinations
|
|
|
|
|
G01AB
|
|
Arsenic compounds
|
|
|
|
|
|
G01AB01
|
Acetarsol
|
|
|
|
|
G01AC
|
|
Quinoline derivatives
|
|
|
|
|
|
G01AC01
|
Diiodohydroxyquinoline
|
|
|
|
|
|
G01AC02
|
Clioquinol
|
|
|
|
|
|
G01AC03
|
Chlorquinaldol
|
|
|
|
|
|
G01AC05
|
Dequalinium
|
|
|
|
|
|
G01AC06
|
Broxyquinoline
|
|
|
|
|
|
G01AC30
|
Oxyquinoline
|
|
|
|
|
G01AD
|
|
Organic acids
|
|
|
|
|
|
G01AD01
|
Lactic acid
|
|
|
|
|
|
G01AD02
|
Acetic acid
|
|
|
|
|
|
G01AD03
|
Ascorbic acid
|
|
|
|
|
G01AE
|
|
Sulfonamides
|
|
|
|
|
|
G01AE01
|
Sulfatolamide
|
|
|
|
|
|
G01AE10
|
Combinations of sulfonamides
|
|
|
|
|
G01AF
|
|
Imidazole derivatives
|
|
|
|
|
|
G01AF01
|
Metronidazole
|
|
|
|
|
|
G01AF02
|
Clotrimazole
|
|
|
|
|
|
G01AF04
|
Miconazole
|
|
|
|
|
|
G01AF05
|
Econazole
|
|
|
|
|
|
G01AF06
|
Ornidazole
|
|
|
|
|
|
G01AF07
|
Isoconazole
|
|
|
|
|
|
G01AF08
|
Tioconazole
|
|
|
|
|
|
G01AF11
|
Ketoconazole
|
|
|
|
|
|
G01AF12
|
Fenticonazole
|
|
|
|
|
|
G01AF13
|
Azanidazole
|
|
|
|
|
|
G01AF14
|
Propenidazole
|
|
|
|
|
|
G01AF15
|
Butoconazole
|
|
|
|
|
|
G01AF16
|
Omoconazole
|
|
|
|
|
|
G01AF17
|
Oxiconazole
|
|
|
|
|
|
G01AF18
|
Flutrimazole
|
|
|
|
|
|
G01AF20
|
Combinations of imidazole derivatives
|
|
|
|
|
G01AG
|
|
Triazole derivatives
|
|
|
|
|
|
G01AG02
|
Terconazole
|
|
|
|
|
G01AX
|
|
Other anti-infectives and antiseptics
|
|
|
|
|
|
G01AX01
|
Clodantoin
|
|
|
|
|
|
G01AX02
|
Inosine
|
|
|
|
|
|
G01AX03
|
Policresulen
|
|
|
|
|
|
G01AX05
|
Nifuratel
|
|
|
|
|
|
G01AX06
|
Furazolidone
|
|
|
|
|
|
G01AX09
|
Methylrosaniline
|
|
|
|
|
|
G01AX11
|
Povidone-iodine
|
|
|
|
|
|
G01AX12
|
Ciclopirox
|
|
|
|
|
|
G01AX13
|
Protiofate
|
|
|
|
|
|
G01AX14
|
Lactobacillus fermentum
|
|
|
|
|
|
G01AX15
|
Copper usnate
|
|
|
|
|
|
G01AX66
|
Octenidine, combinations
|
|
|
|
G01B
|
|
|
Antiinfectives/antiseptics in combination with corticosteroids
|
|
|
|
|
G01BA
|
|
Antibiotics and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BC
|
|
Quinoline derivatives and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BD
|
|
Antiseptics and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BE
|
|
Sulfonamides and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BF
|
|
Imidazole derivatives and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
G02
|
|
|
|
Other gynecologicals
|
|
|
|
G02A
|
|
|
Oxytocics
|
|
|
|
|
G02AB
|
|
Ergot alkaloids
|
|
|
|
|
|
G02AB01
|
Methylergometrine
|
|
|
|
|
|
G02AB02
|
Ergot alkaloids
|
|
|
|
|
|
G02AB03
|
Ergometrine
|
|
|
|
|
G02AC
|
|
Ergot alkaloids and oxytocin including analogues, in combination
|
|
|
|
|
|
G02AC01
|
Methylergometrine and oxytocin
|
|
|
|
|
G02AD
|
|
Prostaglandins
|
|
|
|
|
|
G02AD01
|
Dinoprost
|
|
|
|
|
|
G02AD02
|
Dinoprostone
|
|
|
|
|
|
G02AD03
|
Gemeprost
|
|
|
|
|
|
G02AD04
|
Carboprost
|
|
|
|
|
|
G02AD05
|
Sulprostone
|
|
|
|
|
|
G02AD06
|
Misoprostol
|
|
|
|
|
G02AX
|
|
Other oxytocics
|
|
|
|
|
|
|
empty
|
|
|
|
G02B
|
|
|
Contraceptives for topical use
|
|
|
|
|
G02BA
|
|
Intrauterine contraceptives
|
|
|
|
|
|
G02BA01
|
Plastic IUD
|
|
|
|
|
|
G02BA02
|
Plastic IUD with copper
|
|
|
|
|
|
G02BA03
|
Plastic IUD with progestogen
|
|
|
|
|
G02BB
|
|
Intravaginal contraceptives
|
|
|
|
|
|
G02BB01
|
Vaginal ring with progestogen and estrogen
|
|
|
|
G02C
|
|
|
Other gynecologicals
|
|
|
|
|
G02CA
|
|
Sympathomimetics, labour repressants
|
|
|
|
|
|
G02CA01
|
Ritodrine
|
|
|
|
|
|
G02CA02
|
Buphenine
|
|
|
|
|
|
G02CA03
|
Fenoterol
|
|
|
|
|
G02CB
|
|
Prolactin inhibitors
|
|
|
|
|
|
G02CB01
|
Bromocriptine
|
|
|
|
|
|
G02CB02
|
Lisuride
|
|
|
|
|
|
G02CB03
|
Cabergoline
|
|
|
|
|
|
G02CB04
|
Quinagolide
|
|
|
|
|
|
G02CB05
|
Metergoline
|
|
|
|
|
|
G02CB06
|
Terguride
|
|
|
|
|
G02CC
|
|
Anti-inflammatory products for vaginal administration
|
|
|
|
|
|
G02CC01
|
Ibuprofen
|
|
|
|
|
|
G02CC02
|
Naproxen
|
|
|
|
|
|
G02CC03
|
Benzydamine
|
|
|
|
|
|
G02CC04
|
Flunoxaprofen
|
|
|
|
|
G02CX
|
|
Other gynecologicals
|
|
|
|
|
|
G02CX01
|
Atosiban
|
|
|
|
|
|
G02CX03
|
Agni casti fructus
|
|
|
|
|
|
G02CX04
|
Cimicifugae rhizoma
|
|
|
G03
|
|
|
|
Sex hormones and modulators of the genital system
|
|
|
|
G03A
|
|
|
Hormonal contraceptives for systemic use
|
|
|
|
|
G03AA
|
|
Progestogens and estrogens, fixed combinations
|
|
|
|
|
|
G03AA01
|
Etynodiol and ethinylestradiol
|
|
|
|
|
|
G03AA02
|
Quingestanol and ethinylestradiol
|
|
|
|
|
|
G03AA03
|
Lynestrenol and ethinylestradiol
|
|
|
|
|
|
G03AA04
|
Megestrol and ethinylestradiol
|
|
|
|
|
|
G03AA05
|
Norethisterone and ethinylestradiol
|
|
|
|
|
|
G03AA06
|
Norgestrel and ethinylestradiol
|
|
|
|
|
|
G03AA07
|
Levonorgestrel and ethinylestradiol
|
|
|
|
|
|
G03AA08
|
Medroxyprogesterone and ethinylestradiol
|
|
|
|
|
|
G03AA09
|
Desogestrel and ethinylestradiol
|
|
|
|
|
|
G03AA10
|
Gestodene and ethinylestradiol
|
|
|
|
|
|
G03AA11
|
Norgestimate and ethinylestradiol
|
|
|
|
|
|
G03AA12
|
Drospirenone and ethinylestradiol
|
|
|
|
|
|
G03AA13
|
Norelgestromin and ethinylestradiol
|
|
|
|
|
|
G03AA14
|
Nomegestrol and estradiol
|
|
|
|
|
|
G03AA15
|
Chlormadinone and ethinylestradiol
|
|
|
|
|
G03AB
|
|
Progestogens and estrogens, sequential preparations
|
|
|
|
|
|
G03AB01
|
Megestrol and ethinylestradiol
|
|
|
|
|
|
G03AB02
|
Lynestrenol and ethinylestradiol
|
|
|
|
|
|
G03AB03
|
Levonorgestrel and ethinylestradiol
|
|
|
|
|
|
G03AB04
|
Norethisterone and ethinylestradiol
|
|
|
|
|
|
G03AB05
|
Desogestrel and ethinylestradiol
|
|
|
|
|
|
G03AB06
|
Gestodene and ethinylestradiol
|
|
|
|
|
|
G03AB07
|
Chlormadinone and ethinylestradiol
|
|
|
|
|
|
G03AB08
|
Dienogest and estradiol
|
|
|
|
|
G03AC
|
|
Progestogens
|
|
|
|
|
|
G03AC01
|
Norethisterone
|
|
|
|
|
|
G03AC02
|
Lynestrenol
|
|
|
|
|
|
G03AC03
|
Levonorgestrel
|
|
|
|
|
|
G03AC04
|
Quingestanol
|
|
|
|
|
|
G03AC05
|
Megestrol
|
|
|
|
|
|
G03AC06
|
Medroxyprogesterone
|
|
|
|
|
|
G03AC07
|
Norgestrienone
|
|
|
|
|
|
G03AC08
|
Etonogestrel
|
|
|
|
|
|
G03AC09
|
Desogestrel
|
|
|
|
|
G03AD
|
|
Emergency contraceptives
|
|
|
|
|
|
G03AD01
|
Levonorgestrel
|
|
|
|
|
|
G03AD02
|
Ulipristal
|
|
|
|
G03B
|
|
|
Androgens
|
|
|
|
|
G03BA
|
|
3-oxoandrosten-(4) derivatives
|
|
|
|
|
|
G03BA01
|
Fluoxymesterone
|
|
|
|
|
|
G03BA02
|
Methyltestosterone
|
|
|
|
|
|
G03BA03
|
Testosterone
|
|
|
|
|
G03BB
|
|
5-androstanon-(3) derivatives
|
|
|
|
|
|
G03BB01
|
Mesterolone
|
|
|
|
|
|
G03BB02
|
Androstanolone
|
|
|
|
G03C
|
|
|
Estrogens
|
|
|
|
|
G03CA
|
|
Natural and semisynthetic estrogens, plain
|
|
|
|
|
|
G03CA01
|
Ethinylestradiol
|
|
|
|
|
|
G03CA03
|
Estradiol
|
|
|
|
|
|
G03CA04
|
Estriol
|
|
|
|
|
|
G03CA06
|
Chlorotrianisene
|
|
|
|
|
|
G03CA07
|
Estrone
|
|
|
|
|
|
G03CA09
|
Promestriene
|
|
|
|
|
|
G03CA53
|
Estradiol, combinations
|
|
|
|
|
|
G03CA57
|
Conjugated estrogens
|
|
|
|
|
G03CB
|
|
Synthetic estrogens, plain
|
|
|
|
|
|
G03CB01
|
Dienestrol
|
|
|
|
|
|
G03CB02
|
Diethylstilbestrol
|
|
|
|
|
|
G03CB03
|
Methallenestril
|
|
|
|
|
|
G03CB04
|
Moxestrol
|
|
|
|
|
G03CC
|
|
Estrogens, combinations with other drugs
|
|
|
|
|
|
G03CC02
|
Dienestrol
|
|
|
|
|
|
G03CC03
|
Methallenestril
|
|
|
|
|
|
G03CC04
|
Estrone
|
|
|
|
|
|
G03CC05
|
Diethylstilbestrol
|
|
|
|
|
|
G03CC06
|
Estriol
|
|
|
|
|
G03CX
|
|
Other estrogens
|
|
|
|
|
|
G03CX01
|
Tibolone
|
|
|
|
G03D
|
|
|
Progestogens
|
|
|
|
|
G03DA
|
|
Pregnen-(4) derivatives
|
|
|
|
|
|
G03DA01
|
Gestonorone
|
|
|
|
|
|
G03DA02
|
Medroxyprogesterone
|
|
|
|
|
|
G03DA03
|
Hydroxyprogesterone
|
|
|
|
|
|
G03DA04
|
Progesterone
|
|
|
|
|
G03DB
|
|
Pregnadien derivatives
|
|
|
|
|
|
G03DB01
|
Dydrogesterone
|
|
|
|
|
|
G03DB02
|
Megestrol
|
|
|
|
|
|
G03DB03
|
Medrogestone
|
|
|
|
|
|
G03DB04
|
Nomegestrol
|
|
|
|
|
|
G03DB05
|
Demegestone
|
|
|
|
|
|
G03DB06
|
Chlormadinone
|
|
|
|
|
|
G03DB07
|
Promegestone
|
|
|
|
|
|
G03DB08
|
Dienogest
|
|
|
|
|
G03DC
|
|
Estren derivatives
|
|
|
|
|
|
G03DC01
|
Allylestrenol
|
|
|
|
|
|
G03DC02
|
Norethisterone
|
|
|
|
|
|
G03DC03
|
Lynestrenol
|
|
|
|
|
|
G03DC04
|
Ethisterone
|
|
|
|
|
|
G03DC05
|
Tibolone
|
|
|
|
|
|
G03DC06
|
Etynodiol
|
|
|
|
|
|
G03DC31
|
Methylestrenolone
|
|
|
|
G03E
|
|
|
Androgens and female sex hormones in combination
|
|
|
|
|
G03EA
|
|
Androgens and estrogens
|
|
|
|
|
|
G03EA01
|
Methyltestosterone and estrogen
|
|
|
|
|
|
G03EA02
|
Testosterone and estrogen
|
|
|
|
|
|
G03EA03
|
Prasterone and estrogen
|
|
|
|
|
G03EB
|
|
Androgen, progestogen and estrogen in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
G03EK
|
|
Androgens and female sex hormones in combination with other drugs
|
|
|
|
|
|
G03EK01
|
Methyltestosterone
|
|
|
|
G03F
|
|
|
Progestogens and estrogens in combination
|
|
|
|
|
G03FA
|
|
Progestogens and estrogens, fixed combinations
|
|
|
|
|
|
G03FA01
|
Norethisterone and estrogen
|
|
|
|
|
|
G03FA02
|
Hydroxyprogesterone and estrogen
|
|
|
|
|
|
G03FA03
|
Ethisterone and estrogen
|
|
|
|
|
|
G03FA04
|
Progesterone and estrogen
|
|
|
|
|
|
G03FA05
|
Methylnortestosterone and estrogen
|
|
|
|
|
|
G03FA06
|
Etynodiol and estrogen
|
|
|
|
|
|
G03FA07
|
Lynestrenol and estrogen
|
|
|
|
|
|
G03FA08
|
Megestrol and estrogen
|
|
|
|
|
|
G03FA09
|
Noretynodrel and estrogen
|
|
|
|
|
|
G03FA10
|
Norgestrel and estrogen
|
|
|
|
|
|
G03FA11
|
Levonorgestrel and estrogen
|
|
|
|
|
|
G03FA12
|
Medroxyprogesterone and estrogen
|
|
|
|
|
|
G03FA13
|
Norgestimate and estrogen
|
|
|
|
|
|
G03FA14
|
Dydrogesterone and estrogen
|
|
|
|
|
|
G03FA15
|
Dienogest and estrogen
|
|
|
|
|
|
G03FA16
|
Trimegestone and estrogen
|
|
|
|
|
|
G03FA17
|
Drospirenone and estrogen
|
|
|
|
|
G03FB
|
|
Progestogens and estrogens, sequential preparations
|
|
|
|
|
|
G03FB01
|
Norgestrel and estrogen
|
|
|
|
|
|
G03FB02
|
Lynestrenol and estrogen
|
|
|
|
|
|
G03FB03
|
Chlormadinone and estrogen
|
|
|
|
|
|
G03FB04
|
Megestrol and estrogen
|
|
|
|
|
|
G03FB05
|
Norethisterone and estrogen
|
|
|
|
|
|
G03FB06
|
Medroxyprogesterone and estrogen
|
|
|
|
|
|
G03FB07
|
Medrogestone and estrogen
|
|
|
|
|
|
G03FB08
|
Dydrogesterone and estrogen
|
|
|
|
|
|
G03FB09
|
Levonorgestrel and estrogen
|
|
|
|
|
|
G03FB10
|
Desogestrel and estrogen
|
|
|
|
|
|
G03FB11
|
Trimegestone and estrogen
|
|
|
|
G03G
|
|
|
Gonadotropins and other ovulation stimulants
|
|
|
|
|
G03GA
|
|
Gonadotropins
|
|
|
|
|
|
G03GA01
|
Human chorionic gonadotropin
|
|
|
|
|
|
G03GA02
|
Human menopausal gonadotropin
|
|
|
|
|
|
G03GA03
|
Serum gonadotropin
|
|
|
|
|
|
G03GA04
|
Urofollitropin
|
|
|
|
|
|
G03GA05
|
Follitropin alfa
|
|
|
|
|
|
G03GA06
|
Follitropin beta
|
|
|
|
|
|
G03GA07
|
Lutropin alfa
|
|
|
|
|
|
G03GA08
|
Choriogonadotropin alfa
|
|
|
|
|
|
G03GA09
|
Corifollitropin alfa
|
|
|
|
|
|
G03GA30
|
Combinations
|
|
|
|
|
G03GB
|
|
Ovulation stimulants, synthetic
|
|
|
|
|
|
G03GB01
|
Cyclofenil
|
|
|
|
|
|
G03GB02
|
Clomifene
|
|
|
|
|
|
G03GB03
|
Epimestrol
|
|
|
|
G03H
|
|
|
Antiandrogens
|
|
|
|
|
G03HA
|
|
Antiandrogens, plain
|
|
|
|
|
|
G03HA01
|
Cyproterone
|
|
|
|
|
G03HB
|
|
Antiandrogens and estrogens
|
|
|
|
|
|
G03HB01
|
Cyproterone and estrogen
|
|
|
|
G03X
|
|
|
Other sex hormones and modulators of the genital system
|
|
|
|
|
G03XA
|
|
Antigonadotropins and similar agents
|
|
|
|
|
|
G03XA01
|
Danazol
|
|
|
|
|
|
G03XA02
|
Gestrinone
|
|
|
|
|
G03XB
|
|
Antiprogestogens
|
|
|
|
|
|
G03XB01
|
Mifepristone
|
|
|
|
|
G03XC
|
|
Selective estrogen receptor modulators
|
|
|
|
|
|
G03XC01
|
Raloxifene
|
|
|
|
|
|
G03XC02
|
Bazedoxifene
|
|
|
|
|
|
G03XC03
|
Lasofoxifene
|
|
|
|
|
|
G03XC04
|
Ormeloxifene
|
|
|
G04
|
|
|
|
Urologicals
|
|
|
|
G04B
|
|
|
Urologicals
|
|
|
|
|
G04BA
|
|
Acidifiers
|
|
|
|
|
|
G04BA01
|
Ammonium chloride
|
|
|
|
|
|
G04BA03
|
Calcium chloride
|
|
|
|
|
G04BC
|
|
Urinary concrement solvents
|
|
|
|
|
|
|
empty
|
|
|
|
|
G04BD
|
|
Drugs for urinary frequency and incontinence
|
|
|
|
|
|
G04BD01
|
Emepronium
|
|
|
|
|
|
G04BD02
|
Flavoxate
|
|
|
|
|
|
G04BD03
|
Meladrazine
|
|
|
|
|
|
G04BD04
|
Oxybutynin
|
|
|
|
|
|
G04BD05
|
Terodiline
|
|
|
|
|
|
G04BD06
|
Propiverine
|
|
|
|
|
|
G04BD07
|
Tolterodine
|
|
|
|
|
|
G04BD08
|
Solifenacin
|
|
|
|
|
|
G04BD09
|
Trospium
|
|
|
|
|
|
G04BD10
|
Darifenacin
|
|
|
|
|
|
G04BD11
|
Fesoterodine
|
|
|
|
|
|
G04BD12
|
Mirabegron
|
|
|
|
|
G04BE
|
|
Drugs used in erectile dysfunction
|
|
|
|
|
|
G04BE01
|
Alprostadil
|
|
|
|
|
|
G04BE02
|
Papaverine
|
|
|
|
|
|
G04BE03
|
Sildenafil
|
|
|
|
|
|
G04BE04
|
Yohimbin
|
|
|
|
|
|
G04BE06
|
Moxisylyte
|
|
|
|
|
|
G04BE07
|
Apomorphine
|
|
|
|
|
|
G04BE08
|
Tadalafil
|
|
|
|
|
|
G04BE09
|
Vardenafil
|
|
|
|
|
|
G04BE30
|
Combinations
|
|
|
|
|
|
G04BE52
|
Papaverine, combinations
|
|
|
|
|
G04BX
|
|
Other urologicals
|
|
|
|
|
|
G04BX01
|
Magnesium hydroxide
|
|
|
|
|
|
G04BX03
|
Acetohydroxamic acid
|
|
|
|
|
|
G04BX06
|
Phenazopyridine
|
|
|
|
|
|
G04BX10
|
Succinimide
|
|
|
|
|
|
G04BX11
|
Collagen
|
|
|
|
|
|
G04BX12
|
Phenyl salicylate
|
|
|
|
|
|
G04BX13
|
Dimethyl sulfoxide
|
|
|
|
|
|
G04BX14
|
Dapoxetine
|
|
|
|
|
|
G04BX15
|
Pentosan polysulfate sodium
|
|
|
|
G04C
|
|
|
Drugs used in benign prostatic hypertrophy
|
|
|
|
|
G04CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
|
|
G04CA01
|
Alfuzosin
|
|
|
|
|
|
G04CA02
|
Tamsulosin
|
|
|
|
|
|
G04CA03
|
Terazosin
|
|
|
|
|
|
G04CA04
|
Silodosin
|
|
|
|
|
|
G04CA51
|
Alfuzosin and finasteride
|
|
|
|
|
|
G04CA52
|
Tamsulosin and dutasteride
|
|
|
|
|
|
G04CA53
|
Tamsulosin and solifenacin
|
|
|
|
|
G04CB
|
|
Testosterone-5-alpha reductase inhibitors
|
|
|
|
|
|
G04CB01
|
Finasteride
|
|
|
|
|
|
G04CB02
|
Dutasteride
|
|
|
|
|
G04CX
|
|
Other drugs used in benign prostatic hypertrophy
|
|
|
|
|
|
G04CX01
|
Prunus africanae cortex
|
|
|
|
|
|
G04CX02
|
Sabalis serrulatae fructus
|
|
|
|
|
|
G04CX03
|
Mepartricin
|
| H
|
|
|
|
|
Systemic hormonal preparations, excluding sex hormones and insulins
|
|
|
H01
|
|
|
|
Pituitary and hypothalamic hormones and analogues
|
|
|
|
H01A
|
|
|
Anterior pituitary lobe hormones and analogues
|
|
|
|
|
H01AA
|
|
Adrenocorticotropic hormone
|
|
|
|
|
|
H01AA01
|
Corticotropin
|
|
|
|
|
|
H01AA02
|
Tetracosactide
|
|
|
|
|
H01AB
|
|
Thyrotropin
|
|
|
|
|
|
H01AB01
|
Thyrotropin
|
|
|
|
|
H01AC
|
|
Somatropin and somatropin agonists
|
|
|
|
|
|
H01AC01
|
Somatropin
|
|
|
|
|
|
H01AC02
|
Somatrem
|
|
|
|
|
|
H01AC03
|
Mecasermin
|
|
|
|
|
|
H01AC04
|
Sermorelin
|
|
|
|
|
|
H01AC05
|
Mecasermin rinfabate
|
|
|
|
|
|
H01AC06
|
Tesamorelin
|
|
|
|
|
H01AX
|
|
Other anterior pituitary lobe hormones and analogues
|
|
|
|
|
|
H01AX01
|
Pegvisomant
|
|
|
|
H01B
|
|
|
Posterior pituitary lobe hormones
|
|
|
|
|
H01BA
|
|
Vasopressin and analogues
|
|
|
|
|
|
H01BA01
|
Vasopressin
|
|
|
|
|
|
H01BA02
|
Desmopressin
|
|
|
|
|
|
H01BA03
|
Lypressin
|
|
|
|
|
|
H01BA04
|
Terlipressin
|
|
|
|
|
|
H01BA05
|
Ornipressin
|
|
|
|
|
|
H01BA06
|
Argipressin
|
|
|
|
|
H01BB
|
|
Oxytocin and analogues
|
|
|
|
|
|
H01BB01
|
Demoxytocin
|
|
|
|
|
|
H01BB02
|
Oxytocin
|
|
|
|
|
|
H01BB03
|
Carbetocin
|
|
|
|
H01C
|
|
|
Hypothalamic hormones
|
|
|
|
|
H01CA
|
|
Gonadotropin-releasing hormones
|
|
|
|
|
|
H01CA01
|
Gonadorelin
|
|
|
|
|
|
H01CA02
|
Nafarelin
|
|
|
|
|
H01CB
|
|
Somatostatin and analogues
|
|
|
|
|
|
H01CB01
|
Somatostatin
|
|
|
|
|
|
H01CB02
|
Octreotide
|
|
|
|
|
|
H01CB03
|
Lanreotide
|
|
|
|
|
|
H01CB04
|
Vapreotide
|
|
|
|
|
|
H01CB05
|
Pasireotide
|
|
|
|
|
H01CC
|
|
Anti-gonadotropin-releasing hormones
|
|
|
|
|
|
H01CC01
|
Ganirelix
|
|
|
|
|
|
H01CC02
|
Cetrorelix
|
|
|
H02
|
|
|
|
Corticosteroids for systemic use
|
|
|
|
H02A
|
|
|
Corticosteroids for systemic use, plain
|
|
|
|
|
H02AA
|
|
Mineralocorticoids
|
|
|
|
|
|
H02AA01
|
Aldosterone
|
|
|
|
|
|
H02AA02
|
Fludrocortisone
|
|
|
|
|
|
H02AA03
|
Desoxycortone
|
|
|
|
|
H02AB
|
|
Glucocorticoids
|
|
|
|
|
|
H02AB01
|
Betamethasone
|
|
|
|
|
|
H02AB02
|
Dexamethasone
|
|
|
|
|
|
H02AB03
|
Fluocortolone
|
|
|
|
|
|
H02AB04
|
Methylprednisolone
|
|
|
|
|
|
H02AB05
|
Paramethasone
|
|
|
|
|
|
H02AB06
|
Prednisolone
|
|
|
|
|
|
H02AB07
|
Prednisone
|
|
|
|
|
|
H02AB08
|
Triamcinolone
|
|
|
|
|
|
H02AB09
|
Hydrocortisone
|
|
|
|
|
|
H02AB10
|
Cortisone
|
|
|
|
|
|
H02AB11
|
Prednylidene
|
|
|
|
|
|
H02AB12
|
Rimexolone
|
|
|
|
|
|
H02AB13
|
Deflazacort
|
|
|
|
|
|
H02AB14
|
Cloprednol
|
|
|
|
|
|
H02AB15
|
Meprednisone
|
|
|
|
|
|
H02AB17
|
Cortivazol
|
|
|
|
H02B
|
|
|
Corticosteroids for systemic use, combinations
|
|
|
|
|
H02BX
|
|
Corticosteroids for systemic use, combinations
|
|
|
|
|
|
H02BX01
|
Methylprednisolone, combinations
|
|
|
|
H02C
|
|
|
Antiadrenal preparations
|
|
|
|
|
H02CA
|
|
Anticorticosteroids
|
|
|
|
|
|
H02CA01
|
Trilostane
|
|
|
H03
|
|
|
|
Thyroid therapy
|
|
|
|
H03A
|
|
|
Thyroid preparations
|
|
|
|
|
H03AA
|
|
Thyroid hormones
|
|
|
|
|
|
H03AA01
|
Levothyroxine sodium
|
|
|
|
|
|
H03AA02
|
Liothyronine sodium
|
|
|
|
|
|
H03AA03
|
Combinations of levothyroxine and liothyronine
|
|
|
|
|
|
H03AA04
|
Tiratricol
|
|
|
|
|
|
H03AA05
|
Thyroid gland preparations
|
|
|
|
H03B
|
|
|
Antithyroid preparations
|
|
|
|
|
H03BA
|
|
Thiouracils
|
|
|
|
|
|
H03BA01
|
Methylthiouracil
|
|
|
|
|
|
H03BA02
|
Propylthiouracil
|
|
|
|
|
|
H03BA03
|
Benzylthiouracil
|
|
|
|
|
H03BB
|
|
Sulphur-containing imidazole derivatives
|
|
|
|
|
|
H03BB01
|
Carbimazole
|
|
|
|
|
|
H03BB02
|
Thiamazole
|
|
|
|
|
|
H03BB52
|
Thiamazole, combinations
|
|
|
|
|
H03BC
|
|
Perchlorates
|
|
|
|
|
|
H03BC01
|
Potassium perchlorate
|
|
|
|
|
H03BX
|
|
Other antithyroid preparations
|
|
|
|
|
|
H03BX01
|
Diiodotyrosine
|
|
|
|
|
|
H03BX02
|
Dibromotyrosine
|
|
|
|
H03C
|
|
|
Iodine therapy
|
|
|
|
|
H03CA
|
|
Iodine therapy
|
|
|
|
|
|
|
empty
|
|
|
H04
|
|
|
|
Pancreatic hormones
|
|
|
|
H04A
|
|
|
Glycogenolytic hormones
|
|
|
|
|
H04AA
|
|
Glycogenolytic hormones
|
|
|
|
|
|
H04AA01
|
Glucagon
|
|
|
H05
|
|
|
|
Calcium homeostasis
|
|
|
|
H05A
|
|
|
Parathyroid hormones and analogues
|
|
|
|
|
H05AA
|
|
Parathyroid hormones and analogues
|
|
|
|
|
|
H05AA01
|
Parathyroid gland extract
|
|
|
|
|
|
H05AA02
|
Teriparatide
|
|
|
|
|
|
H05AA03
|
Parathyroid hormone
|
|
|
|
H05B
|
|
|
Anti-parathyroid agents
|
|
|
|
|
H05BA
|
|
Calcitonin preparations
|
|
|
|
|
|
H05BA01
|
Calcitonin (salmon synthetic)
|
|
|
|
|
|
H05BA02
|
Calcitonin (pork natural)
|
|
|
|
|
|
H05BA03
|
Calcitonin (human synthetic)
|
|
|
|
|
|
H05BA04
|
Elcatonin
|
|
|
|
|
H05BX
|
|
Other anti-parathyroid agents
|
|
|
|
|
|
H05BX01
|
Cinacalcet
|
|
|
|
|
|
H05BX02
|
Paricalcitol
|
|
|
|
|
|
H05BX03
|
Doxercalciferol
|
| J
|
|
|
|
|
Antiinfectives for systemic use
|
|
|
J01
|
|
|
|
Antibacterials for systemic use
|
|
|
|
J01A
|
|
|
Tetracyclines
|
|
|
|
|
J01AA
|
|
Tetracyclines
|
|
|
|
|
|
J01AA01
|
Demeclocycline
|
|
|
|
|
|
J01AA02
|
Doxycycline
|
|
|
|
|
|
J01AA03
|
Chlortetracycline
|
|
|
|
|
|
J01AA04
|
Lymecycline
|
|
|
|
|
|
J01AA05
|
Metacycline
|
|
|
|
|
|
J01AA06
|
Oxytetracycline
|
|
|
|
|
|
J01AA07
|
Tetracycline
|
|
|
|
|
|
J01AA08
|
Minocycline
|
|
|
|
|
|
J01AA09
|
Rolitetracycline
|
|
|
|
|
|
J01AA10
|
Penimepicycline
|
|
|
|
|
|
J01AA11
|
Clomocycline
|
|
|
|
|
|
J01AA12
|
Tigecycline
|
|
|
|
|
|
J01AA20
|
Combinations of tetracyclines
|
|
|
|
|
|
J01AA56
|
Oxytetracycline, combinations
|
|
|
|
J01B
|
|
|
Amphenicols
|
|
|
|
|
J01BA
|
|
Amphenicols
|
|
|
|
|
|
J01BA01
|
Chloramphenicol
|
|
|
|
|
|
J01BA02
|
Thiamphenicol
|
|
|
|
|
|
J01BA52
|
Thiamphenicol, combinations
|
|
|
|
J01C
|
|
|
Beta-lactam antibacterials, penicillins
|
|
|
|
|
J01CA
|
|
Penicillins with extended spectrum
|
|
|
|
|
|
J01CA01
|
Ampicillin
|
|
|
|
|
|
J01CA02
|
Pivampicillin
|
|
|
|
|
|
J01CA03
|
Carbenicillin
|
|
|
|
|
|
J01CA04
|
Amoxicillin
|
|
|
|
|
|
J01CA05
|
Carindacillin
|
|
|
|
|
|
J01CA06
|
Bacampicillin
|
|
|
|
|
|
J01CA07
|
Epicillin
|
|
|
|
|
|
J01CA08
|
Pivmecillinam
|
|
|
|
|
|
J01CA09
|
Azlocillin
|
|
|
|
|
|
J01CA10
|
Mezlocillin
|
|
|
|
|
|
J01CA11
|
Mecillinam
|
|
|
|
|
|
J01CA12
|
Piperacillin
|
|
|
|
|
|
J01CA13
|
Ticarcillin
|
|
|
|
|
|
J01CA14
|
Metampicillin
|
|
|
|
|
|
J01CA15
|
Talampicillin
|
|
|
|
|
|
J01CA16
|
Sulbenicillin
|
|
|
|
|
|
J01CA17
|
Temocillin
|
|
|
|
|
|
J01CA18
|
Hetacillin
|
|
|
|
|
|
J01CA19
|
Aspoxicillin
|
|
|
|
|
|
J01CA20
|
Combinations
|
|
|
|
|
|
J01CA51
|
Ampicillin, combinations
בעבודה
|
|
|
|
|
J01CE Beta-lactamase-sensitive penicillins
J01CE01 Benzylpenicillin
J01CE02 Phenoxymethylpenicillin
J01CE03 Propicillin
J01CE04 Azidocillin
J01CE05 Pheneticillin
J01CE06 Penamecillin
J01CE07 Clometocillin
J01CE08 Benzathine benzylpenicillin
J01CE09 Procaine benzylpenicillin
J01CE10 Benzathine phenoxymethylpenicillin
J01CE30 Combinations
|
|
|
|
|
J01CF Beta-lactamase-resistant penicillins
J01CF01 Dicloxacillin
J01CF02 Cloxacillin
J01CF03 Methicillin
J01CF04 Oxacillin
J01CF05 Flucloxacillin
J01CF06 Nafcillin
|
|
|
|
|
J01CG Beta-lactamase inhibitors
J01CG01 Sulbactam
J01CG02 Tazobactam
|
|
|
|
|
J01CR Combinations of penicillins, including beta-lactamase inhibitors
J01CR01 Ampicillin and enzyme inhibitor
J01CR02 Amoxicillin and enzyme inhibitor
J01CR03 Ticarcillin and enzyme inhibitor
J01CR04 Sultamicillin
J01CR05 Piperacillin and enzyme inhibitor
J01CR50 Combinations of penicillins
|
|
|
|
J01D
|
|
|
Other beta-lactam antibacterials
|
|
|
|
|
J01DB First-generation cephalosporins
J01DB01 Cefalexin
J01DB02 Cefaloridine
J01DB03 Cefalotin
J01DB04 Cefazolin
J01DB05 Cefadroxil
J01DB06 Cefazedone
J01DB07 Cefatrizine
J01DB08 Cefapirin
J01DB09 Cefradine
J01DB10 Cefacetrile
J01DB11 Cefroxadine
J01DB12 Ceftezole
|
|
|
|
|
J01DC Second-generation cephalosporins
J01DC01 Cefoxitin
J01DC02 Cefuroxime
J01DC03 Cefamandole
J01DC04 Cefaclor
J01DC05 Cefotetan
J01DC06 Cefonicide
J01DC07 Cefotiam
J01DC08 Loracarbef
J01DC09 Cefmetazole
J01DC10 Cefprozil
J01DC11 Ceforanide
J01DC12 Cefminox
J01DC13 Cefbuperazone
J01DC14 Flomoxef
|
|
|
|
|
J01DD Third-generation cephalosporins
J01DD01 Cefotaxime
J01DD02 Ceftazidime
J01DD03 Cefsulodin
J01DD04 Ceftriaxone
J01DD05 Cefmenoxime
J01DD06 Latamoxef
J01DD07 Ceftizoxime
J01DD08 Cefixime
J01DD09 Cefodizime
J01DD10 Cefetamet
J01DD11 Cefpiramide
J01DD12 Cefoperazone
J01DD13 Cefpodoxime
J01DD14 Ceftibuten
J01DD15 Cefdinir
J01DD16 Cefditoren
J01DD17 Cefcapene
J01DD54 Ceftriaxone, combinations
J01DD62 Cefoperazone, combinations
|
|
|
|
|
J01DE Fourth-generation cephalosporins
J01DE01 Cefepime
J01DE02 Cefpirome
J01DE03 Cefozopran
|
|
|
|
|
J01DF Monobactams
J01DF01 Aztreonam
J01DF02 Carumonam
|
|
|
|
|
J01DH Carbapenems
J01DH02 Meropenem
J01DH03 Ertapenem
J01DH04 Doripenem
J01DH05 Biapenem
J01DH51 Imipenem and enzyme inhibitor
J01DH55 Panipenem and betamipron
|
|
|
|
|
J01DI Other cephalosporins and penems
J01DI01 Ceftobiprole medocaril
J01DI02 Ceftaroline fosamil
J01DI03 Faropenem
|
|
|
|
J01E
|
|
|
Sulfonamides and trimethoprim
J01EA Trimethoprim and derivatives
J01EA01 Trimethoprim
J01EA02 Brodimoprim
J01EA03 Iclaprim
|
|
|
|
|
J01EB Short-acting sulfonamides
J01EB01 Sulfaisodimidine
J01EB02 Sulfamethizole
J01EB03 Sulfadimidine
J01EB04 Sulfapyridine
J01EB05 Sulfafurazole
J01EB06 Sulfanilamide
J01EB07 Sulfathiazole
J01EB08 Sulfathiourea
J01EB20 Combinations
|
|
|
|
|
J01EC Intermediate-acting sulfonamides
J01EC01 Sulfamethoxazole
J01EC02 Sulfadiazine
J01EC03 Sulfamoxole
J01EC20 Combinations
|
|
|
|
|
J01ED Long-acting sulfonamides
J01ED01 Sulfadimethoxine
J01ED02 Sulfalene
J01ED03 Sulfametomidine
J01ED04 Sulfametoxydiazine
J01ED05 Sulfamethoxypyridazine
J01ED06 Sulfaperin
J01ED07 Sulfamerazine
J01ED08 Sulfaphenazole
J01ED09 Sulfamazon
J01ED20 Combinations
|
|
|
|
|
J01EE Combinations of sulfonamides and trimethoprim, including derivatives
J01EE01 Sulfamethoxazole and trimethoprim
J01EE02 Sulfadiazine and trimethoprim
J01EE03 Sulfametrole and trimethoprim
J01EE04 Sulfamoxole and trimethoprim
J01EE05 Sulfadimidine and trimethoprim
J01EE06 Sulfadiazine and tetroxoprim
J01EE07 Sulfamerazine and trimethoprim
|
|
|
|
J01F
|
|
|
Macrolides, lincosamides and streptogramins
J01FA Macrolides
J01FA01 Erythromycin
J01FA02 Spiramycin
J01FA03 Midecamycin
J01FA05 Oleandomycin
J01FA06 Roxithromycin
J01FA07 Josamycin
J01FA08 Troleandomycin
J01FA09 Clarithromycin
J01FA10 Azithromycin
J01FA11 Miocamycin
J01FA12 Rokitamycin
J01FA13 Dirithromycin
J01FA14 Flurithromycin
J01FA15 Telithromycin
|
|
|
|
|
J01FF Lincosamides
J01FF01 Clindamycin
J01FF02 Lincomycin
|
|
|
|
|
J01FG Streptogramins
J01FG01 Pristinamycin
J01FG02 Quinupristin/dalfopristin
|
|
|
|
J01G
|
|
|
Aminoglycoside antibacterials
J01GA Streptomycins
J01GA01 Streptomycin
J01GA02 Streptoduocin
|
|
|
|
|
J01GB Other aminoglycosides
J01GB01 Tobramycin
J01GB03 Gentamicin
J01GB04 Kanamycin
J01GB05 Neomycin
J01GB06 Amikacin
J01GB07 Netilmicin
J01GB08 Sisomicin
J01GB09 Dibekacin
J01GB10 Ribostamycin
J01GB11 Isepamicin
J01GB12 Arbekacin
J01GB13 Bekanamycin
|
|
|
|
J01M
|
|
|
Quinolone antibacterials
J01MA Fluoroquinolones
J01MA01 Ofloxacin
J01MA02 Ciprofloxacin
J01MA03 Pefloxacin
J01MA04 Enoxacin
J01MA05 Temafloxacin
J01MA06 Norfloxacin
J01MA07 Lomefloxacin
J01MA08 Fleroxacin
J01MA09 Sparfloxacin
J01MA10 Rufloxacin
J01MA11 Grepafloxacin
J01MA12 Levofloxacin
J01MA13 Trovafloxacin
J01MA14 Moxifloxacin
J01MA15 Gemifloxacin
J01MA16 Gatifloxacin
J01MA17 Prulifloxacin
J01MA18 Pazufloxacin
J01MA19 Garenoxacin
J01MA21 Sitafloxacin
|
|
|
|
|
J01MB Other quinolones
J01MB01 Rosoxacin
J01MB02 Nalidixic acid
J01MB03 Piromidic acid
J01MB04 Pipemidic acid
J01MB05 Oxolinic acid
J01MB06 Cinoxacin
J01MB07 Flumequine
|
|
|
|
J01R
|
|
|
Combinations of antibacterials
|
|
|
|
|
J01RA Combinations of antbacterials
J01RA01 Penicillins, combinations with other antibacterials
J01RA02 Sulfonamides, combinations with other antibacterials (excluding trimethoprim)
J01RA03 Cefuroxime, combinations with other antibacterials
J01RA04 Spiramycin, combinations with other antibacterials
|
|
|
|
J01X
|
|
|
Other antibacterials
|
|
|
|
|
J01XA
|
|
Glycopeptide antibacterials
J01XA01 Vancomycin
J01XA02 Teicoplanin
J01XA03 Telavancin
J01XA04 Dalbavancin
J01XA05 Oritavancin
|
|
|
|
|
J01XB
|
|
Polymyxins
J01XB01 Colistin
J01XB02 Polymyxin B
|
|
|
|
|
J01XC
|
|
Steroid antibacterials
J01XC01 Fusidic acid
|
|
|
|
|
J01XD
|
|
Imidazole derivatives
J01XD01 Metronidazole
J01XD02 Tinidazole
J01XD03 Ornidazole
|
|
|
|
|
J01XE
|
|
Nitrofuran derivatives
J01XE01 Nitrofurantoin
J01XE02 Nifurtoinol
|
|
|
|
|
J01XX
|
|
Other antibacterials
J01XX01 Fosfomycin
J01XX02 Xibornol
J01XX03 Clofoctol
J01XX04 Spectinomycin
J01XX05 Methenamine
J01XX06 Mandelic acid
J01XX07 Nitroxoline
J01XX08 Linezolid
J01XX09 Daptomycin
J01XX10 Bacitracin
|
|
|
J02
|
|
|
|
Antimycotics for systemic use
|
|
|
J04
|
|
|
|
Antimycobacterials
|
|
|
J05
|
|
|
|
Antivirals for systemic use
|
|
|
|
J05A
|
|
|
Direct acting antiviral drugs
|
|
|
|
|
J05AA
|
|
Thiosemicarbazones
|
|
|
|
|
J05AB
|
|
Nucleosides and nucleotides excluding reverse transcriptase inhibitors
|
|
|
|
|
J05AC
|
|
Cyclic amines
|
|
|
|
|
J05AD
|
|
Phosphonic acid derivatives
|
|
|
|
|
J05AE
|
|
Protease inhibitors
|
|
|
|
|
J05AF
|
|
Nucleoside and nucleotide reverse transcriptase inhibitors
|
|
|
|
|
|
J05AF01
|
Zidovudine
|
|
|
|
|
|
J05AF02
|
Didanosine
|
|
|
|
|
|
J05AF03
|
Zalcitabine
|
|
|
|
|
|
J05AF04
|
Stavudine
|
|
|
|
|
|
J05AF05
|
Lamivudine
|
|
|
|
|
|
J05AF06
|
Abacavir
|
|
|
|
|
|
J05AF07
|
Tenofovir disoproxil
|
|
|
|
|
|
J05AF08
|
Adefovir dipivoxil
|
|
|
|
|
|
J05AF09
|
Emtricitabine
|
|
|
|
|
|
J05AF10
|
Entecavir
|
|
|
|
|
|
J05AF11
|
Telbivudine
|
|
|
|
|
|
J05AF12
|
Clevudine
|
|
|
|
|
J05AG
|
|
Non-nucleoside reverse transcriptase inhibitors
|
|
|
|
|
|
J05AG01
|
Nevirapine
|
|
|
|
|
|
J05AG02
|
Delavirdine
|
|
|
|
|
|
J05AG03
|
Efavirenz
|
|
|
|
|
|
J05AG04
|
Etravirine
|
|
|
|
|
|
J05AG05
|
Rilpivirine
|
|
|
|
|
J05AH
|
|
Neuraminidase inhibitors
|
|
|
|
|
|
J05AH01
|
Zanamivir
|
|
|
|
|
|
J05AH02
|
Oseltamivir
|
|
|
|
|
J05AR
|
|
Antivirals for treatment of HIV infections, combinations
|
|
|
|
|
|
J05AR01
|
Zidovudine and lamivudine
|
|
|
|
|
|
J05AR02
|
Lamivudine and abacavir
|
|
|
|
|
|
J05AR03
|
Tenofovir disoproxil and emtricitabine
|
|
|
|
|
|
J05AR04
|
Zidovudine, lamivudine and abacavir
|
|
|
|
|
|
J05AR05
|
Zidovudine, lamivudine and nevirapine
|
|
|
|
|
|
J05AR06
|
Emtricitabine, tenofovir disoproxil and efavirenz
|
|
|
|
|
|
J05AR07
|
Stavudine, lamivudine and nevirapine
|
|
|
|
|
|
J05AR08
|
Emtricitabine, tenofovir disoproxil and rilpivirine
|
|
|
|
|
|
J05AR09
|
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
|
|
|
|
|
|
J05AR10
|
Lopinavir and ritonavir
|
|
|
|
|
J05AX
|
|
Other antivirals
|
|
|
|
|
|
J05AX01
|
Moroxydine
|
|
|
|
|
|
J05AX02
|
Lysozyme
|
|
|
|
|
|
J05AX05
|
Inosine pranobex
|
|
|
|
|
|
J05AX06
|
Pleconaril
|
|
|
|
|
|
J05AX07
|
Enfuvirtide
|
|
|
|
|
|
J05AX08
|
Raltegravir
|
|
|
|
|
|
J05AX09
|
Maraviroc
|
|
|
|
|
|
J05AX10
|
Maribavir
|
|
|
|
|
|
J05AX11
|
Elvitegravir
|
|
|
J06
|
|
|
|
Immune sera and immunoglobulins
|
|
|
|
J06A
|
|
|
Immune sera
|
|
|
|
|
J06AA
|
|
Immune sera
|
|
|
|
|
|
J06AA01
|
Diphtheria antitoxin
|
|
|
|
|
|
J06AA02
|
Tetanus antitoxin
|
|
|
|
|
|
J06AA03
|
Snake venom antiserum
|
|
|
|
|
|
J06AA04
|
Botulinum antitoxin
|
|
|
|
|
|
J06AA05
|
Gas-gangrene sera
|
|
|
|
|
|
J06AA06
|
Rabies serum
|
|
|
|
J06B
|
|
|
Immunoglobulins
|
|
|
|
|
J06BA
|
|
Immunoglobulins, normal human
|
|
|
|
|
|
J06BA01
|
Immunoglobulins, normal human, for extravascular administration
|
|
|
|
|
|
J06BA02
|
Immunoglobulins, normal human, for intravascular administration
|
|
|
|
|
J06BB
|
|
Specific immunoglobulins
|
|
|
|
|
|
J06BB01
|
Anti-D (rh) immunoglobulin
|
|
|
|
|
|
J06BB02
|
Tetanus immunoglobulin
|
|
|
|
|
|
J06BB03
|
Varicella/zoster immunoglobulin
|
|
|
|
|
|
J06BB04
|
Hepatitis B immunoglobulin
|
|
|
|
|
|
J06BB05
|
Rabies immunoglobulin
|
|
|
|
|
|
J06BB06
|
Rubella immunoglobulin
|
|
|
|
|
|
J06BB07
|
Vaccinia immunoglobulin
|
|
|
|
|
|
J06BB08
|
Staphylococcus immunoglobulin
|
|
|
|
|
|
J06BB09
|
Cytomegalovirus immunoglobulin
|
|
|
|
|
|
J06BB10
|
Diphtheria immunoglobulin
|
|
|
|
|
|
J06BB11
|
Hepatitis A immunoglobulin
|
|
|
|
|
|
J06BB12
|
Encephalitis, tick borne immunoglobulin
|
|
|
|
|
|
J06BB13
|
Pertussis immunoglobulin
|
|
|
|
|
|
J06BB14
|
Morbilli immunoglobulin
|
|
|
|
|
|
J06BB15
|
Parotitis immunoglobulin
|
|
|
|
|
|
J06BB16
|
Palivizumab
|
|
|
|
|
|
J06BB17
|
Motavizumab
|
|
|
|
|
|
J06BB30
|
Combinations
|
|
|
|
|
J06BC
|
|
Other immunoglobulins
|
|
|
|
|
|
J06BC01
|
Nebacumab
|
| L
|
|
|
|
|
Antineoplastic and immunomodulating agents
|
|
|
L01
|
|
|
|
Antineoplastic agents
|
|
|
|
L01A
|
|
|
Alkylating agents
|
|
|
|
|
L01AA
|
|
Nitrogen mustard analogues
|
|
|
|
|
|
L01AA01
|
Cyclophosphamide
|
|
|
|
|
|
L01AA02
|
Chlorambucil
|
|
|
|
|
|
L01AA03
|
Melphalan
|
|
|
|
|
|
L01AA05
|
Chlormethine
|
|
|
|
|
|
L01AA06
|
Ifosfamide
|
|
|
|
|
|
L01AA07
|
Trofosfamide
|
|
|
|
|
|
L01AA08
|
Prednimustine
|
|
|
|
|
|
L01AA09
|
Bendamustine
|
|
|
|
|
L01AB
|
|
Alkyl sulfonates
|
|
|
|
|
|
L01AB01
|
Busulfan
|
|
|
|
|
|
L01AB02
|
Treosulfan
|
|
|
|
|
|
L01AB03
|
Mannosulfan
|
|
|
|
|
L01AC
|
|
Ethylene imines
|
|
|
|
|
|
L01AC01
|
Thiotepa
|
|
|
|
|
|
L01AC02
|
Triaziquone
|
|
|
|
|
|
L01AC03
|
Carboquone
|
|
|
|
|
L01AD
|
|
Nitrosoureas
|
|
|
|
|
|
L01AD01
|
Carmustine
|
|
|
|
|
|
L01AD02
|
Lomustine
|
|
|
|
|
|
L01AD03
|
Semustine
|
|
|
|
|
|
L01AD04
|
Streptozocin
|
|
|
|
|
|
L01AD05
|
Fotemustine
|
|
|
|
|
|
L01AD06
|
Nimustine
|
|
|
|
|
|
L01AD07
|
Ranimustine
|
|
|
|
|
L01AG
|
|
Epoxides
|
|
|
|
|
|
L01AG01
|
Etoglucid
|
|
|
|
|
L01AX
|
|
Other alkylating agents
|
|
|
|
|
|
L01AX01
|
Mitobronitol
|
|
|
|
|
|
L01AX02
|
Pipobroman
|
|
|
|
|
|
L01AX03
|
Temozolomide
|
|
|
|
|
|
L01AX04
|
Dacarbazine
|
|
|
|
L01B
|
|
|
Antimetabolites
|
|
|
|
|
L01BA
|
|
Folic acid analogues
|
|
|
|
|
|
L01BA01
|
Methotrexate
|
|
|
|
|
|
L01BA03
|
Raltitrexed
|
|
|
|
|
|
L01BA04
|
Pemetrexed
|
|
|
|
|
|
L01BA05
|
Pralatrexate
|
|
|
|
|
L01BB
|
|
Purine analogues
|
|
|
|
|
|
L01BB02
|
Mercaptopurine
|
|
|
|
|
|
L01BB03
|
Tioguanine
|
|
|
|
|
|
L01BB04
|
Cladribine
|
|
|
|
|
|
L01BB05
|
Fludarabine
|
|
|
|
|
|
L01BB06
|
Clofarabine
|
|
|
|
|
|
L01BB07
|
Nelarabine
|
|
|
|
|
L01BC
|
|
Pyrimidine analogues
|
|
|
|
|
|
L01BC01
|
Cytarabine
|
|
|
|
|
|
L01BC02
|
Fluorouracil
|
|
|
|
|
|
L01BC03
|
Tegafur
|
|
|
|
|
|
L01BC04
|
Carmofur
|
|
|
|
|
|
L01BC05
|
Gemcitabine
|
|
|
|
|
|
L01BC06
|
Capecitabine
|
|
|
|
|
|
L01BC07
|
Azacitidine
|
|
|
|
|
|
L01BC08
|
Decitabine
|
|
|
|
|
|
L01BC52
|
Fluorouracil, combinations
|
|
|
|
|
|
L01BC53
|
Tegafur, combinations
|
|
|
|
L01C
|
|
|
Plant alkaloids and other natural products
|
|
|
|
|
L01CA
|
|
Vinca alkaloids and analogues
|
|
|
|
|
|
L01CA01
|
Vinblastine
|
|
|
|
|
|
L01CA02
|
Vincristine
|
|
|
|
|
|
L01CA03
|
Vindesine
|
|
|
|
|
|
L01CA04
|
Vinorelbine
|
|
|
|
|
|
L01CA05
|
Vinflunine
|
|
|
|
|
L01CB
|
|
Podophyllotoxin derivatives
|
|
|
|
|
|
L01CB01
|
Etoposide
|
|
|
|
|
|
L01CB02
|
Teniposide
|
|
|
|
|
L01CC
|
|
Colchicine derivatives
|
|
|
|
|
|
L01CC01
|
Demecolcine
|
|
|
|
|
L01CD
|
|
Taxanes
|
|
|
|
|
|
L01CD01
|
Paclitaxel
|
|
|
|
|
|
L01CD02
|
Docetaxel
|
|
|
|
|
|
L01CD03
|
Paclitaxel poliglumex
|
|
|
|
|
|
L01CD04
|
Cabazitaxel
|
|
|
|
|
L01CX
|
|
Other plant alkaloids and natural products
|
|
|
|
|
|
L01CX01
|
Trabectedin
|
|
|
|
L01D
|
|
|
Cytotoxic antibiotics and related substances
|
|
|
|
|
L01DA
|
|
Actinomycines
|
|
|
|
|
|
L01DA01
|
Dactinomycin
|
|
|
|
|
L01DB
|
|
Anthracyclines and related substances
|
|
|
|
|
|
L01DB01
|
Doxorubicin
|
|
|
|
|
|
L01DB02
|
Daunorubicin
|
|
|
|
|
|
L01DB03
|
Epirubicin
|
|
|
|
|
|
L01DB04
|
Aclarubicin
|
|
|
|
|
|
L01DB05
|
Zorubicin
|
|
|
|
|
|
L01DB06
|
Idarubicin
|
|
|
|
|
|
L01DB07
|
Mitoxantrone
|
|
|
|
|
|
L01DB08
|
Pirarubicin
|
|
|
|
|
|
L01DB09
|
Valrubicin
|
|
|
|
|
|
L01DB10
|
Amrubicin
|
|
|
|
|
|
L01DB11
|
Pixantrone
|
|
|
|
|
L01DC
|
|
Other cytotoxic antibiotics
|
|
|
|
|
|
L01DC01
|
Bleomycin
|
|
|
|
|
|
L01DC02
|
Plicamycin
|
|
|
|
|
|
L01DC03
|
Mitomycin
|
|
|
|
|
|
L01DC04
|
Ixabepilone
|
|
|
|
L01X
|
|
|
Other antineoplastic agents
|
|
|
|
|
L01XA
|
|
Platinum compounds
|
|
|
|
|
|
L01XA01
|
Cisplatin
|
|
|
|
|
|
L01XA02
|
Carboplatin
|
|
|
|
|
|
L01XA03
|
Oxaliplatin
|
|
|
|
|
|
L01XA04
|
Satraplatin
|
|
|
|
|
|
L01XA05
|
Polyplatillen
|
|
|
|
|
L01XB
|
|
Methylhydrazines
|
|
|
|
|
|
L01XB01
|
Procarbazine
|
|
|
|
|
L01XC
|
|
Monoclonal antibodies
|
|
|
|
|
|
L01XC01
|
Edrecolomab
|
|
|
|
|
|
L01XC02
|
Rituximab
|
|
|
|
|
|
L01XC03
|
Trastuzumab
|
|
|
|
|
|
L01XC04
|
Alemtuzumab
|
|
|
|
|
|
L01XC05
|
Gemtuzumab
|
|
|
|
|
|
L01XC06
|
Cetuximab
|
|
|
|
|
|
L01XC07
|
Bevacizumab
|
|
|
|
|
|
L01XC08
|
Panitumumab
|
|
|
|
|
|
L01XC09
|
Catumaxomab
|
|
|
|
|
|
L01XC10
|
Ofatumumab
|
|
|
|
|
|
L01XC11
|
Ipilimumab
|
|
|
|
|
|
L01XC12
|
Brentuximab vedotin
|
|
|
|
|
|
L01XC13
|
Pertuzumab
|
|
|
|
|
L01XD
|
|
Sensitizers used in photodynamic/radiation therapy
|
|
|
|
|
|
L01XD01
|
Porfimer sodium
|
|
|
|
|
|
L01XD03
|
Methyl aminolevulinate
|
|
|
|
|
|
L01XD04
|
Aminolevulinic acid
|
|
|
|
|
|
L01XD05
|
Temoporfin
|
|
|
|
|
|
L01XD06
|
Efaproxiral
|
|
|
|
|
L01XE
|
|
Protein kinase inhibitors
|
|
|
|
|
|
L01XE01
|
Imatinib
|
|
|
|
|
|
L01XE02
|
Gefitinib
|
|
|
|
|
|
L01XE03
|
Erlotinib
|
|
|
|
|
|
L01XE04
|
Sunitinib
|
|
|
|
|
|
L01XE05
|
Sorafenib
|
|
|
|
|
|
L01XE06
|
Dasatinib
|
|
|
|
|
|
L01XE07
|
Lapatinib
|
|
|
|
|
|
L01XE08
|
Nilotinib
|
|
|
|
|
|
L01XE09
|
Temsirolimus
|
|
|
|
|
|
L01XE10
|
Everolimus
|
|
|
|
|
|
L01XE11
|
Pazopanib
|
|
|
|
|
|
L01XE12
|
Vandetanib
|
|
|
|
|
|
L01XE13
|
Afatinib
|
|
|
|
|
|
L01XE14
|
Bosutinib
|
|
|
|
|
|
L01XE15
|
Vemurafenib
|
|
|
|
|
|
L01XE16
|
Crizotinib
|
|
|
|
|
|
L01XE17
|
Axitinib
|
|
|
|
|
|
L01XE18
|
Ruxolitinib
|
|
|
|
|
|
L01XE19
|
Ridaforolimus
|
|
|
|
|
|
L01XE21
|
Regorafenib
|
|
|
|
|
|
L01XE22
|
Masitinib
|
|
|
|
|
L01XX
|
|
Other antineoplastic agents
|
|
|
|
|
|
L01XX01
|
Amsacrine
|
|
|
|
|
|
L01XX02
|
Asparaginase
|
|
|
|
|
|
L01XX03
|
Altretamine
|
|
|
|
|
|
L01XX05
|
Hydroxycarbamide
|
|
|
|
|
|
L01XX07
|
Lonidamine
|
|
|
|
|
|
L01XX08
|
Pentostatin
|
|
|
|
|
|
L01XX09
|
Miltefosine
|
|
|
|
|
|
L01XX10
|
Masoprocol
|
|
|
|
|
|
L01XX11
|
Estramustine
|
|
|
|
|
|
L01XX14
|
Tretinoin
|
|
|
|
|
|
L01XX16
|
Mitoguazone
|
|
|
|
|
|
L01XX17
|
Topotecan
|
|
|
|
|
|
L01XX18
|
Tiazofurine
|
|
|
|
|
|
L01XX19
|
Irinotecan
|
|
|
|
|
|
L01XX22
|
Alitretinoin
|
|
|
|
|
|
L01XX23
|
Mitotane
|
|
|
|
|
|
L01XX24
|
Pegaspargase
|
|
|
|
|
|
L01XX25
|
Bexarotene
|
|
|
|
|
|
L01XX27
|
Arsenic trioxide
|
|
|
|
|
|
L01XX29
|
Denileukin diftitox
|
|
|
|
|
|
L01XX32
|
Bortezomib
|
|
|
|
|
|
L01XX33
|
Celecoxib
|
|
|
|
|
|
L01XX35
|
Anagrelide
|
|
|
|
|
|
L01XX36
|
Oblimersen
|
|
|
|
|
|
L01XX37
|
Sitimagene ceradenovec
|
|
|
|
|
|
L01XX38
|
Vorinostat
|
|
|
|
|
|
L01XX39
|
Romidepsin
|
|
|
|
|
|
L01XX40
|
Omacetaxine mepesuccinate
|
|
|
|
|
|
L01XX41
|
Eribulin
|
|
|
|
|
|
L01XX42
|
Panobinostat
|
|
|
|
|
|
L01XX43
|
Vismodegib
|
|
|
|
|
L01XY
|
|
Combinations of antineoplastic agents
|
|
|
|
|
|
|
EMPTY
|
|
|
L02
|
|
|
|
Endocrine therapy
|
|
|
L03
|
|
|
|
Immunostimulants
|
|
|
L04
|
|
|
|
Immunosuppressants
|
| M
|
|
|
|
|
Musculo-skeletal system
|
|
|
M01
|
|
|
|
Anti-inflammatory and antirheumatic products
|
|
|
|
M01A
|
|
|
Anti-inflammatory and antirheumatic products, non-steroids
|
|
|
|
|
M01AA
|
|
Butylpyrazolidines
|
|
|
|
|
M01AB
|
|
Acetic acid derivatives and related substances
|
|
|
|
|
|
M01AB01
|
Indometacin
|
|
|
|
|
|
M01AB02
|
Sulindac
|
|
|
|
|
|
M01AB03
|
Tolmetin
|
|
|
|
|
|
M01AB04
|
Zomepirac
|
|
|
|
|
|
M01AB05
|
Diclofenac
|
|
|
|
|
|
M01AB06
|
Alclofenac
|
|
|
|
|
|
M01AB07
|
Bumadizone
|
|
|
|
|
|
M01AB08
|
Etodolac
|
|
|
|
|
|
M01AB09
|
Lonazolac
|
|
|
|
|
|
M01AB10
|
Fentiazac
|
|
|
|
|
|
M01AB11
|
Acemetacin
|
|
|
|
|
|
M01AB12
|
Difenpiramide
|
|
|
|
|
|
M01AB13
|
Oxametacin
|
|
|
|
|
|
M01AB14
|
Proglumetacin
|
|
|
|
|
|
M01AB15
|
Ketorolac
|
|
|
|
|
|
M01AB16
|
Aceclofenac
|
|
|
|
|
|
M01AB17
|
Bufexamac
|
|
|
|
|
|
M01AB51
|
Indometacin, combinations
|
|
|
|
|
|
M01AB55
|
Diclofenac, combinations
|
|
|
|
|
M01AC
|
|
Oxicams
|
|
|
|
|
M01AE
|
|
Propionic acid derivatives
|
|
|
|
|
M01AG
|
|
Fenamates
|
|
|
|
|
M01AH
|
|
Coxibs
|
|
|
|
|
M01AX
|
|
Other anti-inflammatory and antirheumatic agents, non-steroids
|
|
|
|
|
|
M01AX01
|
Nabumetone
|
|
|
|
|
|
M01AX02
|
Niflumic acid
|
|
|
|
|
|
M01AX04
|
Azapropazone
|
|
|
|
|
|
M01AX05
|
Glucosamine
|
|
|
|
|
|
M01AX07
|
Benzydamine
|
|
|
|
|
|
M01AX12
|
Glucosaminoglycan polysulfate
|
|
|
|
|
|
M01AX13
|
Proquazone
|
|
|
|
|
|
M01AX14
|
Orgotein
|
|
|
|
|
|
M01AX17
|
Nimesulide
|
|
|
|
|
|
M01AX18
|
Feprazone
|
|
|
|
|
|
M01AX21
|
Diacerein
|
|
|
|
|
|
M01AX22
|
Morniflumate
|
|
|
|
|
|
M01AX23
|
Tenidap
|
|
|
|
|
|
M01AX24
|
Oxaceprol
|
|
|
|
|
|
M01AX25
|
Chondroitin sulfate
|
|
|
|
|
|
M01AX26
|
Avocado and soyabean oil, unsaponifiables
|
|
|
|
|
|
M01AX68
|
Feprazone, combinations
|
|
|
|
M01B
|
|
|
Anti-inflammatory/antirheumatic agents in combination
|
|
|
|
M01C
|
|
|
Specific antirheumatic agents
|
|
|
M02
|
|
|
|
Topical products for joint and muscular pain
|
|
|
|
M02A
|
|
|
Topical products for joint and muscular pain
|
|
|
|
|
M02AA
|
|
Anti-inflammatory preparations, non-steroids for topical use
|
|
|
|
|
|
M02AA01
|
Phenylbutazone
|
|
|
|
|
|
M02AA02
|
Mofebutazone
|
|
|
|
|
|
M02AA03
|
Clofezone
|
|
|
|
|
|
M02AA04
|
Oxyphenbutazone
|
|
|
|
|
|
M02AA05
|
Benzydamine
|
|
|
|
|
|
M02AA06
|
Etofenamate
|
|
|
|
|
|
M02AA07
|
Piroxicam
|
|
|
|
|
|
M02AA08
|
Felbinac
|
|
|
|
|
|
M02AA09
|
Bufexamac
|
|
|
|
|
|
M02AA10
|
Ketoprofen
|
|
|
|
|
|
M02AA11
|
Bendazac
|
|
|
|
|
|
M02AA12
|
Naproxen
|
|
|
|
|
|
M02AA13
|
Ibuprofen
|
|
|
|
|
|
M02AA14
|
Fentiazac
|
|
|
|
|
|
M02AA15
|
Diclofenac
|
|
|
|
|
|
M02AA16
|
Feprazone
|
|
|
|
|
|
M02AA17
|
Niflumic acid
|
|
|
|
|
|
M02AA18
|
Meclofenamic acid
|
|
|
|
|
|
M02AA19
|
Flurbiprofen
|
|
|
|
|
|
M02AA21
|
Tolmetin
|
|
|
|
|
|
M02AA22
|
Suxibuzone
|
|
|
|
|
|
M02AA23
|
Indometacin
|
|
|
|
|
|
M02AA24
|
Nifenazone
|
|
|
|
|
|
M02AA25
|
Aceclofenac
|
|
|
|
|
|
M02AA26
|
Nimesulide
|
|
|
|
|
M02AB
|
|
Capsaicin and similar agents
|
|
|
|
|
M02AC
|
|
Preparations with salicylic acid derivatives
|
|
|
|
|
M02AX
|
|
Other topical products for joint and muscular pain
|
|
|
M03
|
|
|
|
Muscle relaxants
|
|
|
M04
|
|
|
|
Antigout preparations
|
|
|
M05
|
|
|
|
Drugs for treatment of bone diseases
|
|
|
M09
|
|
|
|
Other drugs for disorders of the musculo-skeletal system
|
| N
|
|
|
|
|
Nervous system
|
|
|
N01
|
|
|
|
Anesthetics
|
|
|
N02
|
|
|
|
Analgesics
|
|
|
N03
|
|
|
|
Antiepileptics
|
|
|
N04
|
|
|
|
Anti-parkinson drugs
|
|
|
N05
|
|
|
|
Psycholeptics
|
|
|
|
N05A
|
|
|
Antipsychotics
|
|
|
|
|
N05AA
|
|
Phenothiazines with aliphatic side-chain
|
|
|
|
|
N05AB
|
|
Phenothiazines with piperazine structure
|
|
|
|
|
N05AC
|
|
Phenothiazines with piperidine structure
|
|
|
|
|
N05AD
|
|
Butyrophenone derivatives
|
|
|
|
|
N05AE
|
|
Indole derivatives
|
|
|
|
|
N05AF
|
|
Thioxanthene derivative
|
|
|
|
|
N05AG
|
|
Diphenylbutylpiperidine derivatives
|
|
|
|
|
N05AH
|
|
Diazepines, oxazepines, thiazepines and oxepines
|
|
|
|
|
N05AL
|
|
Benzamides
|
|
|
|
|
N05AN
|
|
Lithium
|
|
|
|
|
N05AX
|
|
Other antipsychotics
|
|
|
|
|
|
N05AX07
|
Prothipendyl
|
|
|
|
|
|
N05AX08
|
Risperidone
|
|
|
|
|
|
N05AX10
|
Mosapramine
|
|
|
|
|
|
N05AX11
|
Zotepine
|
|
|
|
|
|
N05AX12
|
Aripiprazole
|
|
|
|
|
|
N05AX13
|
Paliperidone
|
|
|
|
|
|
N05AX14
|
Iloperidone
|
|
|
|
N05B
|
|
|
Anxiolytics
|
|
|
|
|
N05BA
|
|
Benzodiazepine derivatives
|
|
|
|
|
|
|
להשלים
|
|
|
|
N05C
|
|
|
Hypnotics and sedatives
|
|
|
N06
|
|
|
|
Psychoanaleptics
|
|
|
|
N06A
|
|
|
Antidepressants
|
|
|
|
|
N06AA
|
|
Non-selective monoamine reuptake inhibitors
|
|
|
|
|
|
N06AA01
|
Desipramine
|
|
|
|
|
|
N06AA02
|
Imipramine
|
|
|
|
|
|
N06AA03
|
Imipramine oxide
|
|
|
|
|
|
N06AA04
|
Clomipramine
|
|
|
|
|
|
N06AA05
|
Opipramol
|
|
|
|
|
|
N06AA06
|
Trimipramine
|
|
|
|
|
|
N06AA07
|
Lofepramine
|
|
|
|
|
|
N06AA08
|
Dibenzepin
|
|
|
|
|
|
N06AA09
|
Amitriptyline
|
|
|
|
|
|
N06AA10
|
Nortriptyline
|
|
|
|
|
|
N06AA11
|
Protriptyline
|
|
|
|
|
|
N06AA12
|
Doxepin
|
|
|
|
|
|
N06AA13
|
Iprindole
|
|
|
|
|
|
N06AA14
|
Melitracen
|
|
|
|
|
|
N06AA15
|
Butriptyline
|
|
|
|
|
|
N06AA16
|
Dosulepin
|
|
|
|
|
|
N06AA17
|
Amoxapine
|
|
|
|
|
|
N06AA18
|
Dimetacrine
|
|
|
|
|
|
N06AA19
|
Amineptine
|
|
|
|
|
|
N06AA21
|
Maprotiline
|
|
|
|
|
|
N06AA23
|
Quinupramine
|
|
|
|
|
N06AB
|
|
Selective serotonin reuptake inhibitors
|
|
|
|
|
|
N06AB02
|
Zimelidine
|
|
|
|
|
|
N06AB03
|
Fluoxetine
|
|
|
|
|
|
N06AB04
|
Citalopram
|
|
|
|
|
|
N06AB05
|
Paroxetine
|
|
|
|
|
|
N06AB06
|
Sertraline
|
|
|
|
|
|
N06AB07
|
Alaproclate
|
|
|
|
|
|
N06AB08
|
Fluvoxamine
|
|
|
|
|
|
N06AB09
|
Etoperidone
|
|
|
|
|
|
N06AB10
|
Escitalopram
|
|
|
|
|
N06AF
|
|
Monoamine oxidase inhibitors, non-selective
|
|
|
|
|
|
N06AF01
|
Isocarboxazid
|
|
|
|
|
|
N06AF02
|
Nialamide
|
|
|
|
|
|
N06AF03
|
Phenelzine
|
|
|
|
|
|
N06AF04
|
Tranylcypromine
|
|
|
|
|
|
N06AF05
|
Iproniazide
|
|
|
|
|
|
N06AF06
|
Iproclozide
|
|
|
|
|
N06AG
|
|
Monoamine oxidase A inhibitors
|
|
|
|
|
|
N06AG02
|
Moclobemide
|
|
|
|
|
|
N06AG03
|
Toloxatone
|
|
|
|
|
N06AX
|
|
Other antidepressants
|
|
|
|
|
|
N06AX01
|
Oxitriptan
|
|
|
|
|
|
N06AX02
|
Tryptophan
|
|
|
|
|
|
N06AX03
|
Mianserin
|
|
|
|
|
|
N06AX04
|
Nomifensine
|
|
|
|
|
|
N06AX05
|
Trazodone
|
|
|
|
|
|
N06AX06
|
Nefazodone
|
|
|
|
|
|
N06AX07
|
Minaprine
|
|
|
|
|
|
N06AX08
|
Bifemelane
|
|
|
|
|
|
N06AX09
|
Viloxazine
|
|
|
|
|
|
N06AX10
|
Oxaflozane
|
|
|
|
|
|
N06AX11
|
Mirtazapine
|
|
|
|
|
|
N06AX12
|
Bupropion
|
|
|
|
|
|
N06AX13
|
Medifoxamine
|
|
|
|
|
|
N06AX14
|
Tianeptine
|
|
|
|
|
|
N06AX15
|
Pivagabine
|
|
|
|
|
|
N06AX16
|
Venlafaxine
|
|
|
|
|
|
N06AX17
|
Milnacipran
|
|
|
|
|
|
N06AX18
|
Reboxetine
|
|
|
|
|
|
N06AX19
|
Gepirone
|
|
|
|
|
|
N06AX21
|
Duloxetine
|
|
|
|
|
|
N06AX22
|
Agomelatine
|
|
|
|
|
|
N06AX23
|
Desvenlafaxine
|
|
|
|
|
|
N06AX24
|
Vilazodone
|
|
|
|
|
|
N06AX25
|
Hyperici herba
|
|
|
|
|
|
N06AX26
|
Vortioxetine (proposed code)
|
|
|
|
N06B
|
|
|
Psychostimulants, agents used for ADHD and nootropics
|
|
|
|
|
N06BA
|
|
Centrally acting sympathomimetics
|
|
|
|
|
|
N06BA01
|
Amphetamine
|
|
|
|
|
|
N06BA02
|
Dexamphetamine
|
|
|
|
|
|
N06BA03
|
Dextromethamphetamine
|
|
|
|
|
|
N06BA04
|
Methylphenidate
|
|
|
|
|
|
N06BA05
|
Pemoline
|
|
|
|
|
|
N06BA06
|
Fencamfamin
|
|
|
|
|
|
N06BA07
|
Modafinil
|
|
|
|
|
|
N06BA08
|
Fenozolone
|
|
|
|
|
|
N06BA09
|
Atomoxetine
|
|
|
|
|
|
N06BA10
|
Fenetylline
|
|
|
|
|
|
N06BA11
|
Dexmethylphenidate
|
|
|
|
|
|
N06BA12
|
Lisdexamfetamine
|
|
|
|
|
N06BC
|
|
Xanthine derivatives
|
|
|
|
|
|
N06BC01
|
Caffeine
|
|
|
|
|
|
N06BC02
|
Propentofylline
|
|
|
|
|
N06BX
|
|
Other psychostimulants and nootropics
|
|
|
|
|
|
N06BX01
|
Meclofenoxate
|
|
|
|
|
|
N06BX02
|
Pyritinol
|
|
|
|
|
|
N06BX03
|
Piracetam
|
|
|
|
|
|
N06BX04
|
Deanol
|
|
|
|
|
|
N06BX05
|
Fipexide
|
|
|
|
|
|
N06BX06
|
Citicoline
|
|
|
|
|
|
N06BX07
|
Oxiracetam
|
|
|
|
|
|
N06BX08
|
Pirisudanol
|
|
|
|
|
|
N06BX09
|
Linopirdine
|
|
|
|
|
|
N06BX10
|
Nizofenone
|
|
|
|
|
|
N06BX11
|
Aniracetam
|
|
|
|
|
|
N06BX12
|
Acetylcarnitine
|
|
|
|
|
|
N06BX13
|
Idebenone
|
|
|
|
|
|
N06BX14
|
Prolintane
|
|
|
|
|
|
N06BX15
|
Pipradrol
|
|
|
|
|
|
N06BX16
|
Pramiracetam
|
|
|
|
|
|
N06BX17
|
Adrafinil
|
|
|
|
|
|
N06BX18
|
Vinpocetine
|
|
|
|
N06C
|
|
|
Psycholeptics and psychoanaleptics in combination
|
|
|
|
|
N06CA
|
|
Antidepressants in combination with psycholeptics
|
|
|
|
|
|
N06CA01
|
Amitriptyline and psycholeptics
|
|
|
|
|
|
N06CA02
|
Melitracen and psycholeptics
|
|
|
|
|
|
N06CA03
|
Fluoxetine and psycholeptics
|
|
|
|
|
N06CB
|
|
Psychostimulants in combination with psycholeptics
|
|
|
|
|
|
|
empty
|
|
|
|
N06D
|
|
|
Anti-dementia drugs
|
|
|
|
|
N06DA
|
|
Anticholinesterases
|
|
|
|
|
|
N06DA01
|
Tacrine
|
|
|
|
|
|
N06DA02
|
Donepezil
|
|
|
|
|
|
N06DA03
|
Rivastigmine
|
|
|
|
|
|
N06DA04
|
Galantamine
|
|
|
|
|
|
N06DA52
|
Donepezil and memantine
|
|
|
|
|
N06DX
|
|
Other anti-dementia drugs
|
|
|
|
|
|
N06DX01
|
Memantine
|
|
|
|
|
|
N06DX02
|
Ginkgo folium
|
|
|
N07
|
|
|
|
Other nervous system drugs
|
| P
|
|
|
|
|
Antiparasitic products, insecticides and repellents
|
|
|
P01
|
|
|
|
Antiprotozoals
|
|
|
P02
|
|
|
|
Anthelmintics
|
|
|
P03
|
|
|
|
Ectoparasiticides, including scabicides, insecticides and repellents
|
| R
|
|
|
|
|
Respiratory system
|
|
|
R01
|
|
|
|
Nasal preparations
|
|
|
R02
|
|
|
|
Throat preparations
|
|
|
R03
|
|
|
|
Drugs for obstructive airway diseases
|
|
|
R05
|
|
|
|
Cough and cold preparations
|
|
|
R06
|
|
|
|
Antihistamines for systemic use
|
|
|
R07
|
|
|
|
Other respiratory system products
|
| S
|
|
|
|
|
Sensory organs
|
|
|
S01
|
|
|
|
Ophthalmologicals
|
|
|
S02
|
|
|
|
Otologicals
|
|
|
S03
|
|
|
|
Ophthalmological and otological preparations
|
| V
|
|
|
|
|
Various
|
|
|
V01
|
|
|
|
Allergens
|
|
|
V03
|
|
|
|
All other therapeutic products
|
|
|
V04
|
|
|
|
Diagnostic agents
|
|
|
V06
|
|
|
|
General nutrients
|
|
|
V07
|
|
|
|
All other non-therapeutic products
|
|
|
V08
|
|
|
|
Contrast media
|
|
|
V09
|
|
|
|
Diagnostic radiopharmaceuticals
|
|
|
V10
|
|
|
|
Therapeutic radiopharmaceuticals
|
|
|
V20
|
|
|
|
Surgical dressings
|
כניסה 
עקבו אחרינו בפייסבוק